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Mycoplasma gallisepticum (MG), a respiratory pathogen of poultry, was first documented as a 
cause of conjunctivitis in free-living house finches (Haemorhous, formerly Carpodacus, 
mexicanus) in 1994. This work explores virulence and immunogenicity of several isolates of MG 
collected from free-living house finches, and provides evidence that individual birds can have 
very different courses of disease when experimentally inoculated with the same dose of MG. 
 A quantitative PCR assay utilizing the mgc2 gene was developed to quantify MG in 
conjunctival swab samples. To measure house finch lachrymal antibody response, a polyclonal 
reagent was developed to detect house finch IgA. A region of house finch IgA heavy chain was 
PCR-amplified from spleen cDNA, the heavy chain fragment was produced using a bacterial 
expression system, and rabbit anti-sera were generated against the recombinant protein.  
 House finches were inoculated with MG isolates Virginia (VA)1994, California 
(CA)2006, or North Carolina (NC)2006, which were isolated from free-living house finches with 
conjunctivitis in 1994, 2006, and 2006, respectively. Infection with NC2006 resulted in the most 
severe eye lesions, highest pathogen loads, and highest levels of MG-specific lachrymal and 
serum antibodies. Infection with CA2006 caused the least severe eye lesions, lowest pathogen 
load, and weakest antibody response. A small number of birds in each group developed 
protracted, severe disease in spite of robust antibody responses. Immunoblot analyses indicated 
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that isolates are antigenically similar, suggesting that there may be partial cross-protection if a 
house finch encounters two or more strains of MG throughout the course of its lifetime.   
 Chronic disease was further studied with experimental inoculations of house finches 
using VA1994 and North Carolina (NC1995, NC1996, NC2006, NC2008) field isolates. After 
inoculation, birds with chronic disease had significantly higher pathogen loads and antibody 
responses than did birds with acute disease. Using a monoclonal antibody specific for a variant 
of MG VlhA immunodominant surface protein, I show that VlhA expression differs among MG 
isolates studied, and that in vivo VlhA changes occur in house finches infected with MG. The 
results provide evidence that chronic MG disease has both pathogen-mediated and 
immunopathologic components. 
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Bacteria of the genus Mycoplasma cause a range of diseases in both humans and veterinary 
species. These bacteria lack a cell wall, have tiny genomes, and several species are known for 
causing chronic infection in spite of a robust host immune response. In veterinary species, these 
bacteria are often incompletely cleared by antibiotic therapy, and hosts may still harbor the 
organism and may continue to have clinical signs during or after antibiotic therapy (e.g., Bebear 
and Kempf 2005, Donnelly 2004). 
Mycoplasma gallisepticum (MG) is well known for causing acute and chronic respiratory 
disease in chickens and infectious sinusitis in turkeys (Ley 2003). In 1994, MG was documented 
in a novel host, the house finch (Haemorhous, formerly	  Carpodacus, mexicanus) (Ley et al. 
1996). In this species, MG causes predominately conjunctivitis, with respiratory signs being 
much less common compared to infection in poultry. Since its introduction into free-living house 
finch populations, conjunctivitis and positive serum plate agglutination tests have less commonly 
been documented in other songbirds, most notably American goldfinches (Carduelis tristis) and 
purple finches (Carpodacus purpureus) (Hartup et al. 2000, Hartup et al. 2001). 
MG infection in chickens has been subject to much research due to the major economic 
impact of the disease on the poultry industry globally. Strains of MG isolated from commercial 
poultry are quite variable with respect to pathogenicity, transmissibility, and immunogenicity in 
chickens and turkeys (Rodriguez and Kleven 1980, Sanei et al. 2007). While some variations at 
the genomic level have been documented among MG isolates from house finches (Pillai et al. 
2003, Tulman et al. 2012), there has only been one report suggesting differences in pathogenicity 
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based on experimental infections under controlled conditions (Hawley et al. 2010). One goal of 
this work is to examine if circulating house finch “strains” of MG differ in pathogenicity and 
immunogenicity.  
Additionally, previous studies (Kollias et al. 2004, Roberts et al. 2001, Sydenstricker et 
al. 2005) have shown that house finches experimentally infected with the same inoculum dose 
can develop different courses of disease. A small percentage of finches tend to develop severe, 
protracted disease. Another goal of this work is to examine if pathogen load and antibody 
profiles (serum and tear antibodies) of finches that show “acute” disease differ from finches that 
show “chronic” disease. 
Prior to this work, little was known about the house finch antibody response to MG, since 
there is a lack of commercially available products to facilitate this research. Very few reagents 
have been developed to detect immunoglobulins of passerine birds, and monoclonal antibodies 
developed against chicken immunoglobulins often show poor cross-reactivity with those of other 
avian species, especially to those distantly related to the chicken (Jeurissen and Janse 1998, for 
review see Schultz and Magor 2008). This work describes the development of a polyclonal 
reagent that is specific for house finch IgA and uses the reagent to characterize the local 
(lachrymal) antibody response to MG (Chapters 5, 6, 7). 
It is speculated that MG varies cell surface antigens in order to escape the host antibody 
response. It has been demonstrated both in vitro and in vivo (in the chicken) that MG has the 
ability to vary cell surface proteins, most notably, the VlhA lipoprotein. A large multi-gene 
family is responsible for encoding the protein, and one gene is expressed at a time. Implicated 
functions of the VlhA protein include adherence, hemagglutination, and escaping the host 
antibodies (Citti et al. 2005). The ability to vary surface proteins is not unique to MG. M. 
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synoviae and M. imitans, pathogens of poultry, also have multi-gene families thought to be 
homologous to the MG VlhA. There is genetic sequence similarity between the vlhA genes of 
MG and M. synoviae; however, in M. synoviae, only a single copy of the complete vlhA gene 
exists in the genome and all others are pseudogenes and in MG, all or most genes are 
translationally competent (Bencina 2002). 
VlhA protein expression differs among poultry isolates of MG (Glew et al. 1995). 
Another objective of this thesis is to determine if circulating house finch MG strains also differ 
in VlhA expression. Additionally, in vivo variation in VlhA expression is studied in house 
finches experimentally inoculated with MG, with particular emphasis on birds that show chronic 
or severe disease. 
Chapter 2 provides a literature review on relevant topics to this thesis, including an 
overview of the genus Mycoplasma, mycoplasmosis in poultry and other birds, chicken immune 
response to MG, VlhA variation, and the role of the avian Harderian gland in immune defense of 
the eye. Thesis goals are listed at the end of chapter 2, and chapter 3 provides an overview of the 
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CHAPTER 2 
Literature review 
2.1. Pathogen and host 
2.1.1. The genus Mycoplasma  
Members of the genus Mycoplasma belong to the Class Mollicutes (molis – “soft”; cutis – 
“skin”). Mycoplasma species lack a cell wall and have small genomes. Also unique to 
Mycoplasma and some other members of the Mollicutes is the presence of cholesterol in the 
plasma membrane (Razin 1998). Mycoplasma species are parasites of plants, arthropods, fish, 
reptiles, birds, humans, and other mammals. Though they are widespread pathogens, they often 
have strict host and tissue specificity. As a whole, these organisms are often difficult to culture, 
likely due to their dependence on many exogenous nutrients or the presence of unknown 
inhibitory substances in cultures (Razin 1998). 
 Mycoplasmas typically infect mucosal surfaces such as the respiratory and urogenital 
tracts, eyes, mammary gland, and joints. Three of the most common human pathogens include 
M. pneumoniae, a respiratory pathogen, and M. hominis and M. genitalium, primarily pathogens 
of the urogenital tract (Waites and Talkington 2005).  
There are numerous Mycoplasma species that infect animals. Mycoplasma species are 
important respiratory pathogens of cattle, causing pneumonia (M. bovis) and contagious bovine 
pleuropneumonia (M. mycoides mycoides small colony type). M. capricolum capripneumoniae is 
the cause of contagious caprine pleuropneumonia, a highly fatal disease of goats in Europe, 
Africa, and Asia. There are several other species of Mycoplasma causing pneumonia in small 
ruminants (M. mycoides capri and M. mycoides mycoides large colony type) and pigs (M. 
hyopneumoniae). In rats, M. pulmonis is an agent that contributes to chronic respiratory disease, 
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a condition that is often poorly responsive to antibiotic therapy (Donnelly 2004). There are also 
several hemotropic mycoplasmas infecting veterinary species that can cause anemia (e.g., dogs – 
M. haemocanis, cats – M. haemofelis, pigs – M. suis, cattle – M. wenyonii, sheep/goats – M. ovis) 
(Kahn 2010). The avian mycoplasmas will be discussed in the following sections.  
 
2.1.2. Mycoplasmosis in birds 
Approximately 23 species of Mycoplasma are known to infect birds. Most of these species have 
been found in poultry, although 17 are also found in free-living birds, and 5 species have only 
been identified in free-living avian species (Luttrell and Fischer 2007).  
Mycoplasmosis in poultry has been well studied due to the significant agricultural and 
economical impacts of the diseases. Four species are commonly found as poultry pathogens, 
including M. gallisepticum, M. synoviae, M. meleagridis, and M. iowae. M. gallisepticum is the 
most economically important and is discussed in detail in section 2.1.3. M. synoviae typically 
infects chickens and turkeys and causes synovitis or respiratory disease. M. meleagridis causes 
respiratory disease, skeletal abnormalities, and decreased growth in turkeys. M. iowae is a cause 
of embryonic mortality in turkeys (Kleven 1998a, Kleven 1998b).  
 M. gallisepticum and M. sturni cause conjunctivitis in North American passerines; M. 
gallisepticum is most common in finches and M. sturni has been identified in European starlings 
(Sturnus vulgaris), Northern mockingbirds (Mimus polyglottos), blue jays (Cyanocitta cristata), 
American crows (Corvus brachyrhynchos), and American robins (Turdus migratorius) (Forsyth 
et al. 1996, Ley et al. 1998, Wellehan et al. 2001). Three species of Mycoplasma have also been 
isolated from European raptors with respiratory disease, including M. buteonis from common 
buzzards (Buteo buteo), M. falconis from saker falcons (Falco cherrug) and M. gypis from 
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griffon vultures (Gyps fulvus) (Poveda et al. 1994). Other species of Mycoplasma have been 
isolated from free-living birds, including turkeys, ducks, and pigeons (Luttell and Fischer 2007).  
    
2.1.3. Mycoplasma gallisepticum infection in poultry 
M. gallisepticum (MG) is a cause of chronic respiratory disease in chickens and turkeys 
characterized by coughing, nasal discharge, and conjunctivitis (Ley 2003). It can also cause 
severe airsacculitis, especially in conjunction with other bacterial infections (such as Escherichia 
coli) and viral infections (such as infectious bronchitis or Newcastle disease). Weight loss and 
decreased egg production are common during infection. Salpingitis and encephalitis can also 
occur, though less commonly. Serologically positive flocks may also show few, if any, clinical 
signs. Turkeys tend to develop more severe clinical signs than chickens, including sinusitis, 
respiratory distress, depression, and weight loss. Infection can last for months in flocks if 
untreated. Disease tends to be more severe and protracted in colder months and in younger birds 
(Ley 2003). 
 On necropsy, gross lesions often include exudate in the nasal passages, trachea, bronchi, 
and air sacs, and sometimes pneumonia. Microscopic lesions include thickening of mucous 
membranes associated with infiltration of mononuclear cells (often predominantly lymphocytes 
and plasma cells) and hyperplasia of glands. Destruction of cilia can be observed in the trachea 
(Ley 2003). MG antigen can be detected by immunohistochemistry in the trachea, conjunctiva, 
nasal turbinates, and air sacs of experimentally inoculated chickens (Gharaibeh and Hailat 2011).  
 MG transmission occurs via aerosol or droplets associated with direct or indirect contact 
and via fomites (such as dust, feathers, and farm personnel). Vertical transmission can also 
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occur, especially when infected individuals are laying eggs during the acute phase of the disease 
(Ley 2003, Lin and Kleven 1982). 
It is thought that MG resides on the surface of the respiratory tract and conjunctiva, 
although systemic infection can occur, resulting in spread to other organs such as the brain (e.g., 
Chin et al. 1991). In vitro and in vivo studies suggest that MG can adhere to and invade 
nonphagocytic cells (Winner et al. 2000, Vogl et al. 2008), which may encourage systemic 
spread and also allow the organism to evade the host immune system via an intracellular route.  
 Management of MG in poultry flocks involves establishment of MG-free breeder flocks, 
use of vaccines, and use of antimicrobial drugs. Both bacterins and live vaccines have been used 
in the past. Currently, a modified live 6/85 strain of MG is commercially available (Intervet, 
Millsboro, DE), and is administered via aerosol route (spray). Another commercially available 
vaccine is a modified live ts-11 strain (Bioproperties, Ringwood, Australia), and is administered 
via eye-drop route. MG is sensitive to macrolides, tetracyclines, and fluoroquinolones. More 
commonly used flock treatments include oxytetracycline or chlortetracycline in the feed and 
tylosin administered in the drinking water (Ley 2003).  
 
2.1.4. Overview of Mycoplasma gallisepticum in house finches   
Historically, house finches (Haemorhous, formerly Carpodacus, mexicanus) were distributed 
along the western half of North America. A number of captive house finches were introduced to 
Long Island, NY in the 1940s, and from that time, the population spread successfully throughout 
the east coast. House finches commonly take advantage of bird feeders and have a preference for 
human-modified landscapes (Elliot and Arbib 1953, Hill 1993) 
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In early 1994, Mycoplasma gallisepticum (MG) emerged in free-living house finches in 
Maryland and Virginia and subsequently spread throughout the eastern parts of the United States, 
causing major declines throughout the introduced population of the species (Hochachka and 
Dhondt 2000). In 2002, the disease was documented in Montana, part of the native range of the 
species, and reached Oregon by 2004 (Ley et al. 2006). In the native western population, the 
epidemic has progressed more slowly, with lower prevalence levels than in eastern populations 
(Dhondt et al. 2006). It is thought that the disease is transmitted via direct contact (Ley 2003) 
and by fomites (e.g., birdfeeders) (Dhondt et al. 2007a). 
The clinical signs of infection in house finches usually include unilateral or bilateral 
conjunctivitis. In house finches inoculated ocularly with MG, signs of conjunctivitis, sometimes 
in addition to rhinitis, begin between two and six days post-infection. All infected birds remain 
MG-positive by PCR for up to three weeks post-infection, and some remain PCR positive with 
clinical signs for greater than twenty-one weeks (Kollias et al. 2004). Interestingly, Davis (2010) 
documented a left-bias pattern in free-living house finches with conjunctivitis, that is, left eyes 
tend to have more severe conjunctivitis than right eyes. This pattern was speculated to be due to 
an inherent “handedness” in the finches, or preference to turn their head to a specific (left) side, 
leading to increased fomite exposure on that side of the head.  
 
2.1.5. M. gallisepticum infection in other bird species 
Experimentally infected house sparrows (Passer domesticus) show either no clinical signs or 
short-lived mild conjunctivitis (Dhondt et al. 2008). Eight out of ten experimentally infected 
American goldfinches (Carduelis tristis) developed clinical signs. Goldfinches may serve as 
	   9 	  
asymptomatic carriers for MG since they tend to clear clinical signs but remain infectious 
(Dhondt et al. 2008, Dhondt et al. 2013). 
 Farmer et al. (2005) found that clinical signs were not apparent in house sparrows, 
chipping sparrows (Spizella passerine), zebra finches (Taeniopygia guttata) and budgerigars 
(Melopsittacus undulates) after infection with MG. Though they could not detect clinical signs, 
choanal samples of the birds taken after infection were positive for MG in all but the chipping 
sparrows.  
 
2.1.6. Variations in clinical disease   
Although challenged with identical doses of MG, experimentally infected house finches exhibit 
variations in disease progression, such as onset of conjunctivitis, the severity of conjunctivitis, 
and duration of clinical disease (Kollias et al. 2004, Sydenstricker et al. 2005). Roberts et al. 
(2001) found that 73% of infected house finches developed acute, self-limiting conjunctivitis 
while the remaining 27% suffered from chronic disease and had a higher mortality rate. The 
reasons chronic disease only occurs in a fraction of individuals are unclear. 
 
2.1.7. Methods of detecting M. gallisepticum infection in house finches prior to my research 
In house finches, PCR was used to detect MG in conjunctival swab samples. The conventional 
PCR assay was designed for detection of MG in poultry samples using the 16S rRNA gene of 
MG (Garcia et al. 2005, Lauerman 1998). A commercially available serum plate agglutination 
test (Intervet, Millsboro, DE) was used to screen for presence of MG-specific antibodies in the 
serum (Kleven 1998b). Eye lesions are scored for a measure of disease state. This is a visual 
measure based on a score from 0 to 3, with 0 being a normal eye and 3 representing discoloration 
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of the conjunctiva, severe edema of the conjunctiva, supraorbital area, and infraorbital sinus, 
epiphora and feather matting (Sydenstricker et al. 2005). 
 
2.2. Immunology  
2.2.1. Immunological responses during Mycoplasma infection 
Mycoplasma species are known for their ability to cause chronic disease while persisting in their 
hosts in spite of very active immune responses directed against them. Apparently ineffective 
immune responses lead to the immunopathologic lesions often observed during mycoplasmal 
infections (e.g., Cartner et al. 1998, see Simecka 2005 for review). Even after recovery from 
disease, chickens may remain as carriers of MG for many months (Bencina and Dorrer 1984). 
Early studies on the immune response of chickens to MG suggest that resistance is 
mediated by immunoglobulins, since bursectomized chickens show increased susceptibility to 
infection (Alder et al. 1973, Lam and Lin 1984). Earlier studies also noted that there is little 
correlation between serum immunoglobulin levels and immunity (e.g., Talkington and Kleven 
1985) and various studies have provided evidence that local immunity plays an important role 
during MG infection. Yagihashi and Tajima (1986) found that antibody titers in tracheal 
washings of infected chickens increased during the three weeks post-infection and this increase 
was correlated with decreasing tracheal inflammatory lesions. Re-exposed chickens recovered 
faster and had less severe lesions. Chhabra and Goel (1980) found that regression of lesions was 
correlated with peak antibody response in sera and tracheal washings. Avakian and Kleven 
(1990) found that chickens infected with MG responded with antibodies to over twenty proteins, 
determined by western blot. Avakian and Ley (1993) further demonstrated the role of local 
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immune response by using in vitro assays to show that tracheal washings from infected chickens 
inhibited MG growth.  
More recently, in an experiment by Javed et al. (2005), chickens were either vaccinated 
or sham-vaccinated, and subsequently challenged with pathogenic MG strain Rlow. After 
challenge, the vaccinated birds had more MG-specific IgG and IgA-secreting plasma B cells 
within the trachea and developed only mild tracheal lesions, while the sham-vaccinated birds had 
larger numbers of B, CD4+, and CD8+ cells infiltrating the trachea. Gaunson et al. (2006) 
characterized the infiltration of lymphocytes into the chicken trachea at multiple time points after 
MG infection. In unvaccinated birds, CD8+TCR+ and CD4+ cells increased in the trachea after 
infection. In the early stages of disease, a majority of CD8+ cells were TCR-, suggestive of 
natural killer (NK) cells. While the study found T lymphocytes are involved in response to MG, 
recovery from infection in naïve birds correlated well with the development of lymphoid follicles 
that were composed of mostly B-cells (3-6 weeks post-infection), further underscoring the 
importance of local antibody responses.  
 
2.2.2. Immune responses of house finches to M. gallisepticum 
The route of infection in free-living house finches is not known for certain, but experimental 
infection by inoculation into the conjunctiva results in clinical signs seen in free-living birds 
(e.g., see Luttrell et al. 1996 for disease in free-living finches; Sydenstricker et al. 2006 for 
disease in finches after experimental inoculation). In addition, the organism can be cultured from 
conjunctival swabs of free-living birds (Hartup et al. 2000, Ley et al. 1996).  
Dhondt et al. (2007b) found that both conjunctival and oral inoculation results in 
seroconversion, as measured by serum plate agglutination, however, only two out of ten orally 
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inoculated house finches showed signs of conjunctivitis, whereas all birds exhibited 
conjunctivitis when inoculated into the conjunctiva. It is also been demonstrated that birds 
develop partial immunity after initial infection; re-exposed birds are susceptible to infection and 
develop disease after secondary exposure, however, they developed milder disease for a shorter 
duration of time (Sydenstricker et al. 2005).  
 Using microsatellite DNA analysis to examine genetic heterozygosity, Hawley et al. 
(2005) found that house finches with greater heterozygosity developed less severe disease after 
conjunctival MG inoculation. Heterozygosity was also positively correlated with cell-mediated 
immunity as measured by T-cell proliferative response to phytohaemagglutinin, but was not 
correlated with humoral response to sheep red blood cells. The authors suggested that differences 
in the cell-mediated immune response may explain why greater heterozygosity is associated with 
resistance to MG. Additionally, Hawley and Fleischer (2012) found that house finches with 
intermediate to high levels of MHC Class II diversity showed the lowest disease severity after 
experimental infection with MG, compared with finches that had low MHC Class II diversity. 
MHC diversity may be particularly important during MG infection since MG alters expression of 
cell surface antigen (discussed in 2.2.4). 
 Bonneaud et al. (2011) experimentally infected house finches from two North American 
populations: one from an eastern population which was exposed to MG for 12 years (Alabama) 
and a western population without prior exposure to MG (Arizona). They found that finches from 
the exposed population had 33% lower MG loads in their conjunctivae two weeks post-infection, 
as measured by the mgc2 quantitative PCR assay described in chapter 4. Using a cDNA 
microarray, they also found that finches from the eastern population up-regulated more immune-
related genes, providing evidence for evolution of resistance in the eastern population. 
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 Microscopic lesions of house finches with MG infection further confirm the involvement 
of an active immune response. Luttrell et al. (1996) characterized microscopic lesions in a 
number of free-living house finches with MG infection. Most had moderate to severe hyperplasia 
of epithelial and lymphoid tissues of the conjunctiva, with many plasma cells and some 
lymphocytes and macrophages infiltrating the submucosa. A few birds had keratitis characterized 
by mild to moderate infiltration of plasma cells, lymphocytes, and heterophils in the cornea, 
along with hyperplasia of corneal epithelium. In a study of captive house finches with MG 
infection, Luttrell et al. (1998) found similar lesions in the conjunctiva and cornea, in addition to 
nasal turbinate lesions which included submucosal lymphocyte and plasma cell infiltrates and 
focal mucosal necrosis. In the trachea, mucosal and submucosal thickening from epithelial 
hyperplasia and lymphoplasmacytic infiltrate were also present.  
 
2.2.3. Local defense of the avian eye: the role of the Harderian gland 
As discussed, existing evidence suggests that the local antibody response has an important role in 
controlling MG infection in chickens. Since MG infects ocular tissue in finches, the local 
response likely involves peripheral lymphoid tissue associated with the eye. In avian species, the 
principal peripheral lymphoid tissue associated with the eye resides in the Harderian gland. 
Harderian glands are found in terrestrial vertebrates that have a nictitating membrane (Shirama et 
al. 1996). It is thought that its secretions generally act to lubricate the eye, although other 
functions have been proposed and are most often species-dependent. In birds, there are large 
numbers of antibody producing plasma B cells within the Harderian gland (Bang and Bang 
1968). While the gland contains predominately B cells, a small number of helper T cells can also 
be present (Albini et al. 1974).   
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Mueller et al. (1971) established the role of the Harderian gland in the local defense of 
the eye by demonstrating that when an antigen is administered intravenously, antibody 
production did not take place in the gland. However, when antigen was inoculated ocularly, the 
Harderian gland produced antigen-specific antibodies. Baba et al. (1988) found that surgical 
removal of the Harderian gland in day-old chicks resulted in greatly decreased immunoglobulin 
concentrations in the lachrymal fluid. Lachrymal IgA concentration appeared to be especially 
dependent on the presence of the gland.  
 Karaca and Lam (1989) found that the Harderian gland is not necessary for resistance to 
MG infection in chickens. They surgically removed the gland in chicks prior to administering an 
intranasal vaccine for MG and subsequently measured antibody response in the sera and in 
tracheal washings. They reported that after vaccination, chicks without the gland still produced 
an antibody response, in sera and tracheal washings, to the challenge strain. However, given the 
background discussed above, the Harderian gland likely protects against antigens encountered in 
the eye, and so it is not surprising that the gland may not be necessary to produce specific 
antibodies for antigens inoculated via other routes. Also, the antibody-rich secretions of the 
Harderian gland drain into the conjunctiva at the base of the nictitating membrane (Shirama et al. 
1996), and therefore it is generally assumed that the tears contain the highest concentration of 
Harderian gland-derived antibodies, not the tracheal washings. 
Thus, the avian Harderian gland is important for defense against antigens inoculated onto 
the eye and conjunctival tissues. As in mammals, IgA is the predominant antibody involved in 
protection of the mucosal surface (Tizard 2002). Since the Harderian gland appears to be the 
primary source of IgA in the lachrymal fluid (Baba et al. 1988), it may serve as a vital player in 
local antibody response against MG in the house finch conjunctiva.  
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2.2.4. Mycoplasma lipoproteins and the role of MG’s vlhA gene family in immune evasion 
Mycoplasma species are known for their ability to cause chronic infection in their hosts. 
Antigenic variation via cell surface lipoproteins may aid in the ability to cause prolonged 
infection. In these species, proteins make up over two-thirds of plasma membrane mass, with 
membrane lipids composing the rest. Unlike other eubacteria, membrane lipoproteins are 
abundant in the membrane (Razin 1999). Membrane lipoproteins appear to be the major antigens 
in Mycoplasma species, and many cell surface antigens have been found to undergo antigenic or 
size variation (Razin 1999). In these species, all membrane-bound lipoproteins contain a 
lipoylated amino-terminal cysteinyl residue, and these lipoproteins comprise 4-10% of the 
coding sequences in the genome (Rocha et al. 2005). Surface lipoproteins are often the target of 
the humoral immune response (Rocha et al. 2005). Mycoplasma species undergo variation of 
surface antigens in vitro (e.g., Zhang and Wise 2001) and in vivo (Levisohn et al. 1995), likely an 
adaptation to evade the host antibody response.  
The MG vlhA gene family, formerly referred to as the pMGA gene family, encodes 
variants of VlhA protein, a major surface lipoprotein. It is thought that the VlhA protein plays a 
role in adherence, hemagglutination, and evasion of host antibodies (Citti et al. 2005).  
Markham and colleagues at the University of Melbourne have contributed a great deal to 
our knowledge of the MG VlhA protein. Markham et al. (1992) found that hemagglutination of 
chicken erythrocytes by MG strain S6 was inhibited when MG S6 was incubated with pMGA 
(VlhA)-specific monoclonal antibodies, providing evidence of its possible role in attachment to 
host cells. The monoclonal antibodies were also used to identify a protein band with a Mr of 
67,000, and electron microscopy was used to show that the VlhA protein was located on the cell 
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surface of MG. Markham et al. also sequenced the amino terminus of pMGA, which did not have 
significant homology to any other protein in major databases.  
Markham et al. (1993) purified a protein using a monoclonal antibody against pMGA, 
and subsequently sequenced two proteins (pMGA1.2 and 1.3) that were similar but not identical 
to the pMGA protein described previously (pMGA1.1), providing evidence for the existence of a 
gene family encoding these homologous proteins. Based on the sequence of pMGA1.2, it 
appeared that the protein lacked a significant internal hydrophobic region, but had a protein 
sequence flanking the amino-terminal cysteine that could form a signal peptidase II cleavage site. 
Such a site could lead to addition of a fatty acyl group to its alpha-amino group providing an 
amino terminal anchor for the protein. Markham et al. (1994) sequenced several pMGA genes 
and found that all had GAA repeats at the 5’ region of the gene, ranging from 10-15 repeats, that 
were located upstream from the start codon of each gene. Only a single vlhA gene is expressed at 
a time and expression requires a trinucleotide motif ([GAA]12) 5’ to its promoter (Glew et al., 
1998). Change in VlhA expression likely occurs due to slipped-strand mispairing at the 
trinucleotide repeat during DNA synthesis (Citti et al. 2005). 
The complete genome of the strain Rlow has been sequenced, and it has been found that 
the vlhA gene family comprises approximately ten percent of the MG genome. In MG strain Rlow, 
there are 43 vlhA genes that are present at five loci. Sequence identity among the gene variants 
ranges from 41-99% (Papazisi et al. 2003). Among strains of MG, vlhA gene number ranges 
from 32 to 70 (Baseggio et al. 1996), determined by Southern blotting using a probe that was 
complimentary to a leader sequence present in vlhA genes. Genome comparison of strain Rlow (a 
virulent low-passage strain) and strain F (an attenuated strain) shows great variability in the vlhA 
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gene family, and provides evidence for genomic inversion events, gene duplications, and 
insertion/deletion events in this gene family (Szczepanek et al. 2010).  
The MG VlhA surface protein undergoes phenotypic variation in vitro in response to 
VlhA-specific antibodies. To study phenotypic variation, Markham et al. (1998) utilized MG 
strain S6, a monoclonal antibody directed against an epitope on pMGA1.1, and polyclonal 
antisera against pMGA antigens. When included in the growth media, both the monoclonal 
antibody and polyclonal antisera resulted in cessation of pMGA1.1 expression; instead, the 
cultured cells expressed a different member of the pMGA gene family. Additionally, when these 
cells were then allowed to grow in the absence of the antibody, progeny of these cells regained 
expression of the pMGA antigen (Markham et al. 1998).  
In vivo variation of the VlhA protein has also been documented during MG infection in 
chickens (Glew et al. 2000). While it is thought that VlhA phenotypic variation is a possible 
mechanism for host antibody evasion, VlhA switching also occurs in the absence of detectable 
antibodies. Glew et al. (2000) studied MG VlhA switching in chickens by examining colonies of 
MG grown from post-inoculation tracheal wash samples. They found that by two days post-
aerosol inoculation, 40% of MG cells ceased expression of the VlhA surface protein expressed at 
the time of inoculation; however, VlhA specific antibodies were not detected in serum and 
tracheal samples until day 6 post-inoculation. Thus, it may be possible that the vlhA gene family 
plays a role in other functions beside antibody evasion, such as colonization (Glew et al. 2000). 
One possible mechanism for VlhA switching is that antibodies select for individual cells 
within a population that have switched off expression of the target VlhA protein by chance. 
Another possibility is that binding of the antibody to the MG cell influences the rate of VlhA 
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phase variation (Citti et al. 2005). The work by Glew et al. described above, however, suggests 
that VlhA variation can also occur via an antibody independent mechanism.  
Very recent work by Tulman et al. (2012) compared the genomes of eight MG isolates 
collected from free-living house finches between 1994-2008 from different geographic locations. 
The authors found that much of the house finch MG genome is highly conserved between the 
isolates, with a major exception being the vlhA genes, which vary in presence and genomic 
location. House finch MG genomes contain 33 to 48 vlhA genes, and many genes have 
homologues at similar loci in poultry strains R and F, although some have no homologues.   
 
2.3. Thesis goals 
The goal of my thesis was to characterize house finch local and systemic antibody responses to 
Mycoplasma gallisepticum and address several questions. 
1) Temporal and spatial genotypic variation in house finch MG has been documented 
(Pillai et al. 2003, Tulman et al. 2012), but phenotypic variation in pathogenicity and 
immunogenicity has not been examined. Do circulating house finch strains or strain 
variants of MG differ in virulence and immunogenicity? 
2) Previous studies (Kollias et al. 2004, Roberts et al. 2001, Sydenstricker et al. 2005) 
have shown that house finches experimentally infected with the same inoculum dose 
can develop very different courses of disease. Do antibody profiles (serum and tear 
antibodies) of birds that show “acute” disease differ from birds that show “chronic” 
disease? Is there a difference in pathogen load between these two groups? 
3) VlhA protein expression differs among poultry isolates of MG (Glew et al. 1995). Do 
circulating house finch MG strains also differ in VlhA expression? 
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4) Does VlhA expression vary in vivo in house finches experimentally infected with 
MG? What role might this play in chronic infections? 
 
2.4. Significance of study 
2.4.1. Broadening the knowledge of the avian immune system 
The chicken has provided us with the majority of our knowledge of the avian immune system. 
Knowledge of immunity (especially mucosal immunity) of non-galliform birds is greatly limited. 
It will be necessary to study other avian species to substantiate the generalizations we have made 
about avian immunity. In order to fully study the immune system of non-galliform species, new 
reagents must be developed that can detect various components of the immune system. More 
specifically, data on immunity to MG in wild birds was limited, with plate agglutination being 
the predominant serologic test utilized prior to this work (Luttrell and Fischer 2007). The 
development of an ELISA for use in house finches allowed for quantification of antibody 
response and likely greater specificity than plate agglutination. 
 
Broadening knowledge of “comparative mycoplasmology” 
Although each Mycoplasma species has a narrow host range, mycoplasmas infect a wide 
diversity of hosts, including fish, reptiles, birds, and mammals. Mycoplasma species cause a 
multitude of diseases in humans (Waites and Talkington 2005) and domesticated animals 
(Markham and Noormohammadi 2005) as discussed in previous sections. “Comparative 
mycoplasmology” is pertinent to human and domestic animal disease since it will broaden our 
understanding of mycoplasma-host interactions and pathogenesis, and subsequently allow for 
further exploration of strategies to control infection. 
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Conservation  
While house finches appear to be the major free-living host species affected by MG, an 
increasing number of species are being documented as PCR- and/or antibody-positive for MG. 
Conjunctivitis and positive serum plate agglutination tests have less commonly been documented 
in other songbirds, such as American goldfinches and purple finches (Hartup et al. 2000, Hartup 
et al. 2001). Evidence of infection has been identified in over 30 other species, including 
mourning dove (Zenaida macroura), evening grosbeak (Coccothraustes vespertinus), pine 
grosbeak (Pinicola enucleator), wood thrush (Hylocichla mustelina), and northern cardinal 
(Cardinalis cardinalis) (J. DeCoste, personal comm.). In the eastern range of the house finch, the 
MG epidemic has caused a major decline in house finch abundance (Hochachka and Dhondt 
2000). If MG is capable of infecting other species, it is possible MG infection could cause 
population declines in more vulnerable species in the future. The greater knowledge we have of 
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CHAPTER 3 
 
General experimental design 
 
 
To investigate virulence and immunogenicity of M. gallisepticum (MG) and address the thesis 
goals listed in chapter 2, experimental infections were carried out using several isolates of MG. 
These isolates were collected from house finches from various geographic locations and time 
points. Before these experiments were initiated, diagnostic tests were designed for application in 
this system. To detect pathogen, a quantitative PCR was developed for detection of MG in 
conjunctival swab samples (Chapter 4). This assay utilizes the mgc2 gene, present as one copy 
per bacterial cell. A quantitative PCR was also developed for use as a host (house finch) cell 
control, and was based on the rag-1 gene, present in the house finch cell as two copies per cell.  
House finch antibody response to MG was investigated in this thesis. Unfortunately, there 
is a general paucity of immunological reagents for non-agricultural avian species. The 
development of class-specific monoclonal antibodies to chicken immunoglobulins has greatly 
facilitated past research. Many of these monoclonal antibodies developed against chicken 
immunoglobulins, however, show poor cross-reactivity with those of other avian species, 
especially to those distantly related to the chicken (Jeurissen and Janse 1998, for review see 
Schultz and Magor 2008).  
Few reagents have been developed to detect immunoglobulins of passerine birds. 
Commercial polyclonal antibodies are available for the detection of bird IgM (Immunology 
Consultants Laboratory, Newberg, OR) and IgY (Bethyl Laboratories, Montgomery, TX). These 
polyclonal antibodies were generated by immunizing rabbits and goats with immunoglobulin 
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from at least one species of passerine bird (e.g., robin and crow IgM and sparrow IgY). To date, 
no reagents have been developed against IgA from a passerine bird. 
To investigate local immunity, a reagent that recognizes house finch IgA was developed 
(Chapter 5). A fragment of the house finch IgA heavy chain was PCR-amplified from house 
finch spleen cDNA, sequenced, expressed using a bacterial expression system. This protein was 
then used to generate house finch IgA-specific rabbit antisera. A commercially available ELISA 
was then modified for use in house finches for measurement of MG-specific lachrymal IgA and 
serum IgG(Y). 
After the development of the quantitative PCR and ELISAs, MG virulence and house 
finch antibody responses were studied in several experimental infections (Chapter 6). In 
experiment 1, house finches were inoculated via conjunctivae with MG isolates collected from 
house finches in Virginia (1994) and California (2006). In experiment 2, house finches were 
inoculated with the Virginia 1994 isolate and an isolate collected from a house finch in North 
Carolina (2006). Eye lesion scores, MG load and house finch antibody response were measured 
in both experiments.  
In Chapter 7, chronic disease was studied with experimental inoculations of house 
finches using VA1994 and North Carolina (NC1995, NC1996, NC2006, NC2008) field isolates. 
Eye lesion scores, MG load and antibody responses were once again measured. Using a 
monoclonal antibody specific for a variant of MG VlhA immunodominant surface protein, in 
vivo VlhA changes during infection in the house finch were documented.  
 
  




Detection and quantification of Mycoplasma gallisepticum genome load in conjunctival 
samples of experimentally infected house finches (Carpodacus mexicanus) using real-time 






























* Previously published: Grodio, J.L., Dhondt, K.V., O'Connell, P.H. and K.A. Schat. 2008. 
Detection and quantification of Mycoplasma gallisepticum genome load in conjunctival samples 
of experimentally infected house finches (Carpodacus mexicanus) using real-time polymerase 
chain reaction. Avian Pathology. 37: 385-391. Reproduced with permission (no license required). 
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4.1 Abstract 
A TaqMan®-based real-time, quantitative polymerase chain reaction (qPCR) assay utilizing the 
mgc2 gene was developed to detect Mycoplasma gallisepticum (MG) in conjunctival swabs of 
experimentally infected house finches. The assay was demonstrated to be quantitative by the 
standard curve method with reproducible results within runs and between runs. The detection 
limit of the mgc2 assay was examined using two standards. The test had a detection limit of less 
than 14 copies per reaction when tested with a plasmid standard and less than 10 copies per 
reaction when tested with M. gallisepticum genomic DNA. All M. gallisepticum-negative birds 
(10 specific pathogen free chickens and 10 house finches) were negative by mgc2 qPCR assay. 
Existing evidence suggests that an important part of M. gallisepticum pathogenesis includes both 
its attachment to and invasion of host cells. Thus, our test also made use of rag-1 as an internal 
control gene. The rag-1 qPCR results showed that host cell quantity varied greatly between 
conjunctival samples. After inoculation, M. gallisepticum levels in the house finch conjunctiva 
increased over the 7-day period post infection. The bird with the most pronounced clinical 
conjunctivitis harboured the highest level of M. gallisepticum and the bird that did not develop 
conjunctivitis had very low numbers of M. gallisepticum. Thus, it appears that development of 
conjunctivitis may correlate with M.gallisepticum load.  
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4.2 Introduction 
 
Mycoplasma gallisepticum is a prokaryotic pathogen that causes chronic respiratory disease in 
chickens and infectious sinusitis in turkeys. Disease resulting from M. gallisepticum infection 
has considerable economic consequences for the poultry industry worldwide. In 1994, M. 
gallisepticum was detected in house finches (Carpodacus mexicanus) in the eastern part of North 
America (Ley et al. 1996). The infection caused major declines throughout the eastern 
population and eventually spread to the native western range of the house finch (Ley et al. 2006). 
The most prominent clinical sign of infection in finches is unilateral or bilateral conjunctivitis, 
which in experimentally infected birds develops approximately 4 days post infection (p.i.) 
(Kollias et al. 2004). 
Several real-time quantitative polymerase chain reaction (qPCR) assays have been 
developed to measure M. gallisepticum in tracheal and palatine cleft swabs of domestic chickens. 
Two SYBR Green-based assays that use standard curves based on colony-forming units (CFUs) 
have been described. One assay utilizes the 16S rRNA gene (Mekkes and Feberwee 2005), and 
the other utilizes the mga_0319 lipoprotein gene (Carli and Eyigor 2003). Problems associated 
with these assays have been a lack of sensitivity or cross-reaction with other Mycoplasma 
species. Callison et al. (2006) developed a TaqMan®-based assay that quantified M. 
gallisepticum based on mga_0319 gene copy numbers using a plasmid standard, instead of 
CFUs. 
Lacking in the previously developed qPCR assays is the use of a host housekeeping gene. 
The measurement of a host gene is an important control to account for differences in swabbing 
methods, DNA extraction efficiencies, and inflammatory responses. There is also increasing 
evidence for the close association of M. gallisepticum with host cells, including both adhesion to 
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and invasion of host cells. In other Mycoplasma species, adhesion to host cells plays a vital role 
in pathogenesis (Balish and Krause 2005). This is also true for M. gallisepticum, as genes and 
corresponding proteins involved in cytadhesion have been identified and characterized (Keeler et 
al. 1996, Goh et al. 1998, Hnatow et al. 1998, Papazisi et al. 2002). There is also evidence that 
M. gallisepticum has the ability to invade host cells. Winner et al. (2000) demonstrated that M. 
gallisepticum is internalized by human epithelial cells and chicken embryo fibroblasts in vitro. 
More recently, studies by Vogl et al. (2008) provided evidence that M. gallisepticum can invade 
and adhere to chicken erythrocytes in vitro and can invade erythrocytes in vivo after aerosol 
inoculation. 
In many polymerase chain reaction (PCR) assays, the 18S rRNA gene has been used as 
an endogenous control for eukaryotic DNA (for example, Bai et al. 2004, Casabianca et al. 2004) 
and RNA (Li et al. 2005). However, the use of this gene as a DNA control has several 
disadvantages. The gene is present in multiple copies within the eukaryotic genome and copy 
numbers vary among species and at the individual level (Long and Dawid 1980). For example, 
the 18S rRNA copy number varies between chicken strains and among individuals within a given 
strain. Delany (2000) found copy numbers ranging from 302 to 422 in broiler lines. Moreover, 
the 18S rRNA copy number in the house finch is unknown; therefore, quantification of host cell 
number is not feasible using this gene. 
Conventional PCR has been used to identify infected house finches using conjunctival 
swabs. The mgc2 gene, which encodes a cytadhesin protein (Hnatow et al. 1998), is currently the 
one of the preferred gene targets for this assay, due to its specificity for M. gallisepticum (Garcia 
et al. 2005). We selected this gene for the development of our qPCR to quantify the level of M. 
gallisepticum infection in house finches. The recombination-activating gene 1 (rag-1), which is 
	   27 	  
present in two copies/diploid cell in the genome of higher vertebrates (Groth and Barrowclough 
1999), was selected to quantify the number of host cells in conjunctival swab samples. 
 
4.3 Materials and Methods 
Sample sources 
Serum samples and conjunctival samples from both eyes were obtained from 10 chickens from 
the specific pathogen free P2a (Weinstock and Schat 1987) flock at Cornell University. 
Conjunctival samples were collected using cotton-tipped wooden-handle swabs (product #14-
960-3N; Fisher Scientific, Pittsburgh, Pennsylvania, USA), placed in 300  µl tryptose phosphate 
broth and kept at 4°C until the swab was discarded. Then the remaining sample was stored at 
−28°C until DNA extraction. Blood was collected from the wing vein on the date of swab 
collection and also 4 weeks later to confirm M. gallisepticum-negative antibody status using 
serum plate agglutination assays (Charles River Laboratories, Wilmington, Massachusetts, 
USA). The P2a line has been negative for M. gallisepticum antibodies for at least 20 years and is 
tested monthly to confirm its negative status. 
One-year-hatchling house finches were trapped in Tompkins County, New York, USA 
(42°51′N, 76°34′W) during October and November 2006 using mist nets under permits (LCP 99-
039) from the New York State Department of Environmental Conservation (Albany, New York, 
USA) and a federal collecting permit (PRT 802829). Birds were placed in quarantine for a 
minimum of 2 weeks, and blood was collected from the wing vein into lithium-heparinized 
microcapillary tubes and screened for the presence of M. gallisepticum-specific antibody using 
the serum plate agglutination test (Intervet, Millsboro, Delaware, USA) (Kleven 1998). The 
house finches were kept in individual wire bar cages with metal barriers between them to prevent 
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mechanical spread of M. gallisepticum. Water and a pelleted diet (Roudybush, Inc., Cameron 
Park, California, USA) were provided ad libitum. 
Ten additional 1-year-hatchling house finches were sampled during October 2007. After 
M. gallisepticum antibody-negative status was confirmed with serum plate agglutination, 
conjunctival swabs were obtained to serve as M. gallisepticum-negative samples. Samples from 
the left and right eyes were pooled for each bird. 
 
Experimental infection 
Five birds were inoculated in the conjunctival sac of the right and left eyes with 50  µl M. 
gallisepticum inoculum (3.24 x 105 CFU/ml) at day 0. Conjunctival swabs were collected at day 
0 (pre-inoculation), and 1, 3, 5, and 7 days p.i. Conjunctival samples were collected using cotton-
tipped swabs, placed in 300 µl tryptose phosphate broth, and kept at 4°C until the swab was 
removed. The remaining sample was then stored at −28°C until DNA extraction. Samples for the 
right and left eyes were processed separately so that the M. gallisepticum load for each eye could 
be determined. Physical signs of M. gallisepticum infection were quantified by scoring the 
severity of the inflammatory process in each eye using a 0 to 3 scale as described by 
Sydenstricker et al. (2006): 0 = no visible inflammation; 1 = pink conjunctival discolouration and 
slight periorbital oedema, 2 = pink conjunctival discolouration, slight to moderate periorbital 
oedema, and epiphora with mucoid discharge; and 3 = red conjunctiva, epiphora and feather 
matting, feather loss around periorbital ring, severe conjunctival oedema, and at least some 
chemosis or rhinitis. Both eyes were scored on days 0, 1, 3, 5, and 7. 
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M. gallisepticum isolate 
The M. gallisepticum inoculum used in the experiment was the sixth in vitro broth (Frey's 
medium with 15% swine serum, modified from Kleven [1998]) passage from the original M. 
gallisepticum house finch isolate, ADRL 7994-1 (Ley et al. 1996). The viable count of this 
inoculum (ADRL 7994-1 6P) was 3.24 x 105 CFU/ml as determined by colony counts on agar 
from serial dilutions (Kollias et al. 2004). The M. gallisepticum utilized for assay development 
and sequencing was the seventh in vitro broth passage from M. gallisepticum house finch isolate, 
ADRL 7994-1. 
 
DNA extraction and sample preparation 
DNA extraction from conjunctival swab samples was carried out using a Qiagen DNeasy blood 
and tissue kit (Qiagen, Valencia, California, USA), following the manufacturer's recommended 
protocol for the purification of total DNA from animal tissues. The samples of experimentally 
infected house finches were diluted to a DNA concentration of 50 ng/5  µl for use in the qPCR. 
The DNA concentration was determined using a Bio-Rad SmartSpec™ 3000 (Bio-Rad, 
Hercules, California, USA) following the manufacturer's protocol. The samples of M. 
gallisepticum-negative birds were not further diluted because spectrophotometer readings of 
these samples were very low and accurate quantification of DNA in the samples was not feasible. 
 
Preparation of DNA standards 
A 303 base pair (bp) region of the mgc2 gene was amplified from the genome of M. 
gallisepticum strain ADRL 7994.1 by PCR with previously published primer sequences (Garcia 
et al. 2005) using the following PCR parameters: 94°C for 3 min; followed by 35 cycles of 94°C 
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for 30 sec; 58°C for 30 sec, 72°C for 60 sec; followed by one cycle of 72°C for 10 min. A 1100 
bp region of rag-1 was amplified from house finch, American goldfinch (Carduelis tristis), 
house sparrow (Passer domesticus), and chicken (Gallus gallus) DNA with the R17 and R22 
primers published by Groth and Barrowclough (1999). The PCR amplification parameters were: 
5 min at 94°C; followed by 35 cycles of 94°C for 30 sec; 55°C for 40 sec, 72°C for 60 sec; 
followed by one cycle of 72°C for 10 min. A 119 bp fragment of the house sparrow 18S rRNA 
gene was amplified with conserved primer sequences (Lopez-Andreo et al. 2005) using the same 
PCR parameters as described for rag-1. The PCR products were cloned in the pCR®4-TOPO 
vector (Invitrogen, Carlsbad, California, USA) following the manufacturer's protocol. Random 
colonies were grown overnight in Luria-Bertani broth containing ampicillin, and plasmid DNA 
was extracted using a Qiagen MiniPrep kit (Qiagen) following the standard kit protocol. The 
insert was then sequenced (Automated 3730 DNA Analyzer; Applied Biosystems, Foster City, 
California, USA) and purified plasmid DNA from one clone containing the correct insert was 
used to construct the standard curves. For the rag-1 assay standard, plasmid was harvested from 
a clone containing the house finch rag-1 insert. The plasmid standard for the nitric oxide 
synthase 2 (nos2) assay was kindly provided by K.W. Jarosinski, Department of Microbiology 
and Immunology, Cornell University (Jarosinski et al. 2002). M. gallisepticum genomic DNA 
was extracted from the inoculum (ADRL 7994.1) utilized in this study to serve as an additional 
standard for the mgc2 qPCR. Fresh 10-fold dilutions were made from standard stocks in DNase-
free water. 
 
Primer and probe design 
A 303 bp sequence of the mgc2 gene of isolate ADRL 7994-1 was aligned with mgc2 sequences 
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of M. gallisepticum isolated from six house finches and one goldfinch from various locations and 
years. Primers and probes were designed with Primer Express (version 2.0; Applied Biosystems). 
Primers and probes for the real-time assays were synthesized by Integrated DNA Technologies 
(Coralville, Iowa, USA). Probes had 6-FAM on the 5′ end and BHQ-1 on the 3′ end—with the 
exception of the nos2 probe, which had TET on the 5′ end and TAMRA on the 3′ end. 
Lasergene sequence analysis software (DNAstar, Madison, Wisconsin, USA) was utilized to 
create an alignment of rag-1 sequences of two house finches, a goldfinch, a house sparrow and a 
chicken. Primers and probe were chosen to be in areas of 100% identity in the house finch and 
goldfinch to ensure primers anneal to areas conserved among house finches. Table 4.1 presents a 
list of the primer and probe sequences used in this study. 
 
Real-time assays 
The 20  µl reaction was performed in an ABI Prism 7500 (Applied Biosystems). The “fast” 
reaction utilized 10  µl TaqMan® Fast Universal PCR Master Mix (2x), No AmpErase® UNG 
(Applied Biosystems), 0.18  µl each of 100µM forward and reverse primers, 0.5  µl of 10  µM 
probe, 4.14  µl DNase-free water, and 5  µl sample. Samples were run in triplicate. Cycling 
parameters were 95°C for 20 sec and 40 cycles of 95°C for 3 sec and 60°C for 30 sec. The 
automatic threshold settings were used in analysis of samples. Samples were positive for M. 
gallisepticum if the cycle threshold (Ct) value was less than 40. 
 
Nucleotide sequence accession numbers 
Sequences can be accessed from GenBank (http://www.ncbi.nlm.nih.gov) with the following 
accession numbers: M. gallisepticum strain 7994-1 mgc2 (EF462343), house sparrow 18S rRNA 
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gene (EF462342), and rag-1 sequences from two house finches (EU165349, EU165350), a 
chicken (EU165351), a house sparrow (EU165352), and a goldfinch (EU165353). The mgc2 
sequences used in alignment of isolates from free-living finches included GenBank accession 




JMP (version 7.0; SAS Institute) was utilized for the least squares regression analysis presented 
later in Figure 2. We report coefficient estimates (β), P values, and R 2 values. 
 
4.4 Results 
Primers and probe 
The ADRL 7994-1 partial mgc2 sequence was found to be identical to that of the seven other 
house finch and goldfinch isolate sequences available in GenBank, and the real-time primers and 
probe (Table 4.1) were developed to amplify a 227 bp region within the 303 bp region. The 
approximate size was confirmed by running real-time products on an agarose gel (data not 
shown). A BLAST search with the mgc2 real-time primers revealed significant alignments with a 
multitude of M. gallisepticum isolates, and no alignments with other Mycoplasma species. When 
the mgc2 sequence of ADRL 7994-1 and several M. gallisepticum reference strains were 
compared, several nucleotide polymorphisms were present in the qPCR target region (data not 
shown). 
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Table 4.1: Real-time primer and probe sequences utilized in this study 
Gene Primer, probe Sequence  Reference 
























Jarosinski et al., 
2002  
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Standard curves 
The mgc2 standard was based on 10-fold serial dilutions of plasmid containing a 303 bp mgc2 
insert. The curve was created using 3.41 x 101 to 3.41 x 108 copy numbers. Serial 10-fold 
dilutions of the M. gallisepticum genomic DNA were used to create the curve using 1.00 x 100 to 
1.00 x 106 copy numbers. The rag-1 and 18S rRNA gene standards were based on 10-fold serial 
dilutions of plasmids containing the 1100 bp house finch rag-1 and the 119 bp house sparrow 
18S rRNA gene inserts, respectively. To generate the standard curves for rag-1 and 18S rRNA, 
3.76 x 101 to 3.76 x 107 and 1.40 x 101 to 1.40 x 107 copy numbers, respectively, were used. 
Standard curves were generated for each run. The following standard curve equations represent 
typical runs: mgc2 plasmid, y= − 3.382x+39.98, R 2=0.998; M. gallisepticum genomic, 
y= − 3.723x+39.885, R 2=0.996; rag-1, y= − 3.504x+39.16, R 2=0.997; and 18S rRNA gene, 
y= − 3.578x+46.741, R 2=0.987. 
 
Assay detection limit and reproducibility 
The mgc2 assay detection limit was determined using two standards, a plasmid standard and M. 
gallisepticum genomic DNA. The assay exhibited a detection limit of less than 14 copies per 
reaction using the plasmid standard and less than 10 copies per reaction using the genomic DNA 
standard. The inter-assay reproducibility of the mgc2 plasmid standard and genomic DNA 
standard (Table 4.2) was determined using the mean Ct values from three independent runs, 
conducted on different days with new standard dilutions for each run. The intra-assay 
reproducibility of the mgc2 standard curve (Table 4.2) is based on the mean Ct values from the 
standard curve run in triplicate. The linearity of the mgc2 and M. gallisepticum genomic DNA 
standard curves is shown in Figure 4.1, with each curve representing the mean inter-assay Ct 
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values presented in Table 4.2. The data demonstrate that the mgc2 assay is highly reproducible. 
 
Table 4.2: Reproducibility and limit of detection of the standard curves used for mgc2 assay 
 
mgc2 plasmid standard Genomic standard 
Inter-assay reproducibility Intra-assay reproducibility Inter-assay reproducibility 
Copies Mean Ct St. dev Copies  Mean Ct St. dev Copies  Mean Ct St. dev 
1.40x108 12.52 0.452 1.40x108 12.92 0.03 1.00x106 18.39 1.025 
1.40x107 15.70 0.352 1.40x107 15.99 0.05 1.00x105 21.87 1.049 
1.40x106 19.18 0.354 1.40x106 19.59 0.05 1.00x104 25.58 1.097 
1.40x105 22.85 0.344 1.40x105 23.01 0.15 1.00x103 29.18 1.143 
1.40x104 26.36 0.290 1.40x104 26.5 0.16 1.00x102 33.05 1.393 
1.40x103 29.72 0.431 1.40x103 30.04 0.21 1.00x101 36.61 0.795 
1.40x102 32.86 0.313 1.40x102 33.12 0.2 1.00x100 40.00 - 
1.40x101 34.91 0.653 1.40x101 35.5 1.17  
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Figure 4.1. Mgc2-quantitative PCR: linearity of standard curve. A: Standard curve based on 
mgc2 plasmid. B: Standard curve based on M. gallisepticum genomic DNA. 
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Control samples 
Sensitive tests for the presence of M. gallisepticum-specific antibodies in passerine birds are 
lacking, and therefore it is not possible to obtain absolute confirmation that free-living passerine 
birds are truly negative for M. gallisepticum. Thus, we first confirmed that the mgc2 assay tested 
negative with avian DNA by using M. gallisepticum-negative chicken swab samples. The 10 
chickens and 10 house finches, all free of M. gallisepticum infection based on the absence of 
antibodies, were also negative using mgc2 real-time PCR with Ct values >40. Nos2 was used as a 
host DNA control for the chicken swab samples to ensure DNA was efficiently extracted. The 
Nos2 copy number ranged from 363 to 40 000 copies/5  µl, with a mean copy number of 6509 
and a standard deviation of 9177 copies. Rag-1 was used as the house finch DNA control. The 
Rag-1 copy number ranged from 13 to 1520 copies/5  µl, with a mean copy number of 255 and a 
standard deviation of 470 copies. 
 
Quantification of M. gallisepticum load in conjunctival samples of five infected house finches 
After experimental infection with M. gallisepticum, Bird 5 showed clinical signs by day 3, and 
Birds 2, 3, and 4 showed signs by day 7. Bird 1 did not develop clinical signs. Figure 4.2A 
illustrates the mean log10 of total M. gallisepticum eluted from the swab as a function of time p.i. 
in birds that developed clinical signs (Birds 2, 3, 4, 5). Total M. gallisepticum eluted from the 
swab increases with time p.i. (β = 0.985, P<0.0001, R 2=0.80). In Figure 4.2B, the mean log10 of 
M. gallisepticum copy number per house finch cell is plotted as a function of time p.i. in birds 
that developed clinical signs. M. gallisepticum/host cell increases with time p.i. (β = 0.450, 
P<0.0001, R 2=0.84). For each bird, the mean value of the right and left eyes was used to 
construct the plots in Figure 4.2. 
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Figure 4.2. M. gallisepticum conjunctival load post-infection, measured by quantitative PCR. A:  
Mean M. gallisepticum (MG) load present in total swab samples of the conjunctiva of four 
inoculated house finches that developed clinical conjunctivitis, as a function of time p.i., with 
standard error bars. B: Mean M. gallisepticum (MG) load shown as the log10 value of mgc2 copy 
number per host cell, with standard error bars. 
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A summary of maximal M. gallisepticum load and eye score at day 7 post-infection is 
also presented in Table 4.3, showing data without log transformation. Figure 4.3 shows 
individual data for each bird, with the M. gallisepticum load and eye score plotted over the 7 
days p.i. Bird 5 exhibited the earliest eye score at 3 days p.i. and also had the highest M. 
gallisepticum load. Although there is variation among individuals, these data show that the right 
and left eyes of individual birds experience similar M. gallisepticum load. Figure 4.3 also 
illustrates that while birds had similar M. gallisepticum loads throughout the 7-day period (e.g. 
Birds 2 and 5), the clinical signs developed at different time points. There are three data points 
excluded from the analysis. Samples from Bird 1 (day 3, right eye) and Bird 4 (day 7, right eye) 
could not be analysed because of insufficient amount of DNA in the sample. It was also 
suspected that the sample of Bird 1 at day 0 (left eye) was contaminated during the DNA 





Table 4.3. Summary of maximal mycoplasmal load and eye score at day 7 post infection. MG  = 
M. gallisepticum 
 
Bird Day 7 eye score Maximum MG load 
(MG/host cell) 
Day of maximum 
MG load 
1 0 16 7 
2 1 2079 5 
3 1 400 7 
4 1 1328 7 




	   40 	  
 
 
Figure 4.3. Data from individual birds showing M. gallisepticum (MG) load over time and 
occurrence of conjunctivitis. Solid circles, an eye score of 1 on the day of conjunctival sampling; 
dashed circle, a more severe eye score of 2. R, right eye; L, left eye. Eye score code: 0 = no 
visible inflammation; 1 = pink conjunctival discolouration and slight periorbital oedema, 2 = pink 
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Host control genes 
A BLAST search of the house sparrow 18S rRNA gene sequence confirmed that it had 100% 
sequence identity to many other avian species, including chicken. Thus, it was an appropriate 
standard in the house finch 18S rRNA gene qPCR assay. Among the house finches infected with 
M. gallisepticum, the average 18S rRNA gene copy number ranged from 1.57 x 102 to 1.40 x 108 
(mean = 2.40 x 106±1.82 x 107) in 50 ng DNA. House finch rag-1 copy numbers were used to 
standardize the M. gallisepticum conjunctival load. Since rag-1 is present in two copies per 
diploid cell, the number of host cells in each sample was calculated by dividing the rag-1 copy 
number by two. In samples from experimentally infected birds (50 ng DNA/assay), the house 
finch cell number ranged from 7 to 2893 (mean = 212±487). 
 
4.5 Discussion 
We have developed a TaqMan®-based assay to detect M. gallisepticum in conjunctival swab 
samples of experimentally infected house finches. The standard curve was reproducible both 
between runs and within runs. The detection limit of the mgc2 assay was examined using two 
standards: M. gallisepticum genomic DNA extracted from culture, and a plasmid-based standard 
consisting of a partial mgc2 gene inserted into a bacterial vector. The test has a detection limit of 
less than 14 copies per reaction when tested with the plasmid standard and less than 10 copies 
per reaction when tested with the genomic DNA standard. All M. gallisepticum-negative birds 
(10 chickens and 10 house finches) resulted in a negative mgc2 assay result. 
Our test also includes an internal control gene. The occurrence of conjunctivitis in 
infected finches makes the use of a host gene even more imperative, as host cells are being 
actively recruited to site of infection and may influence absolute quantity of the sample obtained. 
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The evidence that M. gallisepticum adheres to host cells and has the ability to invade cells further 
underscores the importance measuring the number of host cells collected in the conjunctival 
swab samples. Because there are potentially hundreds of 18S rRNA gene copies in the house 
finch genome, we decided to explore single-copy gene alternatives and found rag-1 to be an 
acceptable host control gene that allows for quantification of host cells in the conjunctival 
samples. Our rag-1 results demonstrate that host cell quantity varies quite substantially between 
conjunctival samples. The use of rag-1 ensures that variation in samples due to swabbing 
method, infection status (e.g. birds with and without conjunctivitis), and any differences in DNA 
extraction methods are taken into account. 
After experimental inoculation, M. gallisepticum levels in the house finch conjunctiva 
increase exponentially over the 7-day period p.i. The bird with the most severe conjunctivitis 
experienced the highest level of M. gallisepticum and the bird that did not develop conjunctivitis 
had a very low level of M. gallisepticum. Thus, it appears that development of conjunctivitis may 
correlate with M. gallisepticum load. 
In summary, our real-time assay can provide sensitive detection of M. gallisepticum in 
conjunctival samples of house finches. The assay allows for the quantification of M. 
gallisepticum genome copy number while controlling for intrinsic differences that exist as a 
result of variations in sampling method and host inflammatory response. We hope this assay will 
serve as a valuable tool for future studies of M. gallisepticum pathogenesis and transmission in 
house finches. 
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5.1 Abstract 
The IgA antibody response plays a vital role in mucosal immunity because it functions to 
neutralize pathogens at the mucosal surface and thus impedes attachment to underlying tissues. 
Although the importance of IgA in the mucosal immunity of galliform birds has been 
established, studies examining IgA-based immunity in passerine birds are lacking, perhaps due in 
part to the absence of reagents that can detect passerine IgA. A 469 base pair region of the house 
finch (Carpodacus mexicanus) IgA heavy chain was PCR-amplified from spleen cDNA and 
sequenced. The predicted amino acid sequence was found to share 55% and 46% identity with 
the IgA heavy chain of mallard (Anas platyrhynchos) and chicken (Gallus gallus), respectively. 
The heavy chain fragment was produced using a bacterial expression system and purified. Rabbit 
anti-sera were generated against the recombinant protein. The anti-sera reacted with a single 
house finch serum protein (~50–55 kDa) in Western blot. The anti-sera were used to identify 
plasma cells in the Harderian gland and conjunctiva of house finches with conjunctivitis 
associated with Mycoplasma gallisepticum infection. The anti-sera were also utilized in an 
ELISA to detect M. gallisepticum-specific IgA antibodies in lachrymal samples of infected 
finches. 
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5.2 Introduction 
Secretory IgA (sIgA) plays a vital role in mucosal immunity by neutralizing pathogens at 
mucosal surfaces. While IgA antibody response of domestic avian species, particularly the 
chicken, has been well studied (Barbour et al. 1988, Bencina et al. 1991, Suresh et al. 1994, Toro 
et al. 1994), comparatively little is known about sIgA antibody responses of passerine birds. The 
development of class-specific monoclonal antibodies to chicken IgA has facilitated past research. 
Many of these monoclonal antibodies developed against chicken immunoglobulins, however, 
show poor cross-reactivity with those of other avian species, especially to those distantly related 
to the chicken (Jeurissen and Janse 1998, for review see Schultz and Magor 2008). 
Few reagents have been developed to detect immunoglobulins of passerine birds. 
Commercial polyclonal antibodies are available for the detection of bird IgM (Immunology 
Consultants Laboratory, Newberg, OR) and IgY (Bethyl Laboratories, Montgomery, TX). These 
polyclonal antibodies were generated by immunizing rabbits and goats with immunoglobulin 
from at least one species of passerine bird (e.g., robin and crow IgM and sparrow IgY). To date, 
no reagents have been developed against IgA from a passerine bird. 
This chapter describes the production and characterization of a polyclonal reagent 
specific for the house finch (Carpodacus mexicanus) immunoglobulin alpha heavy chain. To 
validate the anti-sera, I utilized serum, lachrymal samples, and tissues samples of house finches 
infected with the pathogenic bacterium Mycoplasma gallisepticum, which causes conjunctivitis 
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5.3 Materials and methods 
RNA isolation and cDNA synthesis 
House finch spleens were provided by K. Dhondt (College of Veterinary Medicine, Cornell 
University) and immediately placed in 500 µL PBS after collection. Total cellular RNA was 
isolated using RNA STAT 60 (Tel-test Inc., Friendswood, TX) following the manufacturer's 
instructions. RNA was re-suspended in 50 µL RNase-free water and DNase-treated with Turbo 
DNA-free system (Ambion Inc., Austin, TX) following manufacturer's instructions. RNA 
samples were stored at −80°C. 
The reverse transcriptase reaction was carried out using GeneAmp RNA PCR Core Kit 
(Applied Biosystems, Foster City, CA) following manufacturer's instructions. The 20 µL reaction 
contained 0.5 µg total cellular RNA, 5 mM MgCl2, 1× PCR buffer II, 1 U/µL RNase inhibitor, 
2.5 U/µL MuLV reverse transcriptase, 2.5 µM random hexamers, and 1 mM each of dGTP, 
dATP, dTTP, and dCTP. The reaction was incubated at 25°C for 10 min, 42°C for 20 min, and 
99°C for 5 min with the GeneAmp PCR system 9700 (Applied Biosystems). 
 
PCR and cloning of partial house finch IgA (alpha) heavy chain cDNA sequence 
Mallard duck (Anas platyrhynchos) and chicken (Gallus gallus) IgA heavy chain cDNA 
sequences available on Genbank (accession numbers U27222 and S40610, respectively) were 
aligned using BLASTN (NCBI) and primers were designed in regions of similarity  
(forward: 5’ TCTGCGCCGAGGAGTGGAAC 3’ and reverse: 
5’AGGATCACCGTGACGTTGACGTTG 3’) 
The house finch alpha heavy chain was amplified from cDNA by PCR in a reaction that 
contained: 2 µL of the RT reaction, 4.8 µL 10× Gold buffer, 3.6 µL of 25 mM MgCl2, 0.8 µL of 
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10 mM dNTP, 0.5 µL each of forward and reverse primers and AmpliTaq Gold polymerase 
(Applied Biosystems). The reaction was incubated at 94°C for 5 min; 35 cycles of: 94°C for 30 s, 
50°C for 40 s, and 72°C for 60 s; and 72°C for 10 min. The resulting PCR product was cloned in 
the pCR®4 TOPO vector (Invitrogen, Carlsbad, CA) following the manufacturer's protocol with 
TOP10 cells. Random colonies were grown overnight in LB broth containing ampicillin, and 
plasmid DNA was extracted using a Qiagen MiniPrep kit (Qiagen, Valencia, CA) following the 
manufacturer's protocol. The insert was sequenced (Automated 3730 DNA Analyzer, Applied 
Biosystems) and Lasergene sequence analysis software (DNAstar, Madison, WI) was utilized to 
determine the reading frame and predicted amino acid sequence. The sequence was submitted to 
Genbank (EU736222). 
 
Construction of house finch IgA expression plasmid 
A blunt-ended sequence was generated using cloned Pfu DNA polymerase in a reaction 
recommended by the manufacturer (Stratagene, La Jolla, CA) using primers designed to add the 
5’ sequence required for insertion into the vector, an ATG start codon, and a stop codon 
(forward: 5’ CACCTGCGCCGAGGAGTGGAAC 3’, reverse: 5’ 
CTAGAGGATCACCGTGACGTTGACGTTG 3’). The reaction was incubated at 95°C for 45 s; 
30 cycles of: 95°C for 45 s, 57°C for 45 s, 72°C for 60 s; and 72°C for 10 min. The resulting 
PCR product was gel-purified using a QIAquick gel extraction kit (Qiagen) and cloned into the 
pET100 vector (Invitrogen) using manufacturer's protocol. TOP10 E. coli were transformed 
following the manufacturer's instructions and plasmid DNA was isolated using a Qiagen 
MiniPrep kit (Qiagen). 
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Expression and purification of partial house finch IgA alpha heavy chain 
Two vials of BL21 Star (DE3) E. coli (Invitrogen) were transformed with 10 ng of plasmid 
DNA, incubated on ice for 30 min, heat-shocked at 42°C for 30 s, and tubes immediately 
transferred to ice. 250 µL of SOC media was added to each tube and incubated at 37°C for 
30 min and the mixture was added to 10 mL of LB broth with ampicillin and 1% glucose and 
grown overnight at 37°C. 250 mL of prewarmed LB/ampicillin/glucose media was inoculated 
with 10 mL of the overnight culture and grown at 37°C until an OD600 of 0.6 was reached. 
1 mM isopropylthio-β-galactoside (Invitrogen) was added to induce expression of the construct 
and the culture was incubated for an additional 1.5 h at 37°C. The culture was pelleted at 
3750 × g for 25 min. Protein was harvested under denaturing conditions as per manufacturer's 
instructions using the Ni-NTA Fast Start kit (Qiagen). 
The purified product was analyzed by a total protein blot using Ponceau S stain (0.1% 
Ponceau S in 5% acetic acid). Protein concentration was determined using a BCA protein assay 
kit (Pierce, Rockford, IL) following the manufacturer's “test tube procedure” protocol. 
 
Production of anti-sera 
Two New Zealand White rabbits were immunized with the recombinant protein. The 
immunization protocol was carried out by Cocalico Biologicals (Reamstown, PA). Both pre-
immunization sera and anti-sera were collected. 
 
Western blotting 
House finch serum and recombinant IgA were prepared under denaturing conditions for SDS-
PAGE. Recombinant protein (0.70 mg/mL) was diluted 1:300 in PBS. House finch serum was 
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diluted 1:100 in PBS. Samples were diluted 1:1 with sample buffer (4% SDS, 20% glycerol, 
50 mM Tris, pH 6.8, 0.1% bromophenol blue, 10% 2-mercaptoethanol) and separated on a 
polyacrylamide gel containing a stacking gel of 5% and a separating gel of 10%. SeeBlue® Plus2 
pre-stained standard (Invitrogen) was run concurrently with the samples. Proteins were 
transferred to 0.45 µM nitrocellulose membranes (Bio-Rad, Hercules, CA) using transfer buffer 
(20 mM Tris, 150 mM glycine, and 20% methanol) at 200 V and 4°C. After transfer, the 
membrane was stained with Ponceau S (0.1% Ponceau S in 5% acetic acid) to visualize transfer. 
Membranes were de-stained by rinsing in distilled water and incubated in blocking buffer (Tris-
buffered saline with 1% Tween 20 [TBS-T] plus 5% non-fat dry milk [Nestlé, Vevey, 
Switzerland]) for 2 h at room temperature. After washing in TBS-T, the blots were incubated 
with either the pre- or post-immunization sera. Sera from rabbit 1 were diluted 1:2000, while 
sera from rabbit 2 were diluted 1:4000 in TBS-T with 5% non-fat dry milk and incubated 
overnight at 4°C on a rocker. After washing in TBS-T, the blots were incubated with HRP-
conjugated goat anti-rabbit IgG (Bethyl Laboratories, Montgomery, TX) diluted 1:10,000 in 
TBS-T with 5% non-fat dry milk for 1 h at room temperature. Blots were washed with TBS-T 
and ECL Western blotting substrate (Pierce) was applied as recommended by the manufacturer, 
incubated for 5 min, covered with plastic wrap and exposed to film (Amersham Hyperfilm ECL, 
GE Healthcare, Piscataway, NJ) in a dark room. 
 
Tissue sources 
Harderian gland and conjunctival tissues were collected from house finches, house sparrows 
(Passer domesticus) and American goldfinches (Carduelis tristis) infected with M. gallisepticum 
6 weeks post-infection. One-year-hatchling birds were trapped in Tompkins County, NY (42° 
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51’ N, 76° 34’ W) during October and November 2006 using mist nets under permits (LCP 99-
039) from New York State Department of Environmental Conservation (Albany, NY) and a 
federal collecting permit (PRT 802829). As part of a larger study (K. Dhondt et al. unpublished) 
the birds were infected with M. gallisepticum by applying 50 µL of inoculum (3.24 × 105 colony 
forming units/mL) to each eye. 
 
Preparation of samples for immunohistochemistry 
After overnight fixation of whole birds in 10% neutral buffered formalin, the Harderian glands 
were dissected from the eye orbit, along with surrounding ocular tissues. The fixed tissues were 
embedded in paraffin, serially sectioned at 5.0 µM, mounted on slides, and used for 
hematoxylin-eosin (H&E), immunoperoxidase, or double immunofluorescence staining. 
 
Immunoperoxidase staining 
Sections were de-waxed in xylene, rehydrated through a series of solutions of decreasing ethanol 
concentrations (100%, 95%, 70%), and placed in water. To block for endogenous peroxidase, the 
slides were immersed in 0.05% hydrogen peroxide in methanol for 10 min, washed in 70% 
ethanol and placed in PBS. The anti-sera were initially tested without antigen retrieval, however, 
at a later date an antigen retrieval step was added by subjecting the sections to microwaving at 
high power (800 W) for 20 min in 0.01 M sodium citrate buffer, pH 6.0. After washing in PBS, 
the sections were incubated in 10% normal goat serum and 10% non-fat dry milk for 20 min at 
room temperature in a humid chamber. The blocking solution was blotted off and rabbit anti-
house finch IgA serum was diluted 1:120 in PBS with casein (Vector Laboratories, Burlingame, 
CA) and incubated in a humid chamber for 2 h at 37°C. After washing in PBS, the sections were 
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incubated with a biotinylated goat anti-rabbit IgG (Vector Laboratories) diluted 1:200 in PBS for 
20 min at room temperature in a humid chamber. After washing in PBS, the sections were 
incubated with HRP-streptavidin (Zymed-Invitrogen, Carlsbad, CA) diluted 1:200 in PBS for 
20 min at room temperature. After washing in PBS, AEC chromogen/substrate solution (Zymed-
Invitrogen) was applied and after appropriate color developed the reaction was stopped with 
distilled water. The sections were counterstained using Gill's #2 hematoxylin for 30 s, rinsed 
with water, and mounted. 
 
Double immunofluorescence 
The sections were blocked with 10% donkey serum and 10% non-fat dry milk in PBS-0.05% 
Tween and incubated with goat anti-bird IgG (Bethyl Laboratories) diluted 1:300 and anti-house 
finch IgA diluted 1:20. Biotin-labeled donkey anti-goat IgG (Jackson ImmunoResearch, West 
Grove, PA) diluted 1:200 and FITC labeled donkey anti-rabbit IgG (Jackson ImmunoResearch) 
diluted 1:80 were applied, followed by incubation with streptavidin Texas Red (Vector 
Laboratories) diluted at 1:200. The sections were mounted with Vectashield mounting medium 
with DAPI (Vector Laboratories). 
 
Experimental infection and collection of lachrymal fluid 
One-year-hatchling house finches were captured with appropriate permits (Montgomery Co., 
VA: VDGIF [031626], Tompkins Co., NY: USGS Bird Banding Lab [23513], CA: [SCL\P 
802041-01]). These birds were inoculated with M. gallisepticum as part of a larger study 
(Hawley et al. 2010), and lachrymal samples were collected pre-inoculation and weekly post-
infection as described below. We used a subset of 119 lachrymal samples (sample sizes: week 
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0 = 37; week 1 = 26; week 2 = 16; week 3 = 24; week 4 = 16) to test whether the anti-sera could 
be used in ELISA to detect M. gallisepticum-specific IgA in lachrymal fluid. 
Schirmer tear test strips (Schering-Plough Animal Health, Union, NJ) were modified to fit into 
the conjunctiva of a house finch. Two cuts were made aseptically to form a rectangle of 
3 mm × 30 mm. When applied to the 3 mm end of the strip, 1 µL saline absorbs onto a 
3 mm × 4 mm area on the strip. This makes it possible to quantify the amount of lachrymal fluid 
collected from each bird. 
For each individual sample, the 3 mm end of the strip was held in the conjunctiva for 
15 s. The fluid boundary mark was recorded and the strip was immediately placed into 250 µL of 
PBS/0.05% Tween 20. The tube was vortexed vigorously, the tear strip was discarded and the 
sample was stored at −28°C. 
 
ELISA 
Idexx FlockChek MG antibody ELISA kit (Idexx, Westbrook, ME) was used to measure M. 
gallisepticum-specific IgA in house finch lachrymal samples by modifying the manufacturer's 
protocol. First, 300 µL of 1% BSA (Pierce 10× BSA, Thermo Fisher Scientific, Rockford, IL) in 
PBS-0.05% Tween 20 was added to each well and plates were incubated at room temperature for 
40 min. After washing three times with 350 µL of PBS-T (ELx50 Auto Strip Washer, Bio-Tek, 
Winooski, VT), lachrymal samples (0.3 µL lachrymal fluid in 100 µL PBS-T) were added to the 
wells and plates were incubated for 1 h at room temperature. After washing with PBS-T, rabbit 
anti-house finch IgA serum (diluted 1:200 in PBS-T) was added to each well and the plates were 
incubated for 1 h at room temperature. After washing, goat anti-rabbit IgG (Bethyl Laboratories) 
diluted 1:60,000 in PBS-T was added and the plates were incubated for 40 min at room 
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temperature. After washing, 100 µL of TMB (included in Idexx kit) was applied to the wells and 
plates were incubated for 15 min followed by the addition of 100 µL of stop solution. The 
absorbance was read at 630 nm (ELx800 Universal Microplate Reader, Bio-Tek). Samples were 
run in duplicate and the average was calculated for further analysis. The authors were blinded to 
the infection status of the samples. 
 
Statistical analysis 
A one-way ANOVA was performed on ELISA data using JMP statistical analysis software 
(version 7.0, SAS Institute). 
 
5.3 Results and discussion 
House finch IgA heavy chain sequence 
A 469 base pair region of house finch alpha heavy chain was amplified from spleen cDNA. 
Based on the predicted sequence of the chicken IgA constant region (Mansikka 1992), the 
forward primer targets a sequence within constant region 3 and the reverse primer targets 
sequences within constant region 4 of the chicken IgA heavy chain. The predicted amino acid 
sequence of the cloned house finch IgA constant region shares 46% and 55% amino acid 
sequence identity with chicken and duck, respectively. Figure 5.1 shows the alignment of house 
finch, chicken, and mallard duck amino acid sequences. The four cysteine residues present in the 









Figure 5.1. Alignment of the partial IgA heavy chain sequence of the house finch, chicken, and 
mallard duck. Conserved cysteine residues are marked with an asterisk. 
 
 
Specificity of the anti-sera 
The house finch IgA cDNA sequence was inserted into an expression vector, expressed in E. 
coli, and a 21 kDa recombinant house finch IgA protein was produced and purified using a 6-
histidine tag added to the recombinant protein (Figure 5.2A). This recombinant protein was used 
for anti-sera production. The anti-sera reacted with a single house finch serum protein in Western 
blot (Figure 5.2B). Used at the same dilution of the anti-sera, the pre-immune sera showed no 
background staining. The protein band was ∼50–55 kDa, approximately equal to the size of the 
alpha heavy chain of the duck (Oliveira et al. 2006). The anti-sera did not react with the light 
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Figure 5.2. (A) Total protein blot showing purification of recombinant IgA. After expression of 
house finch IgA, E. coli cells were lysed. Recombinant IgA (∼21 kDa) was purified from other 
proteins in the supernatant by use of a chromatography column that binds specifically to the 6-
histidine tag present on the recombinant IgA. Lane 1: SeeBlue® Plus2 Pre-stained standard 
ladder, labeled with approximate molecular weight (MW) in kDa, lane 2: E. coli supernatant, 
lane 3: purified recombinant IgA. (B) Western blot using anti-house finch IgA sera. House finch 
sera were run in lane 1 and recombinant IgA protein was run in lane 2 under denaturing 
conditions. The blots were then incubated with either pre- or post-immunization rabbit serum. 
After immunization, both rabbits produced antibodies that reacted to the house finch IgA heavy 
chain (50‒55 kDa) and the recombinant protein (21 kDa). 
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The Harderian gland was chosen for immunohistochemical analysis because in birds it 
contains a large population of IgA-secretion plasma cells (Olah et al. 1992, Ohshima and 
Hiramatsu 2002, Oliveira et al. 2006, Khan et al. 2007). When viewed with H&E stain, the house 
finch Harderian glands contained many plasma cells with eccentrically located nuclei, abundant 
cytoplasm, and prominent Golgi (Figure 5.3). Using immunoperoxidase staining, the anti-sera 
labeled plasma cells in the house finch Harderian gland (Figure 5.4) and in the conjunctiva of 
house finches infected with M. gallisepticum (Figure 5.5). When pre-immunization sera were 
used in place of the anti-sera, no staining was present (Figure 5.4A and C). Many IgA+ cells 
were located in the lamina propria of the Harderian gland (Figure 5.4B). In some areas, the 
luminal linings of the ducts were IgA+ and occasionally, an IgA+ cell was found within the duct 
epithelium (Figure 5.4D). Oliveira et al. (2006) also documented intraepithelial plasma cells in 
the Harderian gland of the duck. Without antigen retrieval, IgA+ cells often stained with a single 
red spot inside the cytoplasm (Figure 5.4D), whereas with antigen retrieval by microwave 
treatment the cytoplasm stained uniformly IgA+. Oliveira et al. (2006) used a similar antigen 
retrieval step to visualize plasma cells in the Harderian gland of the duck. The anti-sera also 
stained cells in the Harderian gland of the house sparrow and American goldfinch (Figure 5.6). 
Thus, it is expected that this reagent will be appropriate for use in other related species. 
There are also IgY+ plasma cells in the lamina propria of the avian Harderian gland 
(Ohshima and Hiramatsu 2002, Oliveira et al. 2006, Khan et al. 2007). To ensure that the anti-
sera were staining IgA+ plasma cells specifically, double immunofluorescence was carried out 
with goat anti-bird IgY affinity-purified polyclonal reagent and the house finch IgA anti-sera. 
The double immunofluorescence of plasma cells in the Harderian gland (Figure 5.4E) and 
conjunctival tissue (Figure 5.4F) showed labeling of IgY+ cells (red) and IgA+ cells (green) with 
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Figure 5.3. Histology of house finch Harderian gland. A. Partial view (40×) of the house finch 
Harderian gland and adjacent ocular muscle, showing duct of Harderian gland. B. Harderian 
gland (100×) showing acini and a highly cellular lamina propria. C. Harderian gland (600×). 
Beneath the glandular epithelium lie lymphocytes, many with cellular characteristics common to 
plasma cells (prominent Golgi, eccentric nucleus, abundant cytoplasm). 
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Figure 5.4.  Immunoperoxidase staining of IgA+ plasma cells in the house finch Harderian gland 
using the pre-immunization sera (A and C) or rabbit anti-house finch IgA sera (B and D). In (D) 
arrowhead points to intraepithelial IgA+ plasma cell, arrows point to IgA+ luminal lining. 
Antigen retrieval was used for (A and B) (resulting in complete cytoplasmic staining), but not in 
(C and D) (resulting in IgA+ spots in cytoplasm). Immunofluorescence staining of IgA+ (green) 
and IgY+ (red) plasma cells in the Harderian gland (E) and conjunctiva of a finch with M. 
gallisepticum-associated conjunctivitis (F). Nuclei are stained blue. Magnification (A–F) 400×.  
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Figure 5.5. Immunoperoxidase staining of IgA+ cells in the conjunctiva of a house finch infected 
with Mycoplasma gallisepticum (200×). Stained with anti-house finch IgA sera (A) or pre-
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Figure 5.6. (A and B) Immunoperoxidase staining of IgA+ plasma cells in the American 
goldfinch Harderian gland using rabbit anti-house finch IgA sera (A) or pre-immunization 
control sera (B). (C and D) Immunoperoxidase staining of IgA+ plasma cells in the house 
sparrow Harderian gland using rabbit anti-house finch IgA sera (C) or pre-immunization control 
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M. gallisepticum-specific IgA in house finch lachrymal samples 
The anti-sera were also utilized in ELISA to detect M. gallisepticum-specific IgA in house finch 
lachrymal samples (Figure 5.7). After experimental inoculation, M. gallisepticum-specific IgA 
was detected at 2, 3, and 4 weeks post-infection in the lachrymal fluid (one-way ANOVA, 
F(4,114) = 7.508, p < 0.0001). Although the changes in optical density (OD) at 2, 3 and 4 weeks 
post-infection are relatively small, the mean background OD values at 0 and 1 week post-
infection show little variation. After inoculating chickens with infectious bronchitis virus, Toro 
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Figure 5.7. Detection of M. gallisepticum-specific IgA in lachrymal fluid. House finches were 
inoculated ocularly with M. gallisepticum. Lachrymal samples were taken pre-infection and 
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Although only small amounts (∼0.75 µL) of lachrymal fluid were collected from the house 
finches, this was adequate to detect changes in IgA level as infection progressed. While 
providing a limited amount of sample, this collection method was simple, quick to perform, and 
posed little harm to the delicate conjunctival tissues. 
In summary, this paper reports the first partial cloning of a passerine IgA constant region 
sequence and the first reagent developed specifically to detect IgA from a passerine species. The 
reagent has been applied successfully in Western blot, immunohistochemistry, and ELISA. The 
anti-sera will be used to study the mucosal antibody response of house finches infected with the 
bacterium M. gallisepticum. 
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6.1 Abstract 
Mycoplasma gallisepticum (MG) has become a common cause of conjunctivitis in free-living 
house finches (Carpodacus mexicanus) since its emergence in the early 1990s. To date, temporal 
and spatial genotypic variation in MG has been documented, but phenotypic variation in 
pathogenicity and immunogenicity has not been examined. House finches were inoculated with 
MG isolates Virginia (VA)1994, California (CA)2006, or North Carolina (NC)2006, which were 
cultured from free-living house finches with conjunctivitis in 1994, 2006, and 2006, respectively. 
Infection with NC2006 resulted in the most severe eye lesions, highest pathogen loads, and 
highest levels of pathogen-specific lachrymal and serum antibodies. Infection with CA2006 
caused the least severe eye lesions, lowest pathogen load, and lowest levels of antibodies. A 
small number of birds in each group developed protracted, severe disease in spite of robust 
antibody responses, suggesting that immunopathology may contribute to the lesions. Immunoblot 
analyses indicated that isolates are antigenically similar; thus, there may be partial cross-
protection if a house finch encounters two or more strains of MG throughout the course of its 
lifetime. This study provides evidence that MG strains or strain variants circulating in house 
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6.2 Introduction 
In 1994, Mycoplasma gallisepticum (MG), a common respiratory pathogen of poultry, emerged 
as a cause of conjunctivitis in free-living house finches (Carpodacus mexicanus) (Ley et al. 
1996, Dhondt et al. 1998) and rapidly resulted in major population declines (Hochachka and 
Dhondt 2000). Among house finches, MG is most likely transmitted via direct contact (Ley 
2003) and fomites such as birdfeeders (Dhondt et al. 2007a). The organism can be cultured from 
conjunctival swabs of free-living house finches (Ley et al. 1996, Hartup et al. 2000) and 
experimental infection by conjunctival exposure results in the clinical signs seen under natural 
conditions (Kollias et al. 2004, Sydenstricker et al. 2006). Experimentally infected house finches 
develop partial immunity after initial infection. These birds remain susceptible to re-infection, 
but clinical signs are generally milder and of shorter duration (Sydenstricker et al. 2005).  
Strains of MG isolated from commercial poultry are quite variable with respect to 
pathogenicity, transmissibility, and immunogenicity in chickens and turkeys (Rodriguez and 
Kleven 1980, Soeripto et al. 1989a, Soeripto et al. 1989b, Dingfelder et al. 1991, Sanei et al. 
2007). While some variations at the genomic level have been documented among MG isolates 
from house finches (Pillai et al. 2003, Cherry et al. 2006), there has only been one recent report 
suggesting differences in pathogenicity based on experimental infections under controlled 
conditions (Hawley et al. 2010). Earlier studies using MG isolates collected from house finches 
in Virginia in 1994 (Sydenstricker et al. 2006), Georgia in 1995 (Farmer et al. 2002), and 
Alabama in 1999 (Farmer et al. 2005) produced clinical signs in experimentally infected birds, 
but variations in disease severity or immune responses were not documented among the isolates. 
Variations in lesion severity and duration in house finches occur among individuals 
experimentally challenged with a given MG isolate. After experimental infection, eye lesions 
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resolve in most birds over the course of several weeks; however, often a small number of birds 
experience a severe, protracted form of the disease (Roberts et al. 2001, Sydenstricker et al. 
2006). Development of chronic disease could be caused by co-infection with viruses (Adler et al. 
1962) or other bacterial species such as Escherichia coli (reviewed by Kleven 1998a, Bradbury 
2005), invasion of non-phagocytic cells (Winner et al. 2000), compromised immunocompetence 
(Cartner et al. 1998), or as a consequence of immunopathology (Bodhankar et al. 2010). The 
development of chronic lesions could also be due to the ability of MG to undergo immune 
evasion by antigenic variation of cell surface lipoproteins, most notably in the VlhA family of 
proteins. The multi-gene family encoding variants of VlhA comprises approximately ten percent 
of the MG genome (Papazisi et al. 2003). The main function of this gene family appears to be 
evasion of host antibody responses via phenotypic variation of the surface protein (Glew et al. 
2000). 
To characterize and compare the pathogenesis of MG infection in house finches, we 
challenged birds with MG isolates VA1994, CA2006, or NC2006 by the ocular route; these 
isolates were cultured from the conjunctivae of free-living house finches with eye lesions typical 
of MG infection in Virginia during 1994, California during 2006, and North Carolina during 
2006, respectively. Eye lesion scores, pathogen loads, and lachrymal and systemic antibody 
responses were measured weekly post-infection. MG load was measured by quantitative (q)PCR 
assay targeting the mcg2 gene, which is present as one copy per MG genome, while MG-specific 
serum antibodies and lachrymal IgA antibodies were measured by ELISA. Additionally, 
antigenic profiles of the three isolates were examined using immunoblotting. 
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6.3 Materials and methods 
House finches  
During August through October 2007, twenty-two house finches were captured via mist-nets and 
cage traps in Montgomery Co., VA (n=17), and Tompkins Co., NY (n=5) under permits from the 
Virginia Department of Game and Inland Fisheries (#031626), New York Department of 
Environmental Conservation (#99-039) and USGS Bird Banding Laboratory (#23513). In 
addition, required permits were obtained for house finch capture in California (SC-9517), 
transfer (USFWS MB158404-0), and importation to Virginia (VDGIF Exotic Import Permit 
031729). Twenty house finches were captured in Contra Costa County, CA using mist nets and 
transported by commercial air to Virginia Tech in January 2008. One month prior to 
experimental challenge, all birds were transferred by state vehicle to Ithaca, NY under Cornell 
University IACUC protocol 2006-094. All birds were housed in individual cages in the Poultry 
Virus Isolation Facility at constant day length (12L:12D) and temperature and provided at ad 
libitum with drinking water and pelleted diet (Daily Maintenance Diet, Roudybush Inc., 
Woodland, CA).  
 During August through October 2008, thirty birds were captured in Tompkins Co., NY 
using mist nets under NY Department of Environmental Conservation (#99-039) and USGS Bird 
Banding Lab (#23513) permits and housed individually until transport to Virginia Tech via state 
vehicle under Virginia Tech IACUC protocol BIOL-07-052. Prior to use in the experiment, 
house finches were tested for the absence of antibodies to Mycoplasma gallisepticum (MG) by 
rapid plate agglutination (RPA) (Kleven 1998b). House finches in experiment 2 were also tested 
for the absence of infection by quantitative PCR assay. All procedures for animal care and use 
were approved by Virginia Tech and Cornell University IACUCs.    
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Mycoplasma gallisepticum isolates  
MG isolate VA1994 (accession 7994-1, Avian Diseases Research Laboratory [ADRL], North 
Carolina State University College of Veterinary Medicine [NCSU CVM]) was obtained from a 
Virginia house finch with conjunctivitis in June 1994 (Ley et al. 1996). An expanded seventh 
passage culture (7994-1 7P, 5/24/04) was used for challenge and had a viable count of 1.66 x 107 
color changing units (CCU)/ml determined by the most probable number method (Meynell and 
Meynell 1970). CA2006 (accession 2006.052-5, ADRL NCSU CVM) was acquired in June 2006 
from a house finch with conjunctivitis in California. Cultures of this isolate were expanded using 
Frey’s medium with 15% swine serum (modified from Kleven 1998b). The fourth passage 
culture (2006.052-5 4P, 11/12/07) was used for experimental infection and had a viable count of 
3.37 x 106 CCU/ ml. The isolate NC2006 (accession 2006.080-5, ADRL NCSU CVM) was 
acquired in 2006 from a house finch with conjunctivitis in North Carolina. The fourth passage 
culture of NC2006 (2006.080-5 4P, 1/9/09) had a viable count of 3.04 x 108 CCU/ml. All MG 
stocks were stored at -70°C until immediately prior to use. Upon thawing, VA1994 was diluted 
1:5 in Frey’s media to approximate the dose (CCU/ml) of CA2006 in experiment 1, while 
NC2006 was diluted 1:18 in Frey’s media prior to use in experiment 2.  
 
Challenge studies  
Experimental design. Two experiments were conducted (see Table 6.1 for a summary of 
experimental designs). In experiment 1, the pathogenesis of infection was examined for the 
VA1994 and CA2006 isolates. Two groups of twenty single-housed house finches were 
challenged by applying 0.05 ml containing approximately 3.3 x106 CCU/ml of VA1994 or 
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CA2006 to both palpebral conjunctivae of each bird. Four birds served as negative controls and 
received 0.05 ml of media alone in each conjunctiva. Two birds inoculated with CA2006 had 
positive RPA test results prior to experimental infection; the two birds did not have clinical signs 
of infection and were negative for the MG qPCR assay. These results may have been false 
positives or may represent prior exposure to MG. These two birds were excluded from statistical 
analyses. 
 The experimental design of experiment 1 is also described by Hawley et al. (2010); the 
study found evidence that, on average, host population origin and genetic diversity did not have 
an effect on host resistance to infection, as measured by lesion score and pathogen load. 
In experiment 2, the pathogenesis of infection was compared for the VA1994 and 
NC2006 isolates. Thirteen single-housed house finches were challenged as described for 
experiment 1 with 0.05 ml containing 1.7 x107 CCU/ml of VA1994 or NC2006. Four birds 
served as negative controls and received 0.05 ml of media in each conjunctiva. 
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Table 6.1: Experimental design of challenge studies using isolates VA1994, CA2006, and 
NC2006. In two experiments, house finches were infected with three isolates of Mycoplasma 
gallisepticum (MG). MG inocula were quantified using color changing units (ccu) and were 
administered to the right and left conjunctivae of each bird.  
 
Experiment MG isolate	  or	  control Sample size (house finches) Approximate dose  (total ccu per eye) 
1 VA1994 20 1.7 x 105 
1 CA2006 20 1.7 x 105 
1 controls 4 0 
2 VA1994 13 8.3 x 105 
2 NC2006 13 8.3 x 105 





Lesion scoring. Birds were examined for eye lesions at day 2, day 7, and weekly thereafter. 
Lesions were scored on a 0 to 3 scale (Sydenstricker et al. 2005) as follows: 1= minor swelling 
around the eye ring, 2= moderate swelling and eversion of the conjunctival tissue, and 3= the eye 
is nearly hidden by swelling and crusted exudates.  
 
Sample collection. Lachrymal fluids were collected pre-challenge and weekly until eight weeks 
post-challenge using modified Schirmer tear test strips (Schering-Plough Animal Health, Union, 
NJ) as described by Grodio et al. (2009). After collection, strips were placed in microcentrifuge 
tubes containing 250 µl of PBS/0.05% Tween 20 (PBS-T); tubes were vortexed vigorously, tear 
strips were discarded and samples were stored at -20°C until assayed. 
Conjunctival swabs for qPCR assays were collected before challenge, on day 2, day 7 and 
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weekly thereafter. Sterile forceps (Fisher Scientific, Pittsburgh, PA) were used to hold the lower 
palpebra and a cotton-tipped wooden-handle swab (Fisher Scientific) dipped in tryptose 
phosphate broth (TPB) was inserted into the lower palpebral sac. Immediately after sample 
collection, the tips of the swabs were placed into 300 µl of sterile TPB. Swabs were swirled and 
wrung out on the inside of tubes to remove liquid from the swabs before discarding. Samples 
were frozen at -20°C prior to DNA extraction.  
Blood was collected from the wing vein into one to two lithium-heparinized 
microcapillary tubes. Tubes were spun in a tabletop centrifuge and plasma was collected and 
frozen at -20°C. 
 
Quantification of pathogen load 
MG loads were quantified using the qPCR assay as described by Grodio et al. (2008). Genomic 
DNA was extracted from conjunctival swab samples using Qiagen DNeasy 96 Blood and Tissue 
kits (Qiagen, Valencia, CA). Primers (Forward: 5’-GGTCCTAATCCCCAACAAAGAAT, 
Reverse: 5’-CTTGGTTGGTTCATATTAGGCATTT, Integrated DNA Technologies, Coralville, 
Iowa) and probe (5’-6-FAM-CCACAGGGCTTTGGTGGCCCA-BHQ-1, Integrated DNA 
Technologies) targeting the mgc2 gene of MG were used. Each 25 µl reaction contained 12.5 µl 
TaqMan PCR Universal Master Mix (2x), 0.125 µl each of 100 µM forward and reverse primers, 
0.25 µl of 10 µM probe, 7 µl DNase-free water, and 5 µl of DNA sample. Cycling was 
performed using an ABI Prism 7700 (Applied Biosystems, Foster City, CA) and the following 
parameters: 50°C for 2 min, 95°C for 10 min and 40 cycles of 95°C for 15 sec and 60°C for 60 
sec. Standard curves were generated for each run using 10-fold serial dilutions of plasmid DNA 
containing 2.53 x 101 to 2.53 x 108 copy numbers of a 303 bp mgc2 insert. The average copy 
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numbers for each bird was calculated using the values for the right and left eye at each time point 
and log10 transformed for statistical analysis. We eliminated a single qPCR value from analysis 
that was obtained from one eye of a bird prior to inoculation, as this value (11.34 log10) was 
much higher than the maximum value of MG (3.08 log10) detected in any individual post-
inoculation in experiment 1 (Hawley et al. 2010). 
 
Antibody assays  
Serum antibodies. The Idexx FlockChek Mycoplasma gallisepticum antibody ELISA kit (Idexx, 
Westbrook, ME) was used to measure serum antibodies with modifications to the manufacturer’s 
protocol. All steps were carried out at room temperature. A blocking step included the addition 
of 300 µl of 1% BSA (Pierce 10X BSA, Thermo Fisher Scientific, Rockford, IL) in PBS for 
forty minutes followed by a washing step. All washing steps consisted of washing the plate three 
times with 350 µl of PBS with 0.05% Tween 20 (PBS-T) using ELx50 Auto Strip Washer (Bio-
Tek, Winooski, VT). House finch serum samples were diluted 1:50 in the kit’s sample buffer, 
100 µl were added to duplicate wells and incubated for 1 h. Plates were then washed, 100 µl pre-
diluted kit antibody (goat anti-chicken/goat anti-turkey, HRPO conjugate) was added to the wells 
and incubated for 1 h, followed by a washing step. TMB substrate and stop solution were added 
as per manufacturer’s protocol and absorbance was read at 630 nm using an ELx800 Universal 
Microplate Reader (Bio-Tek). The average value was calculated for each sample for further 
analysis. To control for inter-assay variation, the ELISA values were calculated using the 
equation (sample mean – negative control)/(positive control – negative control).  
 
	   76 	  
Lachrymal antibodies. MG-specific IgA antibodies in the lachrymal fluids were measured using 
the Idexx FlockChek Mycoplasma gallisepticum antibody ELISA kit as described previously 
(Grodio et al. 2009). All steps were carried out at room temperature. First, 300 µl of 1% BSA in 
PBS-T was added to each well and incubated for forty minutes. After washing three times with 
350 µl of PBS-T, lachrymal samples (0.3 µl lachrymal fluid in 100 µl PBS-T) were added to the 
wells and incubated for 1 h. After washing with PBS-T, rabbit anti-house finch IgA heavy chain 
serum (diluted 1:200 in PBS-T) was added to each well and the plates were incubated for 1 h. 
After washing, goat anti-rabbit IgG (Bethyl Laboratories, Montgomery, TX) diluted 1:60,000 in 
PBS-T was added and the plates were incubated for forty minutes. After washing, TMB substrate 
and stop solution were added as per manufacturer’s protocol and absorbance was read at 630 nm. 
To control for inter-assay variation, the ELISA values were calculated as described above. 
 
Immunoblots 
Broth cultures of VA1994, CA2006, and NC2006 described above were spun down at ~18,000g 
at 4°C for thirty minutes. The cells were washed three times with sterile PBS and after 
centrifugation, supernatant was removed and pellets were placed on ice. Washed cells were 
solubilized in 20 mM Tris containing 0.1% SDS, 140 mM NaCl, 1% IGEPAL, 10% glycerol, 
0.5% deoxycholate acid, and 2 mM EDTA. Protein concentration was determined using 
Bradford’s assay and a BSA standard curve (New England Biolabs, Ipswich, MA). Solubilized 
proteins of the MG isolates (4 µg/well) were diluted 1:1 with sample buffer (4% SDS, 20% 
glycerol, 50 mM Tris, pH 6.8, 0.1% bromophenol blue, 10% 2-mercaptoethanol), incubated at 
100°C for 10 minutes, and separated on a SDS-PAGE gel consisting of 5% stacking/10% 
resolving gels. Proteins were transferred to 0.45 µm nitrocellulose membranes (Bio-Rad, 
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Hercules, CA). Membranes were incubated in blocking buffer (Tris-buffered saline with 1% 
Tween 20 [TBS-T] plus 5% non-fat dry milk [Nestle, Vevey, Switzerland]) for 2 h at room 
temperature. After washing in TBS-T, individual lanes were cut from the blot and incubated with 
sera of infected house finches (14 days post-infection) diluted 1:200 in blocking buffer. The blots 
were incubated overnight at 4ºC, washed with TBS-T and incubated with goat anti-bird IgG-
HRP (Bethyl Laboratories, Montgomery, TX), diluted 1:60,000 in blocking buffer for 1 h at 
room temperature. Blots were washed and SuperSignal WestPico Chemiluminescence substrate 
(Pierce, Thermo Fisher Scientific) was applied as recommended by the manufacturer. The blots 
were covered with plastic wrap and exposed to film (Amersham Hyperfilm ECL, GE Healthcare, 
Piscataway, NJ) in a dark room. 
 
Statistical analyses 
The longitudinal nature of the lesion, qPCR, and antibody data necessitated the use of a general 
linear mixed model to account for repeated measures on individual birds. Past experience 
(Hawley et al. 2010) suggested that both an individual bird random effect and temporally auto-
correlated errors were statistically important for model fit, thus we fit models that contained 
these properties. We examined the influence of experiment (challenge 1 versus challenge 2), MG 
isolate, day post-inoculation (PI), and all interactions on eye score, pathogen load, and serum and 
lachrymal antibody responses using a general linear mixed model (Pinheiro and Bates 2000) that 
included a random intercept effect for individual birds and errors within a bird that were 
autocorrelated across day PI (corCAR1 in R package nlme, R Core Development Team 2006, 
Pinheiro et al. 2007). Separate models were fit to determine the repeatability of the two challenge 
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experiments with VA1994 and the effects of MG isolate, days PI, and the interaction across all 
challenge studies.   
To quantify pathogen clearance and disease recovery, we calculated survival curves 
based on the presence and absence of pathogen (qPCR) and lesions. Because these were only 
observed weekly, the exact time of clearance or disease recovery is only known to the weekly 
interval. Thus, we used techniques appropriate for this interval-censored data to construct non-
parametric survival curves and test for differences between MG isolates (icfit and ictest, 
respectively, in the R package interval, Fay and Shaw 2010). We fit separate curves for each MG 
isolate for both pathogen load and lesion recovery and then tested for differences between strains 
of the survival curves using a logrank test (Fay and Shaw 2010). For this analysis, we pooled 
data across experiments for VA1994 because of the very small sample size for estimating 
survival curves. 
In order to explore the relationship between pathogen load (qPCR), virulence (eye 
lesion), and serum and lachrymal antibody responses across individual finches and pathogen 
strains, we summed each response for each bird over the first 63 days PI. We then calculated 
rank correlations between the responses and used multivariate analysis of variance (MANOVA) 
to explore the effects of MG isolate on the multivariate response. We used a randomization test 
to validate the results from the MANOVA because assumptions of multivariate normality and 
equality of within-group covariance were likely not strictly met. 
GraphPad PRISM (version 5.0b, GraphPad Software, Inc., San Diego, CA) was used to 
generate the graphs illustrated in Figure 6.5. 
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6.3 Results 
Repeatability of challenge studies using VA1994 
Birds were inoculated with VA1994 in two consecutive years, with a higher dose of inoculum 
used in experiment 2. Antibody responses to the VA1994 isolate showed similar trends in both 
experiments, but experiment 2 produced slightly higher pathogen load and lesion score and these 
differences were significantly different between experiments (Figure 6.1). For lesion score, the 
average effect for experiment (F1,31 = 1.15, p = 0.29) was not significant but there was a 
significant interaction between days PI and experiment (F9,279 = 1.98, p = 0.04), such that lesion 
score had a higher peak at weeks 1-4 PI in experiment 2 (Figure 6.1A). For MG load, both the 
average effect (F1,31 = 36.26, p < 0.0001) and days PI by experiment interaction effect (F8,248 = 
5.18, p < 0.0001) was significant and showed that qPCR was higher across all days PI in 
experiment 2 (Figure 6.1B). The serum antibody response was not significantly different 
between experiments (F1,31 = 0.66, p = 0.42) or for the interaction between experiment and days 
PI (F8,242 = 0.75, p = 0.65; Figure 6.2A). For lachrymal IgA, the effect of experiment was not 
significant (F1,31 = 0.26, p = 0.62) but the interaction between days PI and experiment was 
significant (F7,216 = 3.49, p = 0.002). However, inspection of the estimated effects showed that 
there was no consistent difference between experiments, as the estimated interaction effect 
between days PI and experiment for IgA seemed to fluctuate between negative and positive each 
week (Figure 6.2B). Because of these obvious differences between experiments in lesion scores, 
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Lesion scores 
When all isolates were analyzed together, all estimated effects of isolate, days PI, and the isolate 
by days PI interaction were significant (p < 0.0003). Birds infected with NC2006 had the highest 
lesion scores, while birds infected with CA2006 had the lowest lesion scores (Figure 6.1A). 
Birds infected with VA1994 in either experiment had intermediate scores. In experiment 2, one 
uninfected control bird was noted to have irritation of the right eye at day 7 but no clinical signs 
were noted thereafter. This bird subsequently was qPCR positive and displayed elevated serum 
antibodies and lachrymal IgA at various time points. 
 
Pathogen load  
Quantitative PCR data showed significant effects for isolate, days PI, and the interaction between 
days PI and isolate (p < 0.0001). Birds infected with NC2006 had the highest MG load compared 
to the other isolates and infection with CA2006 or VA1994 in experiment 1 resulted in lowest 
bacterial loads (Figure 6.1B), perhaps due to a dose effect (Table 6.1). Pathogen load early in the 
infection (day 2 PI) was very different across isolates (Figure 6.1B). Birds infected with VA1994 
in either experiment had the lowest bacterial loads at day 2 PI, birds infected with CA2006 had 
intermediate bacterial loads at day 2 PI, while birds infected with NC2006 had the highest 
bacterial load on day 2 PI. At one week PI, bacterial load appeared to increase for all isolates 
other than CA2006. After one week PI, bacterial load appeared to decrease, except for NC2006, 
which maintained high bacterial load until week 5 PI. 
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Figure 6.1. Lesions and pathogen load in house finches after infection with one of three isolates 
of Mycoplasma gallisepticum (VA1994, CA2006, or NC2006). Conjunctival lesions (A) were 
graded on a scale from 0-3 and averaged bilaterally. Pathogen load in the conjunctiva was 
quantified for eight weeks post-infection (B). Pathogen load is approximated by M. gallisepticum 
mgc2 gene copy number, determined by quantitative PCR.  
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Antibody responses  
Serum and lachrymal antibody responses showed similar patterns. All estimated effects (isolate, 
days PI, and the interaction between days PI and isolate) in the model were statistically 
significant (p < 0.001) for systemic antibody response; for local antibody response, all effects 
(days PI, and the interaction between days PI and isolate) were significant (p < 0.0001) except 
for the main effect of isolate (p = 0.37). Inspecting the estimated effects (Figure 6.2) shows that 
NC2006 elicited greater antibody responses after day 21 PI than VA1994 or CA2006 both 
systemically (Figure 6.2A) and locally in the lachrymal fluid (Figure 6.2B). Serum antibody 
response to VA1994 was higher than CA2006 at weeks 2, 3, and 4 post-infection (Figure 6.2A). 
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Figure 6.2. Mycoplasma gallisepticum-specific antibodies produced after inoculation of house 
finches with one of three M. gallisepticum isolates (VA1994, CA2006, or NC2006). Serum 
antibodies (A) and lachrymal IgA (B) were measured weekly post-infection. 
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Pathogen clearance and disease resolution  
The time to disease resolution varied with MG isolate (Logrank test, χ2 = 8.43, p = 0.01; Figure 
3A). Birds infected with CA2006 recovered from lesions fastest, those infected with NC2006 
recovered slowest, and birds infected with VA1994 recovered at an intermediate rate. 
The observed pattern of pathogen clearance was similar to lesion recovery in that 
VA1994 was intermediate and CA2006 was fastest, but this was not statistically significant 
(Logrank test, χ2 = 0.27, p = 0.88; Figure 6.3B). Given these results, it appears that birds infected 
with CA2006 recover from lesions much faster than they clear pathogen (compare Figure 6.3A 
to Figure 6.3B). 
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Figure 6.3. Survival curves for (A) lesions and (B) pathogen load based on non-parametric 
maximum likelihood techniques for interval-censored data. Shaded box are “Turbull intervals” 
where the survival function was determined to be changing but the exact functional form of the 
change is unknown, given the observed data.  Dark shading (dotted line) is VA1994, medium 
shading (dashed line) is NC2006, and light shading (solid line) is CA2006.   
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Pathogen load and antibody response compared to disease severity  
All pair-wise correlations between lesion score, pathogen load, serum antibody, and lachrymal 
IgA antibody response were highly significant (Kendall’s Tau > 0.35, p << 0.001; Figure 6.4). 
Pathogen strain or experiments differed in the multivariate response of between lesion score, 
pathogen load, serum antibody, and lachrymal IgA antibody (MANOVA:  F12, 167 = 9.22, p < 
0.001).  Inspection of the pair-wise relationship between pathogen load and eye lesion score 
suggests that the isolate (or experiments) differed in this response (Figure 6.4A); whereas, the 
relationship between antibody response and pathogen load, eye lesion score, or other pair-wise 
relations did not seem to discriminate between isolates (Figure 6.4B, other pair-wise relations not 
shown). This difference between isolates shows that NC2006 and VA1994 in experiment 2 had 
relatively high pathogen loads and variable eye lesion scores across birds (Figure 6.4A). The 
isolates CA2006 and VA1994 from experiment 1 produced lower pathogen load scores and more 
variable eye lesion scores. This indicates that the main difference between isolates is their 
propensity to cause high pathogen load or in the dose of inoculum administered.  
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Figure 6.4. Relationships between summed eye lesion score and pathogen load (A), serum 
antibodies (B), and lachrymal IgA (C). 
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Cases of chronic disease  
To determine if secondary bacterial infections were present in birds exhibiting severe lesions at 
the end of the experiment, conjunctival swab samples from three birds infected with CA2006 
were placed in 200 µL of TPB. Samples were submitted to the NYS Animal Health Diagnostic 
Center at Cornell University for aerobic bacterial culture. No bacterial species were cultured 
from the conjunctival swabs.  
 These three birds displayed such marked differences in lesion scores compared to the rest 
of the birds infected with CA2006 that the qPCR and antibody results are shown separate for this 
small group in Figure 6.5. These birds had greater levels of MG load and produced higher levels 
of serum antibodies and lachrymal IgA compared to the rest of the birds which developed a mild, 
shorter form of the disease. 
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Figure 6.5. Pathogen load, serum antibody response, and lachrymal IgA antibody response in 
birds infected with CA2006, grouped by disease severity.  
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Immunoblots  
Immunoblotting was performed by separating proteins of MG isolates on an SDS-PAGE gel and 
incubating the resulting blot with sera from birds infected with the homologous isolate (Figure 
6.6). Sera from birds infected with NC2006 and VA1994 recognized approximately eight to ten 
proteins at two weeks post-infection. Sera from birds infected with CA2006 reacted with fewer 
proteins. “Heterologous” immunoblotting was used to examine the potential for cross-immunity 
and was performed by separating proteins of a given isolate (e.g. VA1994) and incubating the 
blot with sera from a bird infected with a different isolate (CA2006 or NC2006). The 
heterologous immunoblots showed that antibodies directed against one isolate could also 
recognize proteins of the other isolates. Interestingly, sera from birds infected with NC2006 and 
VA1994 reacted to CA2006 antigen with greater intensity than CA2006-specific antisera reacted 
to CA2006 antigen. 
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Figure 6.6. Immunoblots of M. gallisepticum proteins incubated with antisera collected from 
house finches at two weeks post-infection. “Antigen source” indicates which M. gallisepticum 
isolate was run on the SDS-PAGE gel. “Serum source” identifies antisera from birds infected 
with a specific isolate of M. gallisepticum (VA = VA1994, CA = CA2006, NC = NC2006). 
Approximate sizes in kDa are indicated on the left. 
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6.4 Discussion and conclusions 
The results of this study demonstrate that isolates of MG from house finches with conjunctivitis 
can vary greatly in ability to cause disease and induce production of local and systemic 
antibodies. Infection with NC2006 resulted in the most severe eye lesions, highest MG load, and 
greatest levels of MG-specific lachrymal IgA and serum antibodies after day 21 PI. Infection 
with CA2006 caused the least severe eye lesions, lowest pathogen load, and lowest levels of 
antibodies in most individuals. Infection with VA1994 resulted in intermediate levels of lesion 
severity, pathogen load, and antibody response. NC2006 and CA2006 were collected from house 
finches with eye lesions during the same year but at different locations; therefore, it is likely that 
numerous strain variations of MG are circulating in free-living house finch populations and that 
they vary in their ability to cause disease and induce an antibody response.  
 The mgc2 gene is present as a single copy in the MG genome, and we used mgc2 copy 
number present in conjunctival swab samples to estimate pathogen load. If greater numbers of 
MG in the conjunctiva results in more transmission to susceptible individuals, our results suggest 
that isolates may differ in the potential for disease transmission, with NC2006 being the most 
transmissible of the isolates tested. In addition to MG load, transmissibility is likely dependent 
on many other factors, such as duration of infection, presence of fomites (Dhondt et al. 2007a), 
social status of the bird (Hawley et al. 2007b), house finch population density (Hochachka and 
Dhondt 2000), behavioral changes associated with infection (Hawley et al. 2007a, Bouwman and 
Hawley 2010), flock age composition (Altizer et al. 2004), and ambient temperature. 
 As Figure 6.4 demonstrates, serum and lachrymal antibody responses were positively 
correlated with lesion scores, suggesting that the presence of antibodies may contribute to the 
disease process or that antibodies may be ineffective at clearing MG. Mycoplasma species have 
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multiple adaptations that allow them to survive in the host despite a strong immune response 
directed against them (for review, see Simecka 2005). Mycoplasma species undergo variation of 
surface antigens in vitro (e.g., Zhang and Wise 2001) and in vivo (Levisohn et al. 1995), likely an 
adaptation to evade the host antibody response. The MG VlhA surface protein undergoes 
phenotypic variation in vitro in response to VlhA-specific monoclonal antibodies (Markham et 
al. 1998); additionally, in vivo variation of the VlhA protein has also been documented during 
MG infection in chickens (Glew et al. 2000). Another mechanism that allows Mycoplasma 
species to modulate the immune response includes the ability to induce polyclonal activation of 
lymphocytes (Stanbridge 1982, Williamson et al. 1986, Cole and Atkin 1991). The ability to 
non-specifically activate lymphocytes likely contributes to lesion severity (Naot et al. 1981). 
During Mycoplasma infection, the adaptive immune response plays a role in clearance of 
the organism but also contributes to the clinical lesions observed. In chickens, antibody 
responses are important for clearing MG infection; bursectomized chickens show increased 
susceptibility to infection (Adler et al. 1973, Lam and Lin 1984). Additionally, vaccinated 
chickens develop milder lesions and have increased numbers of MG-specific IgG and IgA 
secreting plasma cells (Javed et al. 2005). Studies utilizing immunocompromised hosts provide 
evidence for both the importance of the adaptive immune response and for the immunopathology 
that ensues during Mycoplasma infection. SCID (severe combined immunodeficiency) mice 
infected with Mycoplasma pulmonis develop less severe lung lesions but have similar pathogen 
loads in the lungs compared to controls; SCID mice also had greater quantity of M. pulmonis in 
the spleen and lesions in other extrapulmonary sites when compared to controls (Cartner et al. 
1998). T-cell deficit hamsters infected with M. pneumoniae had less severe lesions but had 
higher pathogen loads when compared to immunocompetent controls (Taylor et al. 1974). 
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Bodhankar et al. (2010) found that IFN-γ deficient mice immunized with M. pulmonis antigen 
and then infected with M. pulmonis developed more severe lesions than controls, and IL-4 
deficient mice developed less severe disease than the IFN-γ deficit mice and had greater ability 
to clear infection; their study provides evidence of the importance of IFN-γ in protection and the 
contribution of IL-4 mediated responses to the disease pathology. 
In concordance with past experiments (Kollias et al. 2004, Sydenstricker et al. 2006, 
Dhondt et al. 2007b, Hawley et al. 2010), this study demonstrates that there is considerable 
individual variation in response to infection; birds infected with the same MG isolate at identical 
doses can develop very different courses of disease. All isolates caused severe, protracted disease 
in a small number of individuals. Although on average infection with CA2006 resulted in a very 
mild, short-lasting conjunctivitis, three out of twenty (15%) finches experienced a prolonged and 
severe disease course. At the end of eight weeks, these birds had large numbers of MG in the 
conjunctiva; thus, it is likely that these individuals could serve as a source of infection for other 
susceptible birds. It is unclear whether or not the birds that develop severe, persistent infections 
play an important role in transmission of disease in free-living populations. Birds with severe 
lesions have reduced activity (Kollias et al. 2004) and likely compromised vision; these birds 
may not survive in the wild due to increased risk of predation and inability to forage for food. 
The availability of bird feeders, however, could contribute to their survival. Birds with 
conjunctival lesions tend to feed for longer intervals of time at feeders than those without clinical 
signs and tend to move less frequently between feeders and nearby perches (Hawley et al. 
2007a). Altizer et al. (2004) found that free-living house finches with severe lesions had poorer 
measures of body condition; however, Hartup et al. (2000) reported no difference in body 
condition score between diseased and non-diseased birds. In the presence of a stable food source, 
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the individuals with severe, protracted disease may be able to persist in the wild, serving as a 
source of infection. 
The three birds with persistent lesions infected with CA2006 had high numbers of MG in 
spite of developing a very robust antibody response. While the importance of antibody-mediated 
clearance of MG has been demonstrated for chickens (Javed et al. 2005, Gaunson et al. 2006), it 
is clear from the CA2006 experimental challenges that MG can persist in great numbers in the 
house finch host in the presence of vigorous serum and lachrymal antibody responses. The 
ability of MG to persist for prolonged periods in some individuals may be due to the ability of 
the bacteria to vary surface antigens targeted by the host antibody response, particularly the 
VlhA family of surface proteins (Levisohn et al. 1995, Gorton and Geary 1997, Markham et al. 
1998); The reason protracted disease only occurs in a fraction of individuals in unclear, but may 
be due to genetic variation among house finches. 
The ELISA and immunoblot results show that the majority of birds develop only a weak 
antibody response to CA2006 and react to fewer MG proteins compared to birds infected with 
VA1994 and NC2006 isolates. Birds infected with CA2006 had high pathogen load in the 
conjunctiva at day 2, but levels declined quickly thereafter. This may represent a decreased 
ability of CA2006 to colonize house finch conjunctiva (e.g., decreased ability to attach to 
mucosa, decreased growth rate, or increased clearance of bacteria by the innate immune system). 
The heterologous immunoblot results show that isolates are antigenically similar and suggest that 
cross-immunity may be possible; thus, a house finch infected with one strain variant of MG may 
have partial immunity when infected with a different circulating variant. 
 The three isolates used in these experiments were collected from free-living house 
finches with conjunctivitis. There are likely a variety of MG strains or strain variants circulating 
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in free-living house finch populations and our results suggest that they vary in their ability to 
persist in their host and in their ability to cause disease and induce an antibody response. 
Characterizing this phenotypic variation is critical for a broader understanding of the dynamics 
of MG in house finches, which continues to cause annual epidemics in free-living populations.   
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7.1. Abstract 
Previous studies have shown that house finch field isolates of Mycoplasma gallisepticum (MG) 
vary in virulence and ability to induce an antibody response. After experimental inoculation, MG 
causes persistent, severe disease in a subset of individuals. In this study, we further characterized 
MG infection using five field isolates, with an emphasis on chronically diseased birds. After 
experimental inoculation of house finches, MG load was measured by quantitative PCR and anti-
MG antibody responses were measured by ELISAs. Birds with chronic disease had significantly 
higher pathogen loads and antibody responses than did birds without chronic disease. Using a 
monoclonal antibody (MAb86) specific for a variant of the MG VlhA adhesin and 
immunodominant surface protein, we show that VlhA expression differs among MG isolates in 
this study, and that in vivo VlhA changes occur in house finches infected with MG. Overall, our 
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7.2. Introduction 
Mycoplasma gallisepticum (MG) is a common cause of acute and chronic respiratory disease in 
chickens and infectious sinusitis in turkeys (Ley 2003). In 1994, MG was documented in a novel 
host, the house finch (Haemorhous, formerly	  Carpodacus, mexicanus) (Ley et al. 1996). In this 
host, MG causes predominantly conjunctivitis, with respiratory signs being much less common 
compared to infection in poultry (Ley et al. 1996, Ley, 2003). Free-living house finch 
populations suffered major declines after the emergence of MG (Hochachka and Dhondt 2000), 
and the disease has now spread throughout the North American range (Ley et al. 2006). 
When challenged with identical doses of a given MG isolate, infected house finches 
exhibit variation in disease progression, such as onset and severity of conjunctivitis, and duration 
of clinical disease (Kollias et al. 2004, Sydenstricker et al. 2005). Roberts et al. (2001) found that 
73% of infected house finches developed acute, self-limiting conjunctivitis while 27% suffered 
from chronic disease and had a higher mortality rate. Grodio et al. (2012) found that a small 
percentage of house finches infected with an MG isolate of relatively low virulence developed 
severe, prolonged disease characterized by high conjunctival MG load and high levels of MG-
specific tear IgA antibodies and serum antibodies.  
Mycoplasma species are known for their ability to cause chronic infections and diseases, 
which has been attributed in part to antigenic variation of surface lipoproteins (Razin 1999), as 
these lipoproteins appear to be the major antigens targeted by the host humoral immune response 
(Rocha et al. 2005). MG’s vlhA (variable lipoprotein and hemagglutinin A, formerly pMGA) 
gene family is one example. The gene family encodes variants of VlhA protein, a lipoprotein of 
the cell membrane that plays a role in adherence, hemagglutination, and evasion of host immune 
response (Citti et al. 2005, Markham et al. 1992). 
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The chicken MG strain Rlow (low passage, high virulence reference strain), has 43 vlhA 
genes that are present at five loci. Comparison of strain Rlow to the less virulent vaccine F strain 
of MG shows great variability in the vhlA loci of the genome, and sequence data provide 
evidence for genomic inversion events, gene duplications, and insertion/deletion events 
(Szczepanek et al. 2010). A single vlhA gene is expressed at a time and expression requires a 
trinucleotide motif ([GAA]12) 5’ to its promoter (Glew et al. 1998). 
The MG VlhA surface protein undergoes phenotypic variation in vitro in response to the 
addition of VlhA-specific monoclonal antibodies to growth media (Markham et al. 1998). While 
it is thought that VlhA phenotypic variation is a possible mechanism for host immune evasion, 
VlhA switching also occurs in the absence of detectable antibodies. Glew et al. (2000) studied 
MG VlhA switching in chickens by examining colonies of MG grown from post-inoculation 
tracheal wash samples. They found that by two days post-aerosol inoculation, 40% of MG cells 
ceased expression of the VlhA surface protein expressed at the time of inoculation; however, 
VlhA specific antibodies were not detected in serum and tracheal samples until day 6 post-
inoculation. Thus, it may be possible that the vlhA gene family plays a role in other functions 
beside antibody evasion, such as colonization (Glew et al. 2000). 
Recent work by Tulman et al. (2012) compared the genomes of eight MG isolates 
collected from free-living house finches at various geographic locations between 1994 and 2008. 
They found that genomes were highly conserved among the isolates, with most differences 
involving the vlhA gene loci. House finch MG genomes contained 33 to 48 vlhA genes, with 
many genes having homologues at similar loci in poultry strains R and F, although some house 
finch MG vlhA genes lacked homologues in the poultry strains. Variation in VlhA expression 
among house finch isolates has not been documented. 
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In a previous study (Grodio et al. 2012), we found that eye lesion severity was positively 
correlated with pathogen load, serum antibody response, and lachrymal antibody response during 
MG infection in house finches, and we also found that MG isolates vary in their ability to cause 
disease and induce an antibody response. The goal of this study was to further examine 
differences in conjunctival MG load and antibody responses during chronic versus acute self-
limiting MG disease in house finches using MG isolates collected from Virginia, North Carolina, 
and California between 1994 and 2008. To determine if MG VlhA changes were occurring in 
house finches with chronic infection and disease, Western blots were used to study MG protein 
expression using post-inoculation mycoplasmal cultures from a sub-set of birds. 
 
7.3. Materials and methods 
House finches 
In February 2010, 77 house finches of mixed sex and age were captured via cage traps in 
Maricopa Co., Arizona under permits from Arizona State (SP573456), USFWS (MB158404-1) 
and the USGS Bird Banding Lab (23513), shipped via commercial air to Virginia Tech, and 
quarantined for three weeks prior to experimental inoculation. Birds were captured in Arizona 
because there had been no documented cases of MG in this population (e.g., Bonneaud et al. 
2012). All birds were housed in individual cages at constant day length (12L:12D) and 
temperature and provided with drinking water and pelleted diet ad libitum (Daily Maintenance 
Diet, Roudybush Inc., Woodland, CA). All procedures for animal care and use were approved by 
Virginia Tech’s Institutional Animal Care and Use Committees. 
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Mycoplasma gallisepticum isolates 
MG field isolates were acquired from the Mycoplasma Diagnostic and Research Laboratory at 
the NC State University College of Veterinary Medicine. Mycoplasma isolates were obtained 
from conjunctival swabs of free-ranging house finches showing clinical signs of conjunctivitis, 
identified as pure cultures of MG by immunofluorescence, and stored at -70°C. MG isolates 
selected for use as inocula were expanded in culture using Frey’s medium with 15% swine serum 
(modified from Kleven 1998) incubated at 37°C to log phase then frozen at -70°C in 1 ml 
aliquots. Viable counts were determined by the most probable number method (Meynell and 
Meynell 1970). See Table 7.1 for isolates used in experimental inoculation. Upon thawing, 
isolates were diluted in Frey’s media to match the CCU (color changing units)/ml of VA1994. 
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Table 7.1: Mycoplasma gallisepticum (MG) isolates used in experimental infection 
Isolate Origin Year  Passage number Identifier Number of birds 
inoculated 
VA1994 Virginia 1994 7A 7994-1 7P 5/24/04 10 
NC1995 North Carolina 1995 5A 13295-2-5P 11 
NC1996 North Carolina 1996 3A 1596-4-3P 1/13/10 11 
NC2006 North Carolina 2006 4A 2006.080-5-4P 11 
NC2008 North Carolina 2008 3A 2008.031-4-3P 11 
CA2006B California 2006 5 2006.052-5P NPB 
APassage number used in experimental inoculation. An additional passage in culture was 
required to obtain enough protein for use in Western blot analysis 
BSee Grodio et al. (2012) for experimental infection data. This isolate was included in VlhA 





Individually-housed birds were challenged by applying 50 µl containing approximately 1.1 x106 
CCU/ml of MG to each palpebral conjunctivae. Ten birds were inoculated with VA1994. 
NC1995, NC1996, NC2006, and NC2008 treatment groups each included 11 birds (see Table 7.1 
for details). Ten birds served as negative controls and received 50 µl of media alone in each 
conjunctiva. 
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Eye lesion score 
Birds were examined for eye lesions at days 2 and 7, and weekly thereafter up to twelve weeks 
post-inoculation. Lesions were scored on a 0 to 3 scale (Sydenstricker et al. 2005) as follows: 1 = 
minor swelling around the eye, 2 = moderate swelling and eversion of the conjunctival tissue, 
and 3 = the eye is nearly hidden by swelling and crusted exudates. 
 
MG load 
A quantitative PCR assay was used to measure MG load in conjunctival swabs before challenge, 
and on days 2, 7, 14, 21, 28, 42, and 56 post-inoculation. Sterile forceps (Fisher Scientific, 
Pittsburgh, PA) were used to hold the lower palpebra and a cotton-tipped wooden-handle swab 
(Fisher Scientific) dipped in tryptose phosphate broth (TPB) was inserted into the lower 
palpebral sac. Immediately after sample collection, the tip of the swab was placed into 300 µl of 
sterile TPB. The swab was swirled and wrung out on the inside of the tube to remove liquid from 
the swab before discarding. Samples were frozen at -20°C prior to DNA extraction. DNA 
extraction was performed as per Grodio et al. (2012). Quantitative PCR utilizing the mgc2 gene 
of MG was performed as per Grodio et al. (2008 and 2012), except that it was performed using a 
MyiQ Single Color Real-Time PCR Detection System (Bio-Rad, Hercules, CA) with the 
following parameters: 95°C for 3 min and 40 cycles of: 95°C for 3 sec and 60°C for 30 sec with 
a ramp rate at 0.5 degrees/sec. Output values of mgc2 were summed for both eyes within 
individuals and sampling dates, and log10 transformed prior to statistical analysis. 
Two negative control birds tested qPCR positive in one eye on a single day post-
inoculation (n = 1 on day 14 and n = 1 on day 21). Because these individuals were not found to 
be positive at any other point throughout the experiment and the detected pathogen levels were 
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very low (log 2.24-3.08) and limited to one eye, these results were assumed to reflect sampling 
or assay error rather than exposure to MG. 
 
Serum antibodies 
Blood was collected from the brachial vein into lithium-heparinized microcapillary tubes, pre-
inoculation, at weeks 1, 2, and 3 post-inoculation, and every other week thereafter. Tubes were 
spun in a tabletop centrifuge and plasma was collected and frozen at -20°C. MG-specific 
antibodies were measured with Idexx FlockChek Mycoplasma gallisepticum antibody ELISA kit 
utilizing a modified protocol described by Grodio et al. (2012). 
 
Tear IgA 
Lachrymal fluids were collected and analyzed for weeks 8 and 10 post-inoculation using 
modified Schirmer tear test strips (Schering-Plough Animal Health, Union, NJ) as described by 
Grodio et al. (2009). After collection, tear strips from the right and left eye were placed in a 
single microcentrifuge tube containing 500 µl of PBS/0.05% Tween 20 (PBS-T). Tubes were 
vortexed vigorously, tear strips were discarded, and samples were stored at -20°C until assayed. 
MG-specific IgA antibodies in the lachrymal fluids were measured using the Idexx FlockChek 
Mycoplasma gallisepticum antibody ELISA kit and house finch IgA-specific antisera as 
described previously (Grodio et al. 2009, Grodio et al. 2012). 
 
Isolation of MG post-inoculation 
At weeks 7, 9, and 12 post-inoculation, conjunctival swabs were collected for mycoplasmal 
culture from three birds in each MG isolate group. Birds had eye lesions at the time of swab 
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collection. Conjunctival swabs were placed in Remel MicroTest M5 (Thermo Fisher Scientific, 
Lenexa, KS) transport media. Cultures were expanded using Frey’s medium with 15% swine 
serum (modified from Kleven 1998) and viable counts were determined by the most probable 
number method (Meynell and Meynell 1970). 
 
Immunoblots 
Broth cultures of MG isolates used as inocula (Table 7.1) and post-inoculation isolates were 
centrifuged for 30 min at ~18,000g and 4°C. The cells were washed three times with sterile PBS 
and after centrifugation, supernatant was removed and pellets were placed on ice. Washed cells 
were solubilized in a solution containing RIPA buffers (buffer I: 20 mM Tris-HCl, 0.1% SDS, 
150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, protease inhibitor (Roche 
Diagnostics, Indianapolis, IN), buffer II: 20 mM Tris-HCl, 0.1% SDS, 150 mM NaCl, 1% 
Nonidet P-40, 0.5% sodium deoxycholate, 1 mM EDTA) and benzonase nuclease. Protein 
concentrations were determined using BCA protein assay (Thermo Scientific, Rockford, IL). 
Solubilized proteins of the MG isolates (ranging from 1-3 µg/well as detailed in results 
section) were diluted 1:1 with sample buffer (4% SDS, 20% glycerol, 50 mM Tris, pH 6.8, 0.1% 
bromophenol blue, 10% 2-mercaptoethanol) and incubated at 100°C for 10 minutes. Protein 
ladders utilized in this study include SuperSignal Enhanced MW protein ladder and Spectra 
multi-color broad range protein ladder (Thermo Scientific). Protein samples and ladders were run 
on SDS-PAGE gels consisting of 5% stacking/7.5% resolving gels. Replicate gels were created 
and total protein staining was performed with Imperial Protein Stain (Thermo Scientific) using 
the manufacturer’s instructions. 
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Proteins were transferred to 0.45 µm nitrocellulose membranes (Bio-Rad, Hercules, CA). 
Membranes were incubated in blocking buffer (Tris-buffered saline with 1% Tween 20 [TBS-T] 
plus 5% non-fat dry milk [NFDM, Nestle, Vevey, Switzerland]) for 2 h at room temperature. 
Mouse monoclonal MAb86, specific for MG VlhA (kindly provided by Dr. Philip Markham, 
University of Melbourne, Markham et al. 1992), was used at a 1:1000 dilution in TBS-T plus 
NFDM. After washing, the blot was then incubated with anti-mouse IgG-HRP, heavy and light 
chain (Bethyl Laboratories, Montgomery, TX) at a 1:30,000 dilution in TBS-T plus NFDM. 
Blots were washed and SuperSignal WestPico Chemiluminescence substrate (Thermo Scientific) 
was applied as recommended by the manufacturer. The blots were covered with plastic wrap and 
exposed to film (Amersham Hyperfilm ECL, GE Healthcare, Piscataway, NJ) in a dark room. 
 
Statistical analyses 
Birds were categorized as either “chronic” or “recovered” based on the presence or absence, 
respectively, of eye lesions at week 10 (Table 2). We then used mixed models in SAS 9.0 (SAS 
Institute, Cary, NC) in order to test whether disease status (“chronic” or “recovered” based on 
presence of eye lesions at week 10) predicted differences in pathogen load, serum antibodies, or 
tear IgA. Our models included the following fixed effects: disease status, days post-inoculation, 
isolate treatment, and all two-way interactions between these variables. We included bird ID as a 
random effect in all models in order to account for the fact that we included multiple values from 
the same individuals over the course of the trials. 
Virulence (severity of disease) varies among MG isolates. Hawley et al. (in preparation) 
has characterized virulence differences among the isolates from the experiments described in this 
study. In order to control for differences in virulence among the isolates used, isolate identity and 
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isolate in interaction with disease status were included in the model. We were therefore able to 
examine the role of disease status in predicting pathogen load, serum antibodies, and tear IgA 
when variation among isolates (in the tendency to cause chronic disease) was accounted for. 
 We excluded two individuals from our analyses whose pre-inoculation ELISA values 
were above the cut-off for positivity calculated in Hawley et al. (2011); however, all results were 
qualitatively identical when these individuals remained in the analysis.    
 
7.4. Results 
Birds with chronic disease  
Birds with chronic disease had significantly higher pathogen loads than recovered individuals 
(Fig. 7.1B; disease status: F1, 40 = 90.8; p < 0.0001; disease status*days post-inoculation: F7, 308 = 
36.2; p < 0.0001). Additionally, birds with chronic disease had significantly higher levels of 
MG-specific serum antibodies (Fig. 7.1C; disease status: F1, 40 = 6.1; p = 0.017; disease 
status*days post-inoculation: F6, 264 = 8.8; p < 0.0001) and tear IgA (Fig. 7.1D; disease status: F1, 
40 = 22.3; p < 0.001; disease status*days post-inoculation: F1,44 = 12.0; p = 0.001). Consistent 
with previous work (Grodio et al. 2012, Hawley et al. 2010), days post-inoculation was a 
significant main effect in the models of pathogen load (F7, 308 = 339.3, p < 0.0001), serum 
antibodies (F6, 264 = 44.3, p < 0.0001), and tear IgA (F1, 44 = 4.5, p = 0.0391).  
Because MG virulence varies across isolates, we included isolate in our models as a main 
effect and in pairwise interaction with disease status and days post-inoculation. Isolate identity 
was a significant predictor of pathogen load both alone (F4, 40 = 5.0, p = 0.002) and in interaction 
with days post-inoculation (F28, 308 = 1.5, p = 0.04) and disease status (F4, 40 = 3.7, p = 0.013). 
Interestingly, isolate identity did not significantly predict serum antibodies (all F < 1.42, p > 
	   109 	  
0.13) or tear IgA (all F < 1.43, p > 0.24) either as a main effect or in interaction with disease 
status or days post-inoculation. 
 
Fig. 7.1. Eyescore, Mycoplasma gallisepticum (MG) load, MG-specific serum antibody and tear 
IgA are shown after experimental inoculation with MG. Least square means (LSM) were 
calculated to control for variation among MG isolates used in this study. Standard error bars are 
shown.  
 
mAb86 recognition of house finch MG VlhA protein 
Total proteins of inocula and post-inoculation isolates were extracted from broth cultures, 
quantified, and separated on SDS-PAGE gels. The proteins were transferred to nitrocellulose and 
incubated with mAb86, anti-mouse IgG-HRP, and substrate. A summary of MAb86 positive 
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inocula and post-inoculation isolates is listed in Table 7.2. Total protein staining using a 
Coomassie-based stain is shown in Fig. 7.2A, and confirms the presence of protein in all lanes. 
As shown in Fig. 7.2B, mAb86 only recognized NC2006 VlhA protein of approximately 50 kDa 
based on Supersignal ladder. Due to the high intensity of the signal in preliminary blots, a 
smaller sample of NC2006 protein (1 µg) was utilized in the blot shown compared to the other 
isolates (3 µg each). When overexposed to film, a very low intensity band of ~40 kDa was 
observed in inoculum and a few post-inoculation isolates of VA1994 and NC1996; these results 
had poor reproducibility and are not shown. 
 
Table 7.2: Mycoplasma gallisepticum expression of MAb86+ VlhA protein 










CA2006 -B - NPB NPB NPB 
VA1994 4/10 - 0/3 0/3 0/3 
NC1995 6/11 - 1/3 2/3 2/3 
NC1996 9/11 - 0/3 0/3 0/3 
NC2006 9/10 + 3/3 3/3 1/2 
NC2008 9/10 - 0/3 0/3 0/3 
A Number of birds with lesions still present at week 10 post-inoculation, out of the total number 
of birds in experimental group. 
B See Grodio et al. (2012) for experimental inoculation data. NP = post-inoculation mycoplasmal 
cultures were not performed. 
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Fig. 7.2. VlhA and total protein staining of six MG isolates. Proteins of six Mycoplasma 
gallisepticum isolates were separated by size using SDS-PAGE (1 µg NC2006, 3 µg of others). 
Total protein was stained and shown in A. In B, monoclonal antibody MAb86 was used to 
identify MG VlhA protein. Because NC2006 protein had high intensity staining with MAb86, 
only 1 µg protein was used for this isolate. 
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VlhA expression changes during infection with NC2006  
Fig. 7.3A shows total proteins using Coomassie-based stain and confirms the presence of protein 
in all lanes (2 µg protein samples were used). Fig. 7.3B shows high intensity staining of a VlhA 
variant in the inoculum and lower-intensity staining in the post-inoculation isolates, 
demonstrating that expression of the VlhA variant at the time of inoculation decreased post-
inoculation in all birds tested. Week 12 for bird 163 is not shown because the MG culture was 
negative at this time-point. 
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Fig. 7.3. NC2006 VlhA expression changes post-inoculation. Protein samples (2 µg) of 
Mycoplasma gallisepticum (MG) isolate NC2006 were separated by size using SDS-PAGE.  0 = 
NC2006 pre-inoculation. 7, 9, 12 = NC2006 post-inoculation MG cultures from conjunctival 
swabs of three birds at 7, 9, and 12 weeks post-inoculation. MG culture for bird 163 at week 12 
was negative. SpectraTM ladder was used in A. In B, overexposed Supersignal ® ladder was 
present to the left of sample “0.” 
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VlhA expression changes during infection with NC1995  
Fig. 7.4A shows total proteins using a Coomassie-based stain and confirms the presence of 
protein in all lanes (2 µg protein samples were used). Fig. 7.4B shows mAb86 staining of a VlhA 
variant. The original inoculum has no staining for VlhA using MAb86. In two out of three birds 
tested (birds 146 and 153), expression of the VlhA variant recognized by mAb86 is acquired. In 
bird 153, this change occurred between week 7 and 9 post-inoculation. In bird 146, expression of 
the VlhA variant recognized by mAb86 occurred prior to week 7 post-inoculation. 
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Fig. 7.4. NC1995 VlhA expression changes post-inoculation. Protein samples (2 µg) of 
Mycoplasma gallisepticum (MG) isolate NC1995 were separated by size using SDS-PAGE. 0 = 
NC1995 pre-inoculation. 7, 9, 12 = NC1995 post-inoculation MG cultures from conjunctival 
swabs of three birds at 7, 9, and 12 weeks post-inoculation. 
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7.5. Discussion 
Birds with chronic conjunctivitis had high conjunctival loads of MG in spite of high levels of 
MG-specific serum and tear antibodies. These findings are consistent with those of Grodio et al. 
(2012), showing that a small percentage (15%) of house finches infected with MG isolate 
CA2006 developed severe chronic disease characterized by high levels of pathogen and MG-
specific antibodies. A larger percentage of birds in this study (40-90%, see Table 2) developed 
chronic disease compared to birds experimentally inoculated with CA2006. This may be 
explained by the choice of isolates used in this study, as Hawley et al. (in preparation) found that 
more recent eastern isolates (e.g. NC2006, NC2008) have increased virulence compared to 
earlier eastern isolates and western isolates. 
In order to control for the possibility that isolate differences in virulence underlie the 
detected differences between chronic and recovered birds, we included isolate in our statistical 
models. As shown previously (Hawley et al. 2010, Grodio et al. 2012), isolate identity was a 
significant predictor of pathogen load both alone and in interaction with days post-inoculation. 
We also detected a significant interaction between isolate identity and disease status indicating 
that the influence of disease status on pathogen load may vary across isolates. Interestingly, 
isolate identity was not a significant predictor of serum antibodies or tear IgA levels. This 
suggests that chronicity of disease is a more important predictor of antibody differences in the 
serum and tears than the virulence of the MG isolate. 
Birds with chronic disease and infection may play an important role in the spread of MG 
to other susceptible individuals, since these birds presumably remain infectious for long time 
periods. Furthermore, diseased individuals spend longer periods of time on bird feeders (Hawley 
et al. 2007), thus potentially contributing to the spread of MG via fomites (Dhondt et al. 2007). 
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Quantitative PCR data show that birds with chronic disease tend to harbour MG at very high 
levels. While qPCR does not distinguish between viable and non-viable organisms, most 
individuals with clinical signs had positive MG cultures at weeks 7, 9, and 12 post-inoculation, 
and thus, had viable MG in the conjunctiva up to 12 weeks post-inoculation. 
The mouse monoclonal antibody MAb86 specific for MG VlhA recognized a 50 kDa 
protein of NC2006 and post-inoculation isolates of NC1995. MAb86 likely recognizes only a 
subset of VlhA proteins because it was created by immunizing mice with membrane suspensions 
of a single MG strain, poultry strain S6. After subjecting whole S6 cells to SDS-PAGE, 
Markham et al. (1992) found that MAb86 reacted with a single band of Mr 67,000. MAb86 also 
reacted to a protein of similar size in strain R, and a protein of Mr 75,000 in strain F. These 
results suggest that MAb86 may detect at least two VlhA protein variants that share similar 
epitopes. 
 NC2006 was MAb86-positive pre-inoculation, but expression of the VlhA variant 
decreased by seven weeks post-inoculation. In contrast, NC1995 was not MAb86-positive pre-
inoculation. In two out of three birds tested, NC1995 gained expression of the VlhA variant 
detected by MAb86 during the course of infection. Although based on a small sample size, these 
results show that the VlhA variant expressed at the time of inoculation decreases in expression 
post-inoculation and that VlhA expression can change up to seven to nine weeks post-
inoculation. To the authors’ knowledge, only one other study documents MG VlhA expression 
changes in vivo (Glew et al. 2000), and it focused on VlhA changes early (1-28 days) post-
inoculation in the chicken. Our results demonstrate the ability of MG to modify cell-surface 
proteins late in the course of infection in the house finch; alteration of surface proteins could 
promote chronic infection via evasion of the host antibody response. 
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Prior to this work and that of Grodio et al. (2012), it was unclear whether chronic disease 
in house finches is pathogen-mediated or host (immune)-mediated. Existing evidence suggests 
that both pathogen and immune-mediated mechanisms contribute to mycoplasmal disease. Many 
Mycoplasma species have the ability to vary cell surface antigens, which are the main targets of 
the humoral immune response (e.g. vlp of M. hyorhinis, vsp of M. bovis, vlhA of M. synoviae and 
M. imitans) (Citti et al. 2005). Since antibody responses are important for controlling 
extracellular pathogens, the ability to vary cell surface antigens is likely an adaptation for 
evading the host immune response and establishing prolonged infection.  
Studies utilizing immunocompromised hosts provide evidence for both the protective and 
immunopathologic nature of the adaptive immune response during Mycoplasma infection. 
Cartner et al. (1998) found that SCID (severe combined immunodeficiency) mice infected with 
M. pulmonis developed less severe lung lesions but had similar pathogen loads in the lungs 
compared to immunocompetent controls, suggesting that the presence of an adaptive immune 
response increases disease severity. SCID mice had greater quantity of M. pulmonis in the spleen 
and lesions in other extrapulmonary sites when compared to the controls. When SCID mice were 
given anti-M. pulmonis serum, extrapulmonary dissemination was prevented, illustrating the 
importance of antibodies in controlling spread of infection to other tissues (Cartner et al. 1998). 
The method that we used to define chronic individuals is a potential caveat of our study. 
We used the presence of eye lesions at week 10 (day 71 post-inoculation) as our measure of 
chronicity. The time course of eye lesions following experimental infection (Fig. 1A) indicates 
that our method of categorization resulted in two biologically distinct groups of birds, with 
individuals categorized as “chronic” still harboring equivalently high average lesion scores at 
week 12 (day 87 post-inoculation) when compared to week 10, the time interval at which we 
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categorized chronicity of disease. Therefore, our categorization is likely to represent biologically 
meaningful differences in response to infection. However, future work should consider the most 
informative and robust way to classify chronic disease in this system.  
Our results provide evidence that chronic MG disease in house finches has both 
immunopathologic and pathogen-mediated components; birds with chronic disease have high 
pathogen loads in the presence of local and systemic antibody responses that are ineffective at 
clearing infection, but result in an on-going inflammatory response. Our results also indicate that 
MG undergoes antigenic changes during infection in the house finch and provides a possible 
explanation for why the house finch antibody response fails to clear MG infection in cases of 
chronic disease. Further work should test the hypothesis that evasion of the host immune 
response drives antigenic changes in MG during in vivo infection.    
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Summary of conclusions 
 
 
8.1. Quantification of MG genome load in conjunctival samples using real-time PCR 
A TaqMan-based real-time, quantitative polymerase chain reaction (qPCR) assay utilizing the 
mgc2 gene was developed to detect MG in conjunctival swabs of experimentally infected house 
finches. The test had a detection limit of less than 14 copies per reaction when tested with a 
plasmid standard and less than 10 copies per reaction when tested with MG genomic DNA. 
House finch gene rag-1 was used as an internal control. The rag-1 qPCR results showed that 
host cell quantity varied greatly between conjunctival samples. After inoculation, MG levels in 
the house finch conjunctiva increased over the 7-day period post infection. The bird with the 
most pronounced clinical conjunctivitis harbored the highest level of MG and the bird that did 
not develop conjunctivitis had very low numbers of MG. This small-scale experiment provided 
the first evidence that development of conjunctivitis may correlate with MG load in house 
finches. 
Since its development, the mgc2 assay has been used at Cornell and other institutions to 
study the house finch-MG system (Adelman et al. 2013, Balenger 2011, Bonneaud et al. 2011, 
Bonneaud et al. 2012, Dhondt et al. 2012, Dhondt et al. 2013, Hawley et al. 2010, Hawley et al. 
2011, Hawley et al. in preparation, Hurtado 2012a and 2012b, States 2012).  
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8.2. Development of house finch IgA-specific anti-sera 
House finch IgA-specific anti-sera were developed to measure local (lachrymal) antibody 
response in subsequent experiments. A 469 base-pair region of the house finch IgA heavy chain 
was PCR-amplified from spleen cDNA and sequenced. The heavy chain fragment was produced 
using a bacterial expression system and purified. Rabbit anti-sera were generated against the 
recombinant protein. The anti-sera reacted with a single house finch serum protein 
(approximately 50–55 kDa) in Western blots.  
The anti-sera were used to identify plasma cells in the Harderian gland and conjunctiva of 
house finches with conjunctivitis associated with MG infection. The anti-sera also detected IgA+ 
plasma cells in the Harderian glands of house sparrows and American goldfinches (see also 
Cushing et al. 2011). The anti-sera were utilized in an ELISA to detect MG-specific IgA 
antibodies in lachrymal samples of infected finches, and demonstrated that only small amounts 
(approximately 0.75 mL) of lachrymal fluid are adequate to detect changes in IgA level as 
infection progressed. While providing a limited amount of sample, collection of tears using 
modified Schirmer tear strips was simple, quick to perform, and posed no harm to the delicate 
conjunctival tissues.  
 
8.3. Measuring MG-specific serum antibodies 
Prior to this work, serum plate agglutination tests (SPA) were used to screen for the presence of 
MG-specific antibodies in house finch serum (e.g., Kollias et al. 2004, Sydenstricker et al. 2006). 
SPA is a common test used to screen poultry flocks for MG infection (Kleven 1998). The test is 
based on direct visualization of antigen-antibody complexes and does not rely on host-specific 
secondary antibodies; thus, SPA using commercially available antigen has been used to 
	   123 	  
document MG infection in house finches. While the SPA is considered a sensitive test, it has low 
specificity (false positive reactions) (Kleven 1998). Additionally, interpretation can be difficult 
because test results are based on a visual assessment of the agglutination reaction.  
 A commercial ELISA (IDEXX, Westbrook, Maine) is available to detect MG-specific 
serum antibodies in chicken and turkey serum samples. When used as directed with house finch 
serum samples, the test has low sensitivity (Grodio unpublished results). Several modifications 
were performed to increase the sensitivity in house finch samples, as described in appendix 1. 
With modifications, the ELISA has been used to measure MG-specific IgA in house finch tears 
(Grodio et al. 2009, 2012, submitted) and house finch MG-specific serum antibodies (Hawley et 
al. 2011, Grodio et al. 2012, Grodio et al. submitted). The modified ELISA has also been used to 
detect MG-specific serum antibodies in domestic canaries (Hawley et al. 2011, Appendix 2). The 
main advantages of using the ELISA include: (1) quantitative results, (2) fewer difficulties in 
interpretation of results, since the plates are read by a spectrophotometer, and (3) less serum is 
required, therefore samples can be run in duplicate to increase accuracy of results.  
  
8.4. Virulence and immunogenicity of three MG isolates in house finches 
Temporal and spatial genotypic variation in MG was documented prior to this work, but 
phenotypic variation in pathogenicity and immunogenicity was not explored. House finches were 
inoculated with MG isolates Virginia (VA)1994, California (CA)2006, or North Carolina 
(NC)2006, which were cultured from free-living house finches with conjunctivitis in 1994, 2006, 
and 2006, respectively. Infection with NC2006 resulted in the most severe eye lesions, highest 
pathogen loads, and highest levels of pathogen-specific lachrymal and serum antibodies. 
Infection with CA2006 caused the least severe eye lesions, lowest pathogen load, and lowest 
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levels of antibodies. Serum and lachrymal antibody responses were positively correlated with 
lesion scores, suggesting that the presence of antibodies may contribute to the disease process or 
that antibodies may be ineffective at clearing MG. 
In concordance with past experiments (Kollias et al. 2004, Sydenstricker et al. 2006, 
Dhondt et al. 2007b, Hawley et al. 2010), the study demonstrated that there is considerable 
individual variation in response to infection; birds infected with the same MG isolate at identical 
doses can develop very different courses of disease. All isolates caused severe, protracted disease 
in a small number of individuals. The three birds with persistent lesions infected with CA2006 
had high numbers of MG in spite of developing a very robust antibody response.  
Sera from birds infected with NC2006 and VA1994 recognized approximately eight to 
ten proteins at two weeks post-infection. Sera from birds infected with CA2006 reacted with 
fewer proteins. ‘‘Heterologous’’ immunoblotting was used to examine the potential for cross-
immunity and was performed by separating proteins of a given isolate (e.g., VA1994) and 
incubating the blot with sera from a bird infected with a different isolates (CA2006 or NC2006). 
The heterologous immunoblots showed that antibodies directed against one isolate could also 
recognize proteins of the other isolates, showing that they are antigenically similar; thus, there 
may be partial cross-protection if a house finch encounters two or more strains of MG 
throughout the course of its lifetime.  
 
8.5. Chronic MG conjunctivitis in house finches: host antibody response and MG VlhA 
expression 
The study described above showed that MG has the ability to cause persistent, severe infection in 
a subset of individuals. With an emphasis on chronically infected birds, we further characterized 
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MG infection using additional field isolates (VA1994, NC1995, NC1996, NC2006, NC2008). 
Quantitative PCR and ELISAs were used to measure MG load post-infection and house finch 
antibody response, respectively. Birds with chronic infection had high conjunctival loads of MG 
in spite of high levels of MG-specific serum and tear antibodies. While qPCR does not 
distinguish between viable and non-viable organisms, most individuals with clinical signs had 
positive MG cultures at weeks 7, 9, and 12 post-infection, thus, had viable MG in the conjunctiva 
up to 12 weeks post-infection.  
In Chapter 6, I showed that a small percentage (15%) of house finches infected with MG 
isolate CA2006 developed severe chronic disease characterized by high levels of pathogen and 
serum and tear antibodies. A larger percentage of birds in this later study developed chronic 
infection compared to experimental infection with CA2006. This may be explained by the choice 
of isolates used in this study, as Hawley et al. (in preparation) found that more recent eastern 
isolates (e.g., NC2006, NC2008) have increased virulence compared to earlier eastern isolates 
and western isolates. 
Using a monoclonal antibody (MAb86) specific for a variant of the MG VlhA surface 
protein, it was found that VlhA expression differs among MG isolates and that in vivo VlhA 
changes occur in house finches infected with MG. NC2006 was MAb86-positive pre-inoculation, 
but expression of the VlhA variant decreased by seven weeks post-infection. In contrast, 
NC1995 was not MAb86-positive pre-inoculation. In two out of three birds tested, NC1995 
gained expression of the VlhA variant detected by MAb86 during the course of infection. 
Although using a small sample size, these results show that the VlhA variant expressed at the 
time of inoculation decreases in expression post-infection and that VlhA expression can change 
up to seven to nine weeks post-infection. To date, only one other study documents MG VlhA 
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expression changes in vivo (Glew et al., 2000), and it focused on VlhA changes early (1-28 days) 
post-infection in the chicken. These results demonstrate the ability of MG to modify cell-surface 
proteins late in the course of infection in the house finch; alteration of surface proteins could 
promote chronic infection via evasion of the host antibody response. 
Appendix 2 shows house finch antibody response to MG proteins using samples from 
two birds also utilized in the VlhA Western blot study. The results show that birds develop tear 
and serum antibodies to approximately fourteen MG proteins, although a larger sample size 
would be necessary to confirm these conclusions are more generally applicable. 
Prior to this work and that of Grodio et al. (2012), it was unclear whether chronic disease 
in house finches is pathogen-mediated or host (immune)-mediated. These results suggest that 
chronic MG disease in house finches has both immunopathologic and pathogen-mediated 
components; birds with chronic disease have high pathogen loads in the presence of local and 
systemic antibody responses that are ineffective at clearing infection, but result in an on-going 
inflammatory response. The results also indicate that MG undergoes antigenic changes during 
infection in the house finch and provides a possible explanation for why the house finch antibody 
response fails to clear MG infection in cases of chronic disease. 
 
8.6. Future Considerations: study of chronic infection 
8.6.1. MG VlhA  
Recent work by Tulman et al. (2012) compared the genomes of eight MG isolates collected from 
free-living house finches at various geographic locations between 1994 and 2008. They found 
that genomes were highly conserved between the isolates, with most major differences involving 
the vlhA gene loci. House finch MG genomes contain 33 to 48 vlhA genes. Many genes have 
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homologues at similar loci in poultry strains R and F, although some house finch MG vlhA genes 
lack homologues in the poultry strains. This thesis provides evidence that there is also variation 
in VlhA expression among house finch isolates, and that changes in MG VlhA expression occur 
during infection in the house finch. 
Now that the genomes of several house finch MG isolates have been sequenced (Tulman 
et al. 2012), VlhA expression could be more thoroughly investigated with the use of microarray 
analyses. A microarray could be created using all known house finch MG vlhA sequences. 
Sequence identity among the vlhA gene variants in poultry isolates ranges from 41-99%  
(Papazisi et al. 2003), so the high degree of homology must be taken into account when 
constructing the microarray (e.g., short vs. long oligonucleotide).  
Experimental infections, similar to the ones described in this thesis, could then be carried 
out to study in vivo changes in VlhA expression. After inoculating house finches via conjunctival 
route, conjunctival swabs would be collected at various time points post-infection and processed 
for microarray analysis.  
 
Questions that could be addressed with a VlhA microarray include: 
1) How does VlhA expression change with passage in culture?  
• This question is important because all isolates studied in experimental 
infections must be passaged in culture prior to use in experiments. In all 
previous studies, we have made conclusions based on the assumption that the 
MG isolates do not change significantly with only a few passages in culture.  
2) Which VlhA variant is the MG isolate expressing at the time of experimental 
inoculation?  
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• Since we would be testing an isolate with a sequenced genome, we could 
analyze the genome to find which VlhA variant has the required trinucleotide 
repeat, (GAA)12 5’ to the promoter. It would be expected that the VlhA 
variant with the specific GAA repeat would be the one expressed at 
inoculation. 
3) When VlhA expression changes post-infection, is a specific VlhA variant 
preferentially expressed? 
• We would need to compare MG VlhA expression changes occurring in 
multiple birds to answer this question. Example: In 7 out of 10 birds 
experimentally infected, MG isolate VlhA switches from type A (VlhA 
expressed in inoculum) to type B. In 2 out of the 10 birds, MG isolate 
switches from VlhA type A to type C. In 1 out of the 10 birds, there was no 
VlhA switch documented, and this bird recovered quickly post-infection. 
4) How does VlhA expression vary in birds with chronic disease vs. in birds with 
disease of shorter duration?  
5) Within an individual bird, is one predominating MG VlhA expressed, or are multiple 
VlhA variants expressed at each time-point? 
• For this question, we consider the population of MG infecting an individual 
bird at any given time-point. Are most members of this population expressing 
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8.6.2. Other potential mechanisms for establishing chronic infection 
Besides variation of cell surface antigens, MG may have other mechanisms that aid in 
establishment of chronic infection. There is evidence that MG can form biofilms, although the 
ability to form biofilms does not necessary correlate with virulence of poultry strains (Chen et al. 
2012). Biofilm formation would decrease the ability of the humoral immune system to clear 
infection and thus could contribute to chronicity of disease. Additionally, as discussed in Chapter 
2, there is evidence that MG has the ability to invade nonphagocytic cells (Winner et al. 2000, 
Vogl et al. 2008), which may also provide a potential mechanism for establishing chronic 
infection via evasion of the host immune system. The ability of house finch strains of MG to 
form biofilms and establish intracellular infections could be explored in future research.  
 
8.6.3. Chronic disease and the house finch immune system  
This thesis focused mainly on the house finch antibody response to MG because the humoral 
immune system is very important for control of extracellular pathogens. Other facets of the 
house finch immune system could also contribute to chronicity of disease, such as components of 
the innate immune response and production of cytokines.  
After experimental inoculation of house finches, Adelman et al. (in press) measured the 
pro-inflammatory cytokine IL-1β and the anti-inflammatory cytokine IL-10 at 24 hours post-
inoculation using quantitative PCR for cytokine mRNA expression; it was found that cytokine 
levels differed significantly between house finch populations (eastern vs. western), but whether 
cytokine responses differed between birds with “chronic” vs. “acute” disease was not 
investigated. Additionally, Bonneaud et al. (2011, 2012) utilized a cDNA microarray to study 
house finch gene expression changes after experimental inoculation with MG. They documented 
	   130 	  
expression changes in a number of immune-related genes post-infection, although they explored 
differences at the population level (eastern vs. western house finch populations) as opposed to 
investigating differences in birds with chronic and acute disease. Changes in expression of 
immune-related genes could be examined to identify differences in host response that may 
contribute to chronicity of disease.   

























*Text and figure adapted from: 
Hawley, D.M., Grodio, J., Frasca, S., Kirkpatrick, L., and D.H. Ley. 2011. Experimental 
infection of domestic canaries (Serinus canaria domestica) with Mycoplasma gallisepticum: a 
new model system for a wildlife disease. Avian Pathology. 40: 321-327. Reproduced with 
permission (no license required). 
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A1.1. Introduction 
Clinical signs of MG are predominately restricted to members of the finch family (Fringillidae) 
(Hartup et al. 2000, 2001; Mikaelian et al. 2001). Experimental infections by Farmer et al. (2005) 
confirmed that clinical signs occur in the house finch, American goldfinch  (Carduelis tristis), 
pine siskin (Carduelis pinus), and purple finch (Carpodacus purpureus), all members of the 
Fringillidae family. The tufted titmouse (Baelophus bilcolor), a member of the family Paridae, 
also showed some evidence of clinical disease after experimental infection.  
 MG infection in the domestic canary (Serinus canaria domestica), member of the 
Fringillidae family, was not evaluated prior to this work. Since the canary is commonly bred in 
captivity and commercially available, it has the potential to serve as a model species in captive 
studies of MG. Only results and discussions related to canary antibody response are reported 
below. See Hawley et al. (2011) for additional details. 
 
A1.2. Methods 
The experimental infection was performed at Virginia Tech, in Dr. Dana Hawley’s laboratory. 
Seven domestic canaries were purchased from a private breeder. Three house finches were 
captured from Montgomery County, Virginia (n=1) and Tompkins County, New York (n=2) 
under appropriate permits. Seven canaries and two house finches were inoculated with MG 
isolate NC2006. One house finch served as a negative control. 
 Conjunctival swabs were collected on days 7, 14, 21, 28, and 35 post-infection for 
measurement of MG load. Quantitative PCR was performed by the Hawley lab using a protocol 
developed by Grodio et al. (2008). Blood was collected from the brachial vein, once prior to 
inoculation and also on days 14, 21, 28, and 35 post-infection. Plasma was separated and frozen 
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at -20°C until shipment to Cornell for processing. 
 The IDEXX FlockChek MG ELISA kit (IDEXX, Westbrook, Maine, USA) was used to 
measure serum antibodies according to the manufacturer’s protocol with modifications. A 
blocking step consisted of adding 300 ml of 1% bovine serum albumin in phosphate-buffered 
saline (Pierce 10X BSA; Thermo Fisher Scientific, Rockford, Illinois, USA) to room temperature 
plates and incubating for 40 minutes. All washing steps consisted of washing the plate three 
times with 350 ml phosphate-buffered saline with 0.05% Tween 20 using ELx50 Auto Strip 
Washer (Bio-Tek, Winooski, Vermont, USA). Serum samples were diluted 1:50 in sample 
buffer, and incubated for 1 hour. Pre-diluted kit antibody was also incubated for 1 hour. 
Absorbance was measured at 630 nm using an ELx800 Universal Microplate Reader (Bio-Tek). 
Samples were run in duplicate and the average was calculated for further analysis. To control for 
inter-assay variation, an ELISA value was calculated based on the equation: (sample mean - 
negative control)/(positive control - negative control). 
 
A1.3. Results 
Using mixed general linear model (JMP 8.0, SAS Institute), there was no significant effect of 
species on antibodies (F1,6.9 = 0.30; P = 0.60) nor the interaction of species and days post-
infection on antibodies (F1,31.1 = 0.01; P = 0.91). However, the number of days post-infection 
was statistically significant for antibody levels (F1,31.1 = 10.8, P = 0.0025), indicating that this 
measure of infection varied with time post-infection.  
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Fig. A1.1. Serum antibody ELISA values for house finches (HOFI) and domestic canaries 
(DOCA) following experimental inoculation with MG. The dotted line indicates an approximate 
cut-off value (0.0229). The cut-off value (2.5 standard deviations above the mean) was 
determined using ELISA values from 108 uninfected house finches that tested negative for MG 
by qPCR (J. Grodio & D. Hawley, unpublished results).  
 
A1.4. Discussion 
Antibody responses in our study were measured using a modified protocol of a commercially 
available IDEXX kit designed for detecting MG-specific antibodies in chicken sera. This kit has 
been successfully used in house finches for detecting MG-specific IgA antibodies in the lacrimal 
fluid (Grodio et al. 2009). To detect house finch serum antibodies, we introduced several 
modifications to the IDEXX protocol that were aimed at increasing the sensitivity of the test 
(e.g., using less dilute sera). We have consistently observed elevated optical densities after 
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experimental infection of house finches with MG (J. Grodio, unpublished); thus, the kit reagent 
specific for chicken immunoglobulin cross-reacts with house finch immunoglobulin. The results 
of this study show that the reagent also cross-reacts with canary immunoglobulin. Although the 
mean optical densities for canaries were lower on average than for house finches, serological 
responses did not differ statistically between the two songbird species. Larger sample sizes are 
needed in order to determine whether the sensitivity or specificity of the IDEXX kit differs 
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A2.1. Introduction 
In Chapter 7, I show that MG undergoes antigenic variation of the VlhA surface protein during 
infection of several birds inoculated with MG isolates NC2006 and NC1995. This appendix 
shows that bird 142, inoculated with NC2006, and bird 153, inoculated with NC1995, develop 
antibodies to approximately fourteen MG proteins. Using serum and tear samples from bird 142, 
Western blot shows that antibodies present in the serum and tears are specific for a similar array 




House finches 142 and 153 were inoculated via ocular route by application of inoculum 
(NC2006 and NC1995, respectively) as detailed in Chapter 7.  
 
MG protein sources 
Post-inoculation MG isolates were collected as detailed in Chapter 7. Briefly, conjunctival swabs 
were collected from birds at 7, 9, and 12 weeks (days 49, 63, and 87) post-inoculation. Swabs 
were placed in transport media and MG cultures were expanded to obtain enough protein for use 
in Western blotting. Proteins were extracted and measured as detailed in Chapter 7.  
 
Serum and tear samples 
Blood samples were collected pre-inoculation and at 7, 9, and 12 weeks (days 49, 63, and 87) 
post-infection. Tear samples utilized in the Western blots were collected at weeks 7 and 9 post-
infection (see Chapter 7 for details). 
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Immunoblots 
SDS-PAGE was performed as per Grodio et al. (2012, Chapter 6) and Grodio et al. (submitted, 
Chapter 7) using 2 µg of MG protein per lane. After transfer to nitrocellulose, individual lanes 
were cut from the blot and blocked using 5% non-fat dry milk. After washing, the blots were 
then incubated with sera (diluted 1:200) or tears (approximately 0.6 uL tears per blot) of 
inoculated house finches. After incubation, the blots were washed. The blots that were incubated 
with house finch serum were then incubated with goat anti-bird IgG-HRP (Bethyl Laboratories, 
Montgomery, TX), diluted 1:60,000 in blocking buffer for 1 h at room temperature. The blots 
that were incubated with tears were then incubated with anti-house finch IgA used at 1:1000 (1.5 
hrs; Grodio et al. 2009), and followed by incubation with goat anti-rabbit IgG-HRP (Bethyl) 
diluted 1:30,000. Blots were washed and SuperSignal WestPico Chemiluminescence substrate 
(Thermo Scientific) was applied. The blots were covered with plastic wrap and exposed to film 
(Amersham Hyperfilm ECL) in a dark room. 
 
A2.3. Results and discussion 
The immunoblots shown in Fig. A2.1 demonstrate that house finches develop antibodies to 
approximately fourteen MG proteins. As expected, the pre-inoculation sera showed no antibodies 
to MG proteins. Although the array of MG proteins recognized by house finch antibodies seems 
rather constant after infection, Figs. 7.3 and 7.4 (described in Chapter 7) illustrate that VlhA 
expression is changing in these two individuals. 
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Fig. A2.1. Immunoblots of Mycoplasma gallisepticum (MG) proteins incubated with house finch 
sera. Protein samples (2 µg) of MG isolate NC2006 or NC1995 were separated by size using 
SDS-PAGE. MG protein 0 = inoculum, 7, 9, 12 = post-inoculation MG cultures from 
conjunctival swabs of birds at 7, 9, and 12 weeks post-inoculation. House finch serum 0 = pre-
inoculation, 2, 7, 9, 12 = weeks post-inoculation. 
 
 
Using serum and tear samples from bird 142, Fig. A2.2 shows that MG-specific serum IgY and 
tear IgA antibodies have very similar patterns on Western blot, demonstrating that serum 
antibodies likely provide a good representation of local antibody response. This result also 
suggests that collection of lachrymal fluid has the potential to be a less-invasive method to test 
for MG-specific antibodies compared to blood collection, although a larger sample size would be 
necessary to confirm these conclusions.  
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Fig. A2.2. Immunoblots of Mycoplasma gallisepticum (MG) proteins incubated with house finch 
(bird 142) sera and lachrymal fluid. Bird 142 was inoculated with NC2006. MG protein source: 0 
= inoculum, 7, 9 = post-inoculation MG cultures from conjunctival swabs at 7 and 9 weeks post-
inoculation. Serum/tear samples: 0 = pre-inoculation, 7, 9 = MG-specific serum (IgY) and tear 









	   141 	  
REFERENCES 
 
Adelman, J.S., Kirkpatrick, L., Grodio, J.L., and D.M. Hawley. In press. House finch populations 
differ in early inflammatory signalling and pathogen tolerance at the peak of Mycoplasma 
infection. The American Naturalist.  
 
Adler, H.E., Ortmayer, H., and D.A. McMartin. 1962. Effect of infectious bronchitis virus on 
chickens infected with Mycoplasma gallisepticum. Avian Diseases. 6: 267-274. 
 
Adler, H.E., Bryant, B.J., Cordy, D.R., Shifrine, M., and A.J. DaMassa. 1973. Immunity and 
mortality in chickens infected with Mycoplasma gallisepticum: influence of the bursa of 
Fabricius. Journal of Infectious Diseases. 127: S61-66. 
 
Albini, B., Wick, G., Rose, E., and E. Orlans. 1974. Immunoglobulin production in chicken 
Harderian glands. International Archives of Allergy and Immunology. 47: 23-34. 
 
Altizer, S., Davis, A.K., Cook, K.C., and J.J. Cherry. 2004. Age, sex, and season affect the risk 
of mycoplasmal conjunctivitis in a southeastern house finch population. Canadian 
Journal of Zoology. 82: 755-763. 
 
Avakian, A.P. , and S.H. Kleven. 1990. The humoral immune response of chickens to 
Mycoplasma gallisepticum and Mycoplasma synoviae studied by immunoblotting. 
Veterinary Microbiology. 24: 155-169. 
 
Avakian, A.P., and D.H. Ley. 1993. Protective immune response to Mycoplasma gallisepticum  
demonstrated in respiratory-tract washings from M. gallisepticum-infected chickens. 
Avian Diseases. 37: 697-705. 
 
Baba, T., Masumoto, K., Nishida, S., Kajikawa, T., and M. Mitsui. 1988. Harderian gland  
dependency of immunoglobulin A production in the lacrimal fluid of chicken.  
Immunology. 65: 67-71. 
 
Bai, R.K., Perng, C.L., Hsu, C.H., and L.J.C. Wong. 2004. Quantitative PCR analysis of  
mitochondrial DNA content in patients with mitochondrial disease. Annals New York  
Academy of Sciences. 1011: 304-309. 
 
Balish, M.F., and D.C. Krause. 2005. Mycoplasma attachment organelle and cell division. In:  
Mycoplasmas: Molecular Biology, Pathogenicity and Strategies for Control.  
A. Blanchard and G. Browning (eds.). Norfolk, U.K.: Horizon Biosciences, 189-237. 
 
Balenger, S.L. 2011. Evolution of pathogen-induced gene expression of the house finch,  
Carpodacus mexicanus. PhD thesis. Auburn University.  
 
 
	   142 	  
Bang, B., and F.B. Bang. 1968. Localized lymphoid tissues and plasma cells in paraocular and  
paranasal organ systems in chickens. American Journal of Pathology. 53: 735-751.  
 
Barbour, E.K., Newman, J.A., Sivanandan, V., and J. Sasipreeyajan. 1988. New Biotin- 
conjugated antisera for quantitation of Mycoplasma gallisepticum-specific 
immunoglobulin A in chicken. Avian Diseases. 32: 416-420. 
 
Baseggio, N., Glew, M.D., Markham, P.F., Whithear, K.G., and G.F. Browning. 1996. Size and  
genomic location of the pMGA multigene family of Mycoplasma gallisepticum.  
Microbiology. 142: 1429-1435. 
 
Bebear, C.M., and I. Kempf. 2005. Antimicrobial therapy and antimicrobial resistance.  
Mycoplasmas: Molecular Biology, Pathogenicity and Strategies for Control. A.  
Blanchard and G. Browning (eds.). Norfolk, U.K.: Horizon Bioscience, 535-568.  
 
Bencina, D., and D. Dorrer. 1984. Demonstration of Mycoplasma gallisepticum in tracheas of  
healthy carrier chickens by fluorescent-antibody procedure and the signficance of certain  
serologic tests in estimating antibody response. Avian Diseases. 28: 574-578. 
 
Bencina, D., Mrzel, I., Svetlin, A., Dorrer, D., and T. Tadina-Jaksic. 1991. Reactions of chicken  
biliary immunoglobulin A with avian mycoplasmas. Avian Pathology. 20: 303-313. 
 
Bencina, D. 2002. Haemagglutinins of pathogenic avian mycoplasmas. Avian Pathology. 31: 
535-547. 
 
Bodhankar, S., Sun, X.L., Woolard, M.D., and J.W. Simecka. 2010. Interferon gamma and 
interleukin 4 have contrasting effects on immunopathology and the development of 
protective adaptive immunity against mycoplasma respiratory disease. Journal of 
Infectious Diseases. 202: 39-51. 
 
Bonneaud, C., Balenger, S.L., Russell, A.F., Zhang, J., Hill, G.E., and S.V. Edwards. 2011. 
Rapid evolution of disease resistance is accompanied by functional changes in gene 
expression in a wild bird. Proceedings of the National Academy of Sciences. 108: 7866-
7871.  
 
Bonneaud, C., Balenger, S.L., Zhang, J., Edwards, S.V., and G.E. Hill. 2012. Innate immunity 
and the evolution of resistance to an emerging infectious disease in a wild bird. 
Molecular Ecology. 21, 2628-2639. 
 
Bouwman, K.M., and D.M Hawley. 2010. Sickness behaviour acting as an evolutionary trap? 
Male house finches preferentially feed near diseased conspecifics. Biology Letters. 6: 
462-465.  
 
Bradbury, J.M. 2005. Poultry mycoplasmas: sophisticated pathogens in simple guise. British 
Poultry Science. 46: 125-136. 
 
	   143 	  
Browning, G.F., Marenda, M.S., Noormohammadi, A.H., and P.F. Markham. 2011. The central  
role of lipoproteins in the pathogenesis of mycoplasmoses. Veterinary Microbiology.  
153: 44-50. 
 
Callison, S.A., Riblet, S.M., Sun, S., Ikuta, N., Hilt, D., Leiting, V., Kleven, S.H., Suarez, D.L.,  
and M. Garcia. 2006. Development and validation of a real-time Taqman polymerase  
chain reaction assay for the detection of Mycoplasma gallisepticum in naturally infected 
birds. Avian Diseases. 50: 537-544. 
 
Carli, K.T., and A. Eyigor. 2003. Real-time polymerase chain reaction for detection of  
Mycoplasma gallisepticum in chicken trachea. Avian Diseases. 47: 712-717. 
 
Cartner, S.C., Lindsey, J.R., Gibbs-Erwin, J., Cassell, G.H., and J.W. Simecka. 1998. Roles of 
innate and adaptive immunity in respiratory mycoplasmosis. Infection and Immunity. 66: 
3485-3491. 
 
Casabianca, A., Orlandi, C., Fraternale, A., and M. Magnani. 2004. Development of a real-time  
PCR assay using SYBR Green I for provirus load quantification in a murine model of  
AIDS. Journal of Clinical Microbiology. 42: 4361-4364. 
 
Chen, H., Yu, S., Hu, M., Han, X., Chen, D., Qiu, X., and C. Ding. 2012. Identification of  
biofilm formation by Mycoplasma gallisepticum. Veterinary Microbiology. 161: 96-103.  
 
Chhabra, P.C., and M.C. Goel. 1981. Immunological response of chickens to Mycoplasma  
gallisepticum infection. Avian Diseases. 25: 279-293. 
 
Cherry, J.J., Ley, D.H., and S. Altizer. 2006. Genotypic analyses of Mycoplasma gallisepticum 
isolates from songbirds by random amplification of polymorphic DNA and amplified-
fragment length polymorphism. Journal of Wildlife Diseases. 42: 421-428. 
 
Chin, R.P., Daft, B.M., Meteyer, C.U., and R. Yamamoto. 1991. Meningoencephalitis in 
commerical meat turkeys associated with Mycoplasma gallisepticum. Avian Diseases. 35: 
986-993. 
 
Citti, C., Browning, G.F., and R. Rosengarten. 2005. Phenotypic diversity and cell invasion.  
Mycoplasmas: Molecular Biology, Pathogenicity and Strategies for Control.  
A. Blanchard and G. Browning (eds.). Norfolk, U.K.: Horizon Biosciences, 439-483. 
 
Cole, B.C., and C.L. Atkin. 1991. The Mycoplasma arthritidis T-cell mitogen, MAM - a model  
superantigen. Immunology Today. 12: 271-276. 
 
Cushing, T.L., Schat, K.A., States, S.L., Grodio, J.L., O’Connell, P.H., and E.L. Buckles. 2011.  
Characterization of the host response in systemic Isosporosis (Atoxoplasmosis) in a  
colony of captive American goldfinches (Spinus tristis) and house sparrows (Passer  
domesticus). Veterinary Pathology. 48: 985-992.  
 
	   144 	  
Davis, A.K. 2010. Mycoplasmal conjunctivitis in house finches (Carpodacus mexicanus) is more  
severe in left eyes than right. Avian Biology Research. 3: 153-156. 
 
Davison, F., Magor, K.E., and B. Kaspers. 2008. Structure and evolution of avian  
immunoglobulins. Avian Immunology. F. Davison, B. Kaspers and K.A. Schat (eds.).  
London: Elsevier/Academic Press, 107-127. 
 
Delany, M.E. 2000. Patterns of ribosomal gene variation in elite commercial chicken pure line  
populations. Animal Genetics. 31: 110-116. 
 
Dhondt, A.A., Tessaglia, D.L., and R.L. Slothower. 1998. Epidemic mycoplasmal conjunctivitis 
in house finches from Eastern North America. Journal of Wildlife Diseases. 34: 265-280. 
 
Dhondt, A.A., Badyaev, A.V., Dobson, A.P., Hawley, D.M., Driscoll, M.J.L., Hochachka, W.M., 
and D.H. Ley. 2006. Dynamics of mycoplasmal conjunctivitis in the native and 
introduced range of the host. EcoHealth. 3: 95-102. 
 
Dhondt, A.A., Dhondt, K.V., Hawley, D.M., and C.S. Jennelle. 2007a. Experimental evidence 
for transmission of Mycoplasma gallisepticum in house finches by fomites. Avian 
Pathology. 36: 205-208. 
 
Dhondt, K.V., Dhondt, A.A., and D.H. Ley. 2007b. Effects of route of inoculation on 
Mycoplasma gallisepticum infection in captive house finches. Avian Pathology. 36: 475-
479. 
 
Dhondt, A.A., Dhondt, K.V., and B.V. McCleery. 2008. Comparative infectiousness of three 
passerine bird species after experimental inoculation with Mycoplasma gallisepticum. 
Avian Pathology. 37: 635-640.  
 
Dhondt, A.A., States, S.L., Dhondt, K.V., and K.A. Schat. 2012. Understanding the origin of 
seasonal epidemics of mycoplasmal conjunctivitis. Journal of Animal Ecology. 81: 996-
1003.  
 
Dhondt, A.A. Dhondt, K.V., Hochachka, W.M., and Karel A. Schat. 2013. Can American 
goldfinches function as reservoirs for Mycoplasma gallisepticum? Journal of Wildlife 
Diseases. 49: 49-54.  
 
Dingfelder, R.S., Ley, D.H., McLaren, J.M., and C. Brownie. 1991. Experimental infection of  
turkeys with Mycoplasma gallisepticum of low virulence, transmissibility, and 
immunogenicity. Avian Diseases. 35: 910-919. 
 
Donnelly, T.M. 2004. Disease problems of small rodents. Ferrets, Rabbits, and Rodents: 
Clinical Medicine and Surgery, 2nd edition. K.E. Quesenberry and J.W. Carpenter (eds.). 
St. Louis, Missouri: Saunders, 299-315. 
 
	   145 	  
Elliot, J.J. and R.S. Arbib, Jr. 1953. Origin and status of the house finch in the eastern United 
States. The Auk. 70: 31-37. 
 
Farmer, K.L., Hill, G.E., and S.R. Roberts. 2002. Susceptibility of a naive population of house 
finches to Mycoplasma gallisepticum. Journal of Wildlife Diseases. 38: 282-286. 
 
Farmer, K.L., Hill, G.E., and S.R. Roberts. 2005. Susceptibility of wild songbirds to the house 
finch strain of Mycoplasma gallisepticum. Journal of Wildlife Diseases. 41: 317-325. 
 
Fay, M.P., and P.A. Shaw. 2010. Exact and asymptotic weighted logrank tests for interval 
censored data: the interval R package. Journal of Statistical Software. 36: 1-34. 
 
Forsyth, M.H., Tully, J.G., Gorton, T.S., Hinckley, L., Frasca, Jr., S., Van Kruiningen, H.J., and 
S.J. Geary. 1996. Mycoplasma stumi sp. nov., from the conjunctiva of a European starling 
(Sturnus vulgaris). International Journal of Systemic Bacteriology. 46: 716-719. 
 
Garcia, M., Ikuta, N., Levisohn, S., and S.H. Kleven. 2005. Evaluation and comparison of  
various PCR methods for detection of Mycoplasma gallisepticum infection in chickens.  
Avian Diseases. 49: 125-132. 
 
Gaunson, J.E., Philip, C.J., Whithear, K.G., and G.F. Browning. 2006. The cellular immune 
response in the tracheal mucosa to Mycoplasma gallisepticum in vaccinated and 
unvaccinated chickens in the acute and chronic stages of disease. Vaccine. 24: 2627-
2633. 
 
Gharaibeh, S., and A. Hailat. 2011. Mycoplasma gallisepticum experimental infection and tissue 
distribution in chickens, sparrows and pigeons. Avian Pathology. 40: 349-154.  
 
Glew, M.D., Markham, P.F., Browning, G.B., and I.D. Walker. 1995. Expression studies on four 
members of the pMGA multigene famiy in Mycoplasma gallisepticm strain S6. 
Microbiology. 141: 3005-3014.  
 
Glew, M.D., Baseggio, N., Markham, P.F., Browning, G.F., and I.D. Walker. 1998. Expression 
of the pMGA genes of Mycoplasma gallisepticum is controlled by variation in the GAA 
trinucleotide repeat lengths within the 5’ noncoding regions. Infection and Immunity. 66: 
5833-5841. 
 
Glew, M.D., Browning, G.F., Markham, P.F., and I.D. Walker. 2000. pMGA phenotypic 
variation in Mycoplasma gallisepticum occurs in vivo and is mediated by trinucleotide 
repeat length variation. Infection and Immunity. 68: 6027-6033. 
 
Goh, M.S., Gorton, T.S., Forsyth, M.H., Troy, K.E., and S.J. Geary. 1998. Molecular and  
biochemical analysis of a 105 kDa Mycoplasma gallisepticum cytadhesin (GapA).  
Microbiology. 144: 2971-2978.  
 
	   146 	  
Gorton, T.S., and S.J. Geary. 1997. Antibody-mediated selection of a Mycoplasma gallisepticum 
phenotype expressing variable proteins. FEMS Microbiology Letters. 155: 31-38. 
 
Grodio, J.L., Dhondt, K.V., O'Connell, P.H., and K.A. Schat. 2008. Detection and quantification 
of Mycoplasma gallisepticum genome load in conjunctival samples of experimentally 
infected house finches (Carpodacus mexicanus) using real-time polymerase chain 
reaction. Avian Pathology. 37: 385-391. 
 
Grodio, J.L., Buckles, E.L., and K.A. Schat. 2009. Production of house finch (Carpodacus 
mexicanus) IgA specific anti-sera and its application in immunohistochemistry and in 
ELISA for detection of Mycoplasma gallisepticum-specific IgA. Veterinary Immunology 
and Immunopathology. 132: 288-294. 
 
Grodio, J.L., Hawley, D.M., Osnas, E.E., Ley, D.H., Dhondt, K.V., Dhondt, A.A., and K.A.  
Schat. 2012. Pathogenicity and immunogenicity of three Mycoplasma gallisepticum  
isolates in house finches (Carpodacus mexicanus). Veterinary Microbiology. 155: 53-61. 
 
Groth, J.G., and G.F. Barrowclough. 1999. Basal divergences in birds and the phylogenetic  
utility of the nuclear RAG-1 gene. Molecular Phylogenetics and Evolution. 12: 115-123. 
 
Hartup, B.K., Kollias, G.V., and D.H. Ley. 2000. Mycoplasmal conjunctivitis in songbirds from 
New York. Journal of Wildlife Diseases. 36: 257-264. 
 
Hartup, B.K., Dhondt, A.A., Sydenstricker, K.V., Hochachka, W.M., and G.V. Kollias. 2001. 
Host range and dynamics of mycoplasmal conjunctivitis among birds in North America. 
Journal of Wildlife Diseases. 37: 72-81. 
 
Hawley, D.M., Davis, A.K., and A.A. Dhondt. 2007a. Transmission-relevant behaviours shift 
with pathogen infection in wild house finches (Carpodacus mexicanus). Canadian 
Journal of Zoology. 85: 752-757. 
 
Hawley, D.M., Jennelle, C.S., Sydenstricker, K.V., and A.A. Dhondt. 2007b. Pathogen resistance 
and immunocompetence covary with social status in house finches (Carpodacus 
mexicanus). Functional Ecology. 21: 520-527. 
 
Hawley, D.M., Dhondt, K.V., Dobson, A.P., Grodio, J.L., Hochachka, W.M., Ley, D.H., Osnas, 
E.E., Schat, K.A., and A.A. Dhondt. 2010. Common garden experiment reveals pathogen 
isolate but no host genetic diversity effect on the dynamics of an emerging wildlife 
disease. Journal of Evolutionary Biology. 23: 1680-1688. 
 
Hawley, D.M., Grodio, J., Frasca, S., Kirkpatrick, L., and D.H. Ley. 2011. Experimental 
infection of domestic canaries (Serinus canaria domestica) with Mycoplasma 




	   147 	  
Hawley, D.M. and R.C. Fleischer. 2012. Contrasting epidemic histories reveal pathogen- 
mediated balancing selection on class II MHC diversity in a wild songbird. PLoS ONE: 
7. 
 
Hawley, D.M., Osnas, E.E., Dobson, A., Hochachka, W., Ley, D.H., and A.A. Dhondt.  
Parallel evolution of increased virulence in a recently emerged wildlife pathogen.  
In preparation. 
 
Hill, G.E. 1993. House Finch (Carpodacus mexicanus), The Birds of North America Online.  
A. Poole (ed.). Ithaca: Cornell Lab of Ornithology; Retrieved from The Birds of North  
America Online: http://bna.birds.cornell.edu/bna/species/046. 
 
Hnatow, L.L., Keeler, C.L., Tessmer, L.L., Czymmek, K., and J.E. Dohms. 1998.  
Characterization of MGC2, a Mycoplasma gallisepticum cytadhesin with homology to  
the Mycoplasma pneumoniae 30-kilodalton protein P30 and Mycoplasma genitalium P32.  
Infection and Immunity. 66: 3436-3442. 
 
Hochachka, W.M., and A.A. Dhondt. 2000. Density-dependent decline of host abundance 
resulting from a new infectious disease. Proceedings of the National Academy of 
Sciences of the U.S.A. 97: 5303-5306. 
 
Hurtado, P.J. 2012a. Infectious disease ecology immune-pathogen dynamics, and how trophic  
interactions drive predator-prey-disease dynamics. PhD thesis. Cornell University. 
 
Hurtado, P.J. 2012b. Within-host dynamics of mycoplasma infection: conjunctivitis in wild  
passerine birds. Journal of Theoretical Biology. 306: 73-92.  
 
Jarosinski, K.W., Yunis, R., O’Connell, P.H., Markowski-Grimsrud, C.J., and K.A. Schat. 2002.  
Influence of genetic resistance of the chicken and virulence of Marek’s disease virus  
(MDV) on nitric oxide responses after MDV infection. Avian Diseases. 46: 636-649. 
 
Javed, M.A., Frasca, S., Rood, D., Cecchini, K., Gladd, M., Geary, S.J., and L.K. Silbart. 2005. 
Correlates of immune protection in chickens vaccinated with Mycoplasma gallisepticum 
strain GT5 following challenge with pathogenic M. gallisepticum strain R-low. Infection 
and Immunity. 73: 5410-5419. 
 
Jeurissen, S.H.M., and E.M. Janse. 1998. The use of chicken-specific antibodies in veterinary  
research involving three other avian species. The Veterinary Quarterly. 20: 140-143. 
 
Karaca, K., and K.M. Lam. 1989. Role of Harderian glands in resistance against Mycoplasma  
gallisepticum challenge. Research in Veterinary Science. 47: 323-326. 
 
Keeler, C.L. Jr., Hnatow, L.L., Whetzel, P.L., and J.E. Dohms. 1996. Cloning and  
characterization of a putative cytadhesin gene (mgc1) from Mycoplasma gallisepticum.  
Infection and Immunity. 64: 1541-1547. 
 
	   148 	  
Khan, C.M (editor). 2010. The Merck Veterinary Manual. 10th edition. Whitehouse Station, New  
Jersey: Merck & Co.  
 
Khan, M.Z.I., Jahan, M.R., Islam, M.N., Haque, Z., Islam, M.R., and Y. Kon. 2007.  
Immunoglobulin (Ig)-containing plasma cells in the Harderian gland in broiler and native  
chickens of Bangladesh. Tissue and Cell. 39: 141-149. 
 
Kleven, S.H. 1998a. Mycoplasmas in the etiology of multifactorial respiratory disease. Poultry 
Science. 77: 1146-1149. 
 
Kleven, S.H. 1998b. Mycoplasmosis. A Laboratory Manual for the Isolation and Identification 
of Avian Pathogens. D.E. Swayne, J.R. Glisson, M.W. Jackwood, J.E. Pearson and W.M. 
Reed (eds.). Kennett Square, Pennsylvania: American Association of Avian Pathologists, 
74-80. 
 
Kollias, G.V., Sydenstricker, K.V., Kollias, H.W., Ley, D.H., Hosseini, P.R., Connolly, V., and  
A.A. Dhondt. 2004. Experimental infection of house finches with Mycoplasma  
gallisepticum. Journal of Wildlife Diseases. 40: 79-86. 
 
Lam, K.M., and W.Q. Lin. 1984. Resistance of chickens immunized against Mycoplasma 
gallisepticum is mediated by bursal dependent lymphoid-cells. Veterinary Microbiology. 
9: 509-514. 
 
Lauerman, L.H. 1998. Mycoplasma PCR assays. Nucleic acid amplification for diagnosis of 
animal diseases. L.H. Lauerman (ed.). Turkock, California: American Association of 
Veterinary Laboratory Diagnosticians, 41-42. 
 
Levisohn, S., Rosengarten, R., and D. Yogev. 1995. In-vivo variation of Mycoplasma 
gallisepticum antigen expression in experimentally infected chickens. Veterinary 
Microbiology. 45: 219-231. 
 
Ley, D.H., Berkhoff, E., and J.M. McLaren. 1996. Mycoplasma gallisepticum isolated from  
house finches (Carpodacus mexicanus) with conjunctivitis. Avian Diseases. 40: 480-483. 
 
Ley, D.H., Geary, S.J., Berkhoff, J.E., McLaren, J.M., and S. Levisohn. 1998. Mycoplasma 
sturni from blue jays and northern mockingbirds with conjunctivitis in Florida. Journal of 
Wildlife Diseases. 34: 403-406. 
 
Ley, D.H. 2003. Mycoplasma gallisepticum infection. Diseases of Poultry. Y.M. Saif (ed.). 
Ames, Iowa: Iowa State Press, 722-744. 
 
Ley, D.H., Sheaffer, D.S., and A.A. Dhondt. 2006. Further western spread of Mycoplasma  




	   149 	  
Li, Y.P., Bang, D.D., Handberg, K.J., Jorgensen, P.H. and M.F. Zhang. 2005. Evaluation of the  
suitability of six host genes as internal control in real-time RT-PCR assays in chicken  
embryo cell cultures infected with infectious bursal disease virus. Veterinary  
Microbiology. 110: 155-165. 
 
Lin, M.Y., and S.H. Kleven. 1982. Egg transmission of two strains of Mycoplasma gallisepticum  
in chickens. Avian Diseases. 26: 487-495. 
 
Long, E.O., and I.B. Dawid. 1980. Repeated genes in eukaryotes. Annual Review of  
Biochemistry. 49: 727-764. 
 
Lopez-Andreo, M., Lugo, L., Garrido-Pertierra, A., Prieto, M.I., and A. Puyet. 2005.  
Identification and quantification of species in complex DNA mixtures by real-time  
polymerase chain reaction. Analytical Biochemistry. 339: 73-82. 
 
Lundqvist, M.L., Middleton, D.L., Radford, C., Warr, G.W., and K.E. Magor. 2006.  
Immunoglobulins of the non-galliform birds: antibody expression and repertoire in the 
duck. Developmental and Comparative Immunology. 30: 93-100. 
 
Luttrell, M.P., Fischer, J.R., Stallknecht, D.E., and S.H. Kleven. 1996. Field investigation of  
Mycoplasma gallisepticum infections in house finches (Carpodacus mexicanus) from  
Maryland and Georgia. Avian Diseases. 40: 335-341. 
 
Luttrell, M.P., Stallknecht, D.E., Fischer, J.R., Sewell, C.T., and S.H. Kleven. 1998. Natural  
Mycoplasma gallisepticum infection in a captive flock of house finches. Journal of  
Wildlife Diseases. 34: 289-296. 
 
Luttrell, P., and J.R. Fischer. 2007. Mycoplasmosis. Infectious Diseases of Wild Birds.  
N.J. Thomas, D.B. Hunter and C.T. Atkinson (eds.). Ames, Iowa: Blackwell Publishing, 
317-331. 
 
Mansikka, A. 1992. Chicken IgA H chains. Journal of Immunology. 149: 855-861 
 
Markham, P.F., Glew, M.D., Brandon, M.R., Walker, I.D., and K.G. Whithear. 1992. 
Characterization of a major hemagglutinin protein from Mycoplasma gallisepticum. 
Infection and Immunity. 60: 3885-3891. 
 
Markham, P.F., Glew, M.D., Brandon, M.R., Whithear, K.G, and I.D. Walker. 1993. Molecular 
cloning of a member of the gene family that encodes pMGA, a hemagglutinin of 
Mycoplasma gallisepticum. Infection and Immunity. 61: 903-909. 
 
Markham, P.F., Glew, M.D., Sykes, J.E., Bowden, T.R., Pollocks, T.D., Browning, G.F., 
Whithear, K.G., and I.D. Walker. 1994. The organisation of the multigene family which 
encodes the major cell surface protein, pMGA, of Mycoplasma gallisepticum. FEBS 
Letters. 352: 347-352. 
 
	   150 	  
Markham, P.F., Glew, M.D., Browning, G.F., Whithear, K.G., and I.D. Walker. 1998. 
Expression of two members of the pMGA gene family of Mycoplasma gallisepticum 
oscillates and is influenced by pMGA-specific antibodies. Infection and Immunity. 66: 
2845-2853. 
 
Mekkes, D.R., and A. Feberwee. 2005. Real-time polymerase chain reaction for the qualitative  
and quantitative detection of Mycoplasma gallisepticum. Avian Pathology. 34: 348-354. 
 
Meynell, G.G., and E. Meynell. 1970. Quantitative Aspects in Theory and Practice in 
Experimental Bacteriology. Cambridge: Cambridge University Press. 
 
Mikaelian, I., Ley, D.H., Clavaeu, R., Lemieux, M. and J.P. Berube. 2001. Mycoplasmosis in 
evening and pine grosbeaks with conjunctivitis in Quebec. Journal of Wildlife Diseases. 
37: 826-830. 
 
Mueller, A.P., Sato, K, and B. Glick. 1971. The chicken lacrimal gland, gland of harder, caecal 
tonsil, and accessory spleens as sources of antibody-producing cells. Cellular 
Immunology. 2: 140-152. 
 
Naot, Y., Davidson, S., and E.S. Lindenbaum. 1981. Mitogenicity and pathogenicity of 
Mycoplasma pulmonis in rats. 1. Atypical interstitial pneumonia induced by mitogenic 
mycoplasmal membranes. Journal of Infectious Diseases. 143: 55-62. 
 
Ohshima, K., and K. Hiramatsu. 2002. Immunohistochemical localization of three different  
immunoglobulin classes in the Harderian gland of young chickens. Tissue and Cell. 34:  
129-133. 
 
Olah, I., Scott, T.R., Gallego, M., Kendall, C., and B. Glick. 1992. Plasma cells expressing  
immunoglobulins M and A but not immunoglobulin G develop an intimate relationship  
with central canal epithelium in the Harderian gland of the chicken. Poultry Science. 71: 
664-676. 
 
Oliveira, C.A., Telles, L.F., Oliveira, A.G., Kalapothakis, E., Goncalves-Dornelas, H., and  
G.A.B. Mahecha. 2006. Expression of different classes of immunoglobulin in  
intraepithelial plasma cells of the Harderian gland of domestic ducks Anas platyrhynchos.  
Veterinary Immunology and Immunopathology. 113: 257-266. 
 
Papazisi, L., Frasca, S. Jr., Gladd, M., Liao, X., Yogev, D., and S.J. Geary. 2002. GapA and  
CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and  
virulence. Infection and Immunity. 70: 6839-6845. 
 
Papazisi, L., Gorton, T.S., Kutish, G., Markham, P.F., Browning, G.F., Nguyen, D.K., Swartzell, 
S., Madan, A., Mahairas, G., and S.J. Geary. 2003. The complete genome sequence of the 
avian pathogen Mycoplasma gallisepticum strain R-low. Microbiology SGM. 149: 2307-
2316. 
 
	   151 	  
Pillai, S.R., Mays, H.L., Ley, D.H., Luttrell, P., Panangala, V.S., Farmer, K.L., and S.R. Roberts. 
2003. Molecular variability of house finch Mycoplasma gallisepticum isolates as revealed 
by sequencing and restriction fragment length polymorphism analysis of the pvpA gene. 
Avian Diseases. 47: 640-648. 
 
Pinheiro, J., and D. Bates. 2000. Mixed-Effects Models in S and S-Plus. New York: Springer 
Verlag. 
 
Pinheiro, J., Bates, D., DebRoy, S., and D. Sarkar. 2007. nlme: Linear and Nonlinear Mixed 
Effects Models. R Package Version 3, 1-83. 
 
Poveda, J.B., Giebel, J., Flossdorf, J., Meier, J., and H. Kirchhoff. 1994. Mycoplasma buteonis 
sp. nov., Mycoplasma falconis sp.nov., and Mycoplasma gypis sp. nov., three species 
from birds of prey. International Journal of Systemic Bacteriology. 44: 94-98. 
 
R Development Core Team. 2006. R: A Language and Environment for Statistical Computing. 
Vienna, Austria: R Foundation for Statistical Computing.  
 
Razin, S., Yogev, D., and Y. Naot. 1998. Molecular biology and pathogencity of Mycoplasmas.  
Microbiology and Molecular Biology Reviews. 62: 1094-1156. 
 
Roberts, S.R., Nolan, P.M., and G.E. Hill. 2001. Characterization of Mycoplasma gallisepticum 
infection in captive house finches (Carpodacus mexicanus) in 1998. Avian Diseases. 45: 
70-75. 
 
Rocha, E., Sirand-Pugnet, P., and A. Blanchard. 2005. Genome analysis: recombination, repair  
and recombinational hotspots. Mycoplasmas: Molecular Biology, Pathogenicity and  
Strategies for Control. A. Blanchard and G. Browning (eds.). Norfolk, U.K.: Horizon 
Biosciences, 31-73. 
 
Rodriguez, R., and S.H. Kleven. 1980. Pathogenicity of 2 strains of Mycoplasma gallisepticum in 
broilers. Avian Diseases. 24: 800-807. 
 
Sanei, B., Barnes, H.J., Vaillancourt, J.P., and D.H. Ley. 2007. Experimental infection of 
chickens and turkeys with Mycoplasma gallisepticum reference strain S6 and North 
Carolina field isolate RAPD type B. Avian Diseases. 51: 106-111. 
 
Schultz, U., and K.E. Magor. 2008. Comparative immunology of agricultural birds. Avian 
Immunology. F. Davison, B. Kaspers and K.A. Schat (eds.). London: Elsevier/Academic 
Press, 395-420. 
 
Shirama, K., Satoh, T., Kitamura, T., and J. Yamada. 1996. The avian Harderian gland: 
morphology and immunology. Microscopy Research and Technique. 34: 16-27.  
 
	   152 	  
Simecka, J.W. 2005. Immune responses following Mycoplasma infection. Mycoplasmas: 
Molecular Biology, Pathogenicity and Strategies for Control. A. Blanchard and G. 
Browning (eds.). Norfolk, U.K.: Horizon Bioscience, 485-534. 
 
Simmons, W.L., and K. Dybvig. 2007. How some Mycoplasmas evade host immune responses: 
variable surface antigen proteins are key for how these microorganims evade host 
immune responses. Microbe. 2: 537-543. 
 
Soeripto, Whithear, K.G., Cottew, G.S., and K.E. Harrigan. 1989a. Immunogenicity of 
Mycoplasma gallisepticum. Australian Veterinary Journal. 66: 73-77. 
 
Soeripto, Whithear, K.G., Cottew, G.S., and K.E. Harrigan. 1989b. Virulence and 
transmissibility of Mycoplasma gallisepticum. Australian Veterinary Journal. 66: 65-72. 
 
Stanbridge, E.J. 1982. Mycoplasma-lymphocyte interactions and their possible role in 
immunopathologic manifestations of mycoplasmal disease. Reveiws of Infectious 
Diseases. 4: S219-S226. 
 
States, S.L. 2012. Infection dynamics in a host-pathogen system. PhD thesis. Cornell University.  
 
Suresh, P., Arp, L.H., and E.L. Huffman. 1994. Mucosal and systemic humoral immune response  
to Bordetella avium in experimentally infected turkeys. Avian Diseases. 38: 225-230. 
 
Sydenstricker, K.V., Dhondt, A.A., Ley, D.H., and G.V. Kollias. 2005. Re-exposure of captive 
house finches that recovered from Mycoplasma gallisepticum infection. Journal of 
Wildlife Diseases. 41: 326-333. 
 
Sydenstricker, K.V., Dhondt, A.A., Hawley, D.M., Jennelle, C.S., Kollias, H.W., and G.V.  
Kollias. 2006. Characterization of experimental Mycoplasma gallisepticum infection in  
captive house finch flocks. Avian Diseases. 50: 39-44. 
 
Szczepanek, S.M., Tulman, E.R., Gorton, T.S., Liao, X., Lu, Z., Zinski, J., Aziz, F., Frasca Jr.,  
S., Kutish, G.F., and S.J. Geary. 2010. Comparative genomic analyses of attenuated  
strains of Mycoplasma gallisepticum. Infection and Immunity. 78: 1760-1771. 
 
Talkington, F.D., and S.H. Kleven. 1985. Evaluation of protection against colonization of the  
chicken trachea following administration of Mycoplasma gallisepticum bacterin. Avian  
Diseases. 29: 998-1003. 
 
Taylor, G., Taylor-Robinson, D., and G.W. Fernald. 1974. Reduction in severity of Mycoplasma  
pneumoniae-induced pneumonia in hamsters by immunosuppressive treatment with  
antithymocyte sera. Journal of Medical Microbiology. 7: 343-348. 
 
Tizard, I. 2002. The avian antibody response. Seminars in Avian and Exotic Pet Medicine. 11:  
2-14. 
 
	   153 	  
Toro, H., Hidalgo, H., and A.N. Collingwood-Selby. 1994. Lachrymal antibody response of  
specific pathogen free chickens and chickens with maternal immunity after infectious  
bronchitis virus vaccination. Preventive Veterinary Medicine. 18: 267-274. 
 
Tulman, E.R., Liao, X., Szczepanek, S.M., Ley, D.H., Kutish, G.F., and S.J. Geary. 2012.  
Extensive variation in surface lipoprotein gene content and genomic changes associated  
with virulence during evolution of a novel North American house finch epizootic strain  
of Mycoplasma gallisepticum. Microbiology. 158: 2073-2088. 
 
Vogl, G., Plaickner, A., Szathmary, S., Stipkovits, L., Rosengarten, R., and M.P. Szostak. 2008.  
Mycoplasma gallisepticum invades chicken erythrocytes during infection. Infection and  
Immunity. 76: 71-77. 
 
Waites, K., and D. Talkinton. 2005. New developments in human diseases due to Mycoplasmas.  
Mycoplasmas: Molecular Biology, Pathogenicity, and Strategies for Control. A.  
Blanchard and G. Browning (eds.). Norfold, U.K.: Horizen Bioscience, 289-354. 
 
Weinstock, D., and K.A. Schat. 1987. Virus specific syngeneic killing of reticuloendotheliosis  
virus transformed cell line target cells by spleen cells. Avian Immunology. W.T. Weber 
and D.L. Ewert (eds.). New York: Alan R. Liss, 253-263. 
 
Wellehan, J.F.X., Calsaminglia, M., Ley, D.H., Zens, M.S., Amonsin, A., and V. Kapur. 2001.  
Mycoplasmosis in captive crows and robins from Minnesota. Journal of Wildlife  
Diseases. 37: 547-555.  
 
Williamson, J.S.P., Davis, J.K., and G.H. Cassell. 1986. Polyclonal activation of rat splenic 
lymphocytes after in vivo administration of Mycoplasma pulmonis and its relation to in 
vitro response. Infection and Immunity. 52: 594-599. 
 
Winner, F., Rosengarten, R., and C. Citti. 2000. In vitro cell invasion of Mycoplasma  
gallisepticum. Infection and Immunity. 68: 4238-4244. 
 
Yagihashi, T., and M. Tajima. 1986. Antibody responses in sera and respiratory secretions from 
chickens infected with Mycoplasma gallisepticum. Avian Diseases. 30: 543-550. 
 
Zhang, Q.J., and K.S. Wise. 2001. Coupled phase-variable expression and epitope masking of 
selective surface lipoproteins increase surface phenotypic diversity in Mycoplasma 
hominis. Infection and Immunity. 69: 5177-5181. 	  
 
 
 
 
